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ABSTRACT 
 Precise electrochemical signaling is essential for neural network computation. 
Over the past century, we have learned much about the links between behavior and the 
activity patterns of specific neurons. The development of optogenetic tools to control and 
monitor specific neurons in the living brain has enabled the causal analysis of neuron 
populations with unique genetic identity in brain computation. In this thesis, we 
developed a novel genetically encoded voltage indicator (GEVI), SomArchon, for optical 
voltage recording in behaving mice, and assembled a viral toolbox of genetically encoded 
synaptic tags. Overall, these novel genetically encoded tools will facilitate the study of 
synaptic wiring and neural activity in a wide variety of neuroscience applications. 
Optical voltage imaging enables the monitoring of neural activity with 
millisecond temporal precision and cellular resolution. However, current state-of-the-art 
GEVIs only report spiking activity in 1-2 cells simultaneously in vivo. We developed a 
soma-localized GEVI, SomArchon, compatible with optogenetic control and capable of 
reporting subthreshold and spiking activity in populations of individual neurons in awake 
mice. We found that highly coherent subthreshold activity does not govern highly 
coherent spike outputs in neighboring neurons. Overall, SomArchon outperforms existing 
 
 viii 
sensors and enables in vivo population voltage imaging suitable for a diversity of 
neuroscience experiments. 
Synaptic labeling is important in understanding the wiring of neural circuits or the 
synaptic changes involved in development, plasticity, and disease. Fibronectin 
intrabodies generated with mRNA display (FingRs) are genetically encoded fluorescent 
synaptic labels that do not alter synaptic transmission. Here, we generated a set of adeno-
associated virus (AAV) FingR variants for labeling of excitatory or inhibitory synapses in 
multiple brain regions, and in specific cell types in cre-transgenic mice. We optimized a 
red synaptic tag for inhibitory synapses that allowed for dual labeling of both excitatory 
and inhibitory synapses in the same cells. Finally, we generated FingR retroviruses and 
tracked synaptic development of adult born hippocampal granule cells. These AAV and 
retrovirus variants label excitatory or inhibitory synapses in specific cell types and 
provide a comprehensive viral toolbox for multi-color, cell type specific synaptic 
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CHAPTER ONE: INTRODUCTION 
1.1 SIGNIFICANCE 
Neurological disorders affect almost 1 billion people worldwide and account for 
almost 7 million deaths1. Millions of people currently suffer from Alzheimer’s Disease; 
there are over 50,000 new cases of Parkinson’s Disease in the United States each year; 
and almost 1 in 4 people suffer from mental disorders2. Furthermore, neurological 
diseases are among the most expensive to treat, partially due to a lack of therapies, and 
also because patients can still live for many years following disease onset. Although there 
is a large, lucrative market for drugs and treatments for neurological diseases, many 
pharmaceutical companies are reluctant to invest too much money in this market due to 
the lack of successful neurological drugs3,4. One of the biggest reasons for this lack of 
treatments is that there is still so much basic information about the brain that is unknown. 
In order to better understand these disorders and how to treat them, it is important to 
understand the underlying neural circuits.  For this reason, it is extremely important to 
continue to develop new tools to probe brain function and continue to learn how neural 
circuits work.  
1.2 BASIC BACKGROUND ON NEURAL CIRCUITS 
Neurons are the main cell type in the brain responsible for performing neural 
computation. There are two major neuron populations, excitatory cells and inhibitory 
cells. An excitatory neuron will excite downstream cells, whereas inhibitory neurons 
inhibit downstream cells. Each neuron consists of a cell body or soma, dendrites, and an 




the cell body where all signals are processed. If the electrical signal received at the cell 
body raises the membrane potential from its resting potential, near -70mV, above a 
certain threshold, roughly -55mV, the cell will fire an action potential5. This is an all or 
nothing event where the cell membrane potential will rapidly depolarize, reaching close 
to +30mV, before quickly repolarizing back to the membrane potential, all within a few 
milliseconds5. The action potential will propagate down the axon and excite or inhibit the 
downstream neurons on which the given neuron forms synaptic connections.  
Synapses are the junctions between neurons where the axon of one neuron 
contacts the dendrite of another neuron. The neuron sending the information (axon side) 
is considered the presynaptic side, and the neuron receiving the signal (dendrite side) is 
termed the postsynaptic side. Therefore, the flow of information is from presynaptic to 
postsynaptic terminal. Generally, an action potential reaches the axon terminal and 
triggers an influx of calcium through voltage gated ion channels. This indirectly leads to 
the release of synaptic vesicles containing excitatory or inhibitory neurotransmitters 
across the synaptic cleft where the neurotransmitters will diffuse and bind to receptors on 
the postsynaptic neuron. These neurotransmitter receptors will convert this chemical 
signal into an electrical signal and depolarize or hyperpolarize the dendrites.  
In order to further understand neural circuitry, we need to know 1) how neurons 
communicate with each other (neural activity), and 2) how neurons are connected to one 
another (synapses). The development of new tools continues to enable new analysis of 
neural circuits. For instance, different iterations of electrophysiology tools have helped us 




the visualization of neurons on a cellular and molecular level. Now, there has been a 
focus on generating new genetically encoded tools for cell type specific labeling with 
high spatial and temporal resolution. These molecular probes provide a toolbox for 
neuroscientists to trace cells and their connections (green fluorescent protein (GFP) and 
Brainbow), perturb cellular firing (optogenetic rhodopsins), and track neural activity 
(GCaMP)6–10. The sections below will provide a more in-depth background on the history 
of tools for studying neural activity and synaptic connections. 
1.3 TOOLS FOR MONITORING NEURAL ACTIVITY 
1.3.1 Electrophysiology techniques 
Due to the electrical properties of neurons discussed above, it is possible to 
monitor neural activity using electrophysiological methods. The ability to record the 
electrical activity of individual neurons and populations of neurons has revolutionized the 
field of neuroscience. In the 19th century, scientists first discovered changes in the electric 
potential of neurons and the all-or-nothing action potential11. The invention of the 
cathode ray oscilloscope revealed the time course and refractory period of action 
potentials12. The field continued to move forward with the groundbreaking work of 
Hodgkin and Huxley in the 1950’s. It was the ability to hold the voltage constant by 
“voltage clamp” or “space clamp” of the giant squid axon while studying changes in 
current that allowed Hodgkin and Huxley to derive their groundbreaking models13,14. 
These early discoveries paved the way for new, sophisticated ways to probe neural 
activity. Different electrophysiology tools can be used to measure neural activity from the 




differs for each technique, they all exhibit high temporal resolution on the millisecond 
time scale.  
Intracellular recording is the most invasive and spatially precise of these 
techniques. For intracellular recordings, a glass electrode is used to puncture the cell 
membrane and form a tight seal, so the electrode potential reflects the intracellular 
membrane potential15. The whole cell patch clamp technique is commonly used to 
monitor synaptic inputs, cell spiking, or subthreshold oscillations by clamping the voltage 
or current of the neuron15. While intracellular recordings provide the most detailed 
information regarding cellular inputs and outputs, these recordings are very difficult to 
employ and restrict monitoring to single cells or, at most, a few cells for a very skilled 
scientist. These recordings can only be performed for a short time period before losing 
the seal between the electrode and cell membrane, and the technique itself kills the 
neurons once the recording is over16. In addition, intracellular recordings are commonly 
performed in vitro in neuron cultures or in brain slices, but rarely in vivo in the live 
mouse brain. One recent groundbreaking study actually used whole cell patch clamping 
to explore neural spiking and subthreshold oscillations in hippocampal neurons during 
treadmill running17. For the most part, intracellular recordings are plagued by their low 
throughput, short time window, and difficulty to perform in vivo, especially in behaving 
mice. 
Extracellular recording techniques span various spatial scales ranging from the 
recording of single unit activity from individual cells to measuring network activity of 




ability to resolve spiking activity from single neurons, while larger electrodes only have 
the ability to track broad neural dynamics18. When placed in close proximity to a cell, 
microelectrodes can detect the spiking activity of this cell. This is generally termed single 
unit recording. Microelectrode arrays have been developed with hundreds of 
microelectrodes to observe spiking in neural populations. Microelectrode recordings can 
be performed in awake mice, but the spike waveforms are sensitive to any small 
movements in electrode placement. Broader electrodes are not as location sensitive and 
can pick up the spiking activity from multiple neurons at once18. In these multi-unit 
recordings, firing from different units can be separated by the shape of the waveforms, 
and cells closer to the electrode generate a larger amplitude signal19. In addition, because 
electrode position is not as sensitive, it is easier to perform these recordings in freely 
moving mice. However, it is not possible to record synaptic potentials or identify the 
location of individual neurons during multi-unit recordings. With slightly larger 
electrodes placed into the brain, it is possible to record local field potentials, which are 
believed to represent the synaptic inputs to neurons20. Local field potentials cannot 
resolve activity in individual neurons, but rather record the electrical potential of a 
broader brain area on the order of millimeters. These recordings are generally used to 
monitor different oscillation patterns in a brain area. Finally, electroencephalography and 
electrocorticography require electrodes to be placed on the surface of the head, or the 
surface of the brain, respectively, to record broader brain oscillations. These techniques 
are less invasive and can even be used on humans, but do not offer the spatial resolution 




1.3.2 Optical probes of neural activity: Calcium indicators 
More recently, GFP and other fluorescent proteins have been used to engineer 
molecular neural activity sensors21,22. Given the electrical nature of neurons, it was 
natural to try to develop sensors to track the flow of ions across the membrane and track 
changes in voltage. Voltage sensitive probes have existed for decades, but their 
sensitivity was not originally suitable for imaging in brain slices and live animals23. 
However, calcium levels in the neuron change drastically in response to action potentials, 
making calcium sensors a prime candidate for monitoring neural activity. As early as the 
1980’s, several different calcium sensitive dyes were developed to monitor cytosolic 
calcium activity in different cell types24,25. Although these dyes did not have the temporal 
resolution of electrophysiological tools, their spatial resolution was far superior. 
Individual cells could be identified. With optimization, these dyes continued to improve 
and could even be used in the live mouse brain26,27. Longitudinal imaging, especially of 
the same neurons, was one major concern for calcium dyes, because dyes were 
metabolized in the cells within 30 hours of loading28. Another issue was that calcium 
dyes non-specifically labeled neurons, preventing any cell type specific studies29.  
To overcome these two issues, there was considerable effort to develop a 
genetically encoded calcium sensor. The first iterations of genetically encoded calcium 
sensors were fluorescence resonance energy transfer (FRET)-based, and future 
generations utilized a circularly permuted GFP (cpGFP)22,30. Moving the C terminal 
residues of GFP (amino acids 140-238) to the N terminal destabilized the chromophore 




However, conformational changes in the protein restabilize the chromophore and result in 
elevated fluorescence levels. In 2001, the first cpGFP calcium sensor was developed by 
flanking cpGFP with the calmodulin and M13 calcium binding domains22. In response to 
calcium binding, calmodulin and M13 interact with each other and this conformational 
change in the protein sensor stabilizes the GFP chromophore, and thus increases its 
fluorescence. Over the next decade, many groups worked to optimize this calcium sensor, 
mainly through brute force site directed mutagenesis, which finally resulted in the 
GCaMP6 family9,31–33. The GCaMP6 family was the first iteration of genetically encoded 
calcium sensors that outperformed calcium dyes, exhibiting a higher intensity and larger 
signal to noise ratio9. The improved kinetics and increased signal intensity (dF/F) of 
GCaMP6 enabled widespread adoption of calcium imaging for systems level 
neuroscience experiments34–37. For instance, it is possible to simultaneously record neural 
activity from hundreds of neurons in a single viewing window using a simple one photon 
microscope or to even image calcium transients in subcellular compartments such as 
dendritic spines or axon terminals34,35,38. Following the success of GCaMP6, there has 
been increased focus on developing calcium sensors in multiple colors such as red 
(RCaMP, jRGECO) and near infrared (NIR-GECO1)39–42. The most recent generation of 
the GCaMP family, jGCaMP7, demonstrated improvement in the numbers of cells 
imaged and spikes detected over the parent GCaMP6 molecule43. 
While genetically encoded calcium sensors have become widely adopted across 
the neuroscience field, they still have major limitations. The largest issue is that calcium 




reporting individual action potentials, let alone subthreshold membrane oscillations. 
Calcium transients generally occur on the order of tens or hundreds of milliseconds as 
opposed to the millisecond time scale of action potentials. In addition, calcium event 
rates occur by the minute whereas action potentials event rates occur by the second. 
Finally, calcium is a common secondary messenger in the cell, so not all calcium 
transients necessarily reflect neural activity. To overcome this issue, it was necessary to 
develop genetically encoded voltage sensors. 
1.3.3 Optical probes of neural activity: voltage indicators 
While electrophysiology tools have been instrumental in furthering our 
understanding of the electrical properties of the brain on the single cell, multi-unit, and 
field potential levels, neuroscientists have continued developing and employing optical 
techniques for monitoring voltage in order to gain more information on the electrical 
properties of neurons and neural circuitry. Optically measuring voltage would open the 
possibility of monitoring subthreshold membrane potentials and spiking activity in 
populations of neurons with the precision of intracellular patch clamp methods. In 
addition, optical methods would enable the possibility of monitoring voltage in 
subcellular compartments such as dendrites or dendritic spines where it is not possible to 
patch neurons. 
It was first recognized by Cohen et al. in 1968 that light scattering and 
birefringence could be used to optically monitor structural changes in the neuron during 
action potentials44. The first voltage sensitive dyes were used in the 1970’s in the squid 




invertebrates and mammals45–47. Similar to calcium, the limitations of voltage sensitive 
dyes led to the development of genetically encoded voltage sensors. 
Genetically encoded voltage indicators are composed of two main features: a 
membrane-bound voltage sensing domain and a fluorescence reporting domain. The first 
genetically encoded voltage sensor, FlaSh, was developed in 1997 and consisted of a 
fluorescent protein fused to a non-conducting voltage sensitive potassium channel48. 
Voltage fluctuations would alter conformation of the potassium channel, and thus, induce 
changes in the fluorescent protein intensity. Other first generation genetically encoded 
voltage indicators (GEVIs) employed a similar strategy using the voltage sensing 
domains of ion channels fused to a fluorescent protein (SPARC) or a FRET pair (VSFP1) 
which would undergo fluorescence changes in response to voltage fluctuations49,50. 
However, these initial sensors were plagued by poor membrane localization and slow 
kinetics51. The next generation of sensors incorporated voltage sensing domains from 
phosphatases, mainly the Ciona intestinalis voltage-sensitive phosphatase, which was 
first identified in 200552. These new sensors used fluorescence protein fusions (VSFP3.1, 
ArcLight) or FRET pairs (VSFP2.1, VSFP-Butterfly) for detection of voltage changes 
similar to previous sensors53–56. In addition, ASAP1 was the first sensor to incorporate a 
cpGFP, which became destabilized and decreased in fluorescence due to voltage 
transients57. Also, a FRET-based chemigenetic voltage sensor was developed where a 
membrane bound fluorescence protein would interact with the chemical dipicrylamine58–
60. Meanwhile, in 2010, Kralj et al. realized that driving the green-absorbing 




voltage changes61. Deprotonation of the molecule induced changes in the endogenous 
proteorhodopsin fluorescence. Thus, voltage changes could be reported through 
fluorescence. This new molecule was called PROPS and demonstrated the ability to use a 
rhodopsin protein as the voltage sensing domain of new GEVIs61. Future rhodopsin based 
voltage sensors used endogenous fluorescence (Arch, QuasAr1/2, Archon1) or FRET 
(MacQ, Ace2N) as an optical readout of voltage changes62–66. Unlike PROPS, these new 
variants properly localized to the membrane in eukaryotic cells and were also mutated to 
prevent light-induced photocurrents from altering cell physiology. For a more detailed 
overview of all genetically encoded voltage sensors, see refs67,68. 
Many of these early optical voltage sensors were plagued by poor membrane 
localization, slow kinetics, or low voltage sensitivity67,68. Early demonstrations were 
performed in bacteria, Xenopus oocytes and PC12 cells and other non-neuronal cell types 
because early sensors did not localize to the membrane in mammalian cells and did not 
exhibit the low millisecond response times necessary to detect individual action 
potentials49,50. There was no previous demonstration of GEVIs in neurons until the 
development of ArcLight54. Progress continued with the development of ASAP2, which 
could report spikes in live drosophila, and QuasAr2, which reported spiking in 
organotypic and acute mouse brain slices63,69–71. Because QuasAr2 exhibited fluorescence 
in the near-infrared spectrum, it was possible to simultaneously excite neurons with blue 
light stimulation with CheRIFF while recording voltage with QuasAr263,71. This 
arrangement was termed Optopatch. Even after these improvements to GEVIs, it was 




a live mouse until the development of Ace2N-mNeon in 201565. Ace2N is a rhodopsin- 
based FRET sensor that exhibits decreases in fluorescence in response to voltage 
increases. In the original study, 1-2 neurons were monitored simultaneously in the visual 
cortex while the mouse was presented visual gradients65. Although voltage imaging in 
live mice with single neuron, single spike precision has been a longstanding goal in 
neuroscience, Ace2N has still not been widely adopted, likely due to the low throughput 
of recording from 1-2 cells at a time. The widespread adoption of calcium imaging 
coupled with the recent innovations in genetically encoded voltage indicators presents an 
opportunity for in vivo population voltage imaging with single cell, single spike 
precision. These next generation voltage indicators could revolutionize the field of 
neuroscience and our basic understanding of the electrical properties of basic neural 
circuitry. 
1.4 TOOLS FOR SYNAPTIC LABELING 
In addition to tracking neural activity, it is also important to understand the basic 
wiring of neural circuitry. This work has become increasingly prominent in recent 
decades due to the development of new tools, higher throughput techniques, and 
automation, which have enabled bold new projects aspiring to map the whole mouse 
brain connectome72,73. One important factor in mapping the brain connectome and 
understanding neural circuitry is to explore the individual synapses that connect neurons. 
Mapping the whole brain synaptome will be a complementary resource to the 
connectome. The density and size of synapses varies by cell type and within brain 




plasticity related to learning or disease states. 
Although the term ‘synapse’ was not used until Sherrington adopted the name in 
1897, the first recognition of synapses or junctions in the nervous system came back in 
the 2nd and 3rd centuries by Galen and his students74. They recognized that muscles must 
receive nerves from the brain or spinal cord in order to produce movement. It was not 
until the late 18th century that Galvani actually demonstrated electrical conduction 
between nerves and muscles74. The invention of Golgi staining enabled the visualization 
of individual nerve cells, and later, Ramon y Cajal developed the neuron doctrine stating 
that each cell is discrete and that neurons do not actually touch each other75–77. The first 
anatomical data providing evidence and elucidating the basic structure for synapses 
between neurons came in the 1950’s using electron microscopy78.  
Electrophysiology methods and drug studies could be used to probe synaptic 
connectivity, but neither technique can anatomically identify the location or number of 
individual synapses. It has been the new developments in microscopy and molecular 
probes that have improved our basic understanding of synapses. As mentioned 
previously, the electron microscope enabled visualization of individual synapses78. With 
this technique, it was possible to identify the vesicle rich presynaptic terminal of one cell 
adjacent to the densely packed post synaptic density of another cell. Furthermore, 
symmetric and asymmetric synapses could be identified as a way to distinguish inhibitory 
and excitatory synapses79. However, electron microscopy requires technological expertise 
and suffers from low throughput, making it difficult to use across large brain areas. In 




live animals or tissues.  
Although the resolution is poorer, fluorescence microscopy can be used to 
identify fluorescently labeled synapses. While widefield microscopy does not have the 
resolution needed to visualize the 0.1–2µm synapses due to out of focus fluorescence, 
confocal microscopy is commonly used80–82. In confocal microscopy, a field of view is 
scanned and excited with a laser, and the emitted light is collected through a pinhole to 
eliminate out of focus fluorescence. This technique exhibits sub-micron level resolution 
and is sufficient for most synaptic visualization80. Furthermore, superresolution 
techniques are now being used to bypass the diffraction limit and image molecules with 
nanometer precision80,83–85.  
While innovations in microscopy have and continue to improve the imaging 
quality of synapses, the quality of imaging and labeling is also highly dependent on 
molecular synaptic labels. Coons discovered in the early 20th century that antibodies 
conjugated to fluorophores could label specific antigens within cells86. Indirect staining 
methods with primary and secondary antibodies led to multi-color staining, and the 
ability to develop antibodies with predetermined specificity greatly increased the number 
of proteins that could be studied87,88. The specificity and spatial resolution of antibodies 
made them suitable for labeling individual synapses. This is commonly done using 
antibodies that bind to common synaptic proteins. Now, proteomics studies have even 
identified over 1000 different synaptic proteins from the mouse brain89,90. Antibody 
staining is commonly visualized using confocal microscopy, but it is also possible to 




electron microscopy. Furthermore, the development of array tomography has coupled the 
nanometer resolution of electron microscopy with the ability to image a large number of 
antigens and fluorescence91. With this technique, it is possible to label and then re-label 
brain tissue with different antibodies, enabling the high-resolution imaging of tens of 
different synaptic proteins. However, all electron microscopy or antibody labeling 
methods require tissue fixation, which prevents imaging of live specimens, and cell type 
specific labeling is impossible.  
1.4.1 Genetically Encoded Synaptic Probes 
Genetically encoded tools overcome both of these issues. First, they can be 
expressed in live cells, tissues, or animals and be imaged over weeks or months. In 
addition, cell type specific expression can be achieved using different promoters, 
enhancers, viral serotypes, or other genetic expression systems such as cre-lox29. GFP 
forms the basis for most genetically encoded labeling or sensing methods. Expressing 
GFP in individual neurons illustrates the cell morphology including the dendritic tree, 
cell body, and axons. In several studies, GFP labeled neurons have been used to quantify 
excitatory synapses. GFP labeling makes it possible to identify individual dendritic 
spines, and these spines serve as proxies for excitatory synapses92,93. Yet, this method 
prevents the detection of inhibitory synapses which occur primarily on dendritic shafts, 
and it does not work for aspiny cell types such as cholinergic interneurons81,94. In 
addition, diluted GFP labeling can be used to identify axon boutons95. Techniques such as 
Brainbow can be used in a similar manner to identify dendritic spines or axon boutons in 




To increase labeling specificity, several groups started fusing GFP to endogenous 
synaptic proteins and expressing them exogenously in neurons. For example, 
overexpression of a PSD95-GFP fusion protein localizes to and labels excitatory 
synapses96. Theoretically, this method could be extended to any synaptic protein and 
would function as an intracellular antibody labeling. These synaptic fusion proteins have 
been used in acute brain slices to study long term potentiation (LTP) and in live mice to 
monitor synaptic remodeling and plasticity81,97–99. While these synaptic fusion proteins 
have enabled high spatial resolution labeling of synapses in live or fixed tissue, these 
methods are not physiologically relevant as they overexpress endogenous proteins and 
also have been shown to alter synaptic physiology96. 
More recently, there has been increased focus on developing new genetically 
encoded synaptic tags that do not interrupt endogenous cell machinery. mGRASP utilizes 
targeting sequences to express split GFP fragments at the pre- and post-synapse100. 
Therefore, only functional synapses where the pre- and post-synapse are adjacent to one 
another will reconstitute GFP fluorescence. In another new, exciting study, Gross et al. 
developed fibronectin intrabodies developed using mRNA display (FingRs) targeting 
PSD95 and Gephyrin101. These FingRs were developed using a small (~90 amino acids) 
fibronectin (10FNIII) scaffold lacking disulfide bonds, allowing for soluble intracellular 
expression102. Following multiple rounds of mRNA display, two intrabodies were 
selected that bound to their target proteins, PSD95 and gephyrin, with nanomolar 
affinity101. PSD95 is a scaffolding protein in the membrane associated guanylate kinase 




for the organization of inhibitory receptors103,104. Thus, PSD95 and gephyrin are markers 
of excitatory and inhibitory synapses, respectively. Fusions of these intrabodies to 
fluorescent proteins act as fluorescent markers to visualize the distribution of excitatory 
and inhibitory synapses in a neuron in vitro and in vivo without disrupting endogenous 
synaptic activity. A novel transcriptional control method matches intrabody expression 
levels with the expression of its endogenous binding partner101. These FingR probes are 
still in their infancy and can help elucidate important synaptic information. 
1.5 OVERVIEW 
As illustrated above, a variety of new genetically encoded tools have helped 
advance our knowledge of neural circuitry. Building off of these previous advances, this 
thesis describes 1) a new genetically encoded voltage sensor for monitoring neural 
activity in live mice, and 2) a viral toolbox of synaptic tags for studying global synaptic 
architecture, synapse development, and synaptic plasticity. 
In chapter 2, we describe a new soma-localized voltage sensor, SomArchon, for in 
vivo population imaging. Currently, there is only one voltage sensor with high enough 
signal to noise ratio (SNR) to detect single spikes in individual neurons in a live mouse, 
and even then, optical voltage monitoring is restricted to single neurons65. We sought to 
develop a new optical voltage probe for population imaging in tens of cells. We soma-
localized the high performance Archon164 sensor and named the new probe SomArchon. 
We demonstrated SomArchon’s high performance in multiple brain regions and 
compatibility with optogenetics in an awake mouse brain. With SomArchon, it is possible 




show that coherent synaptic inputs can lead to divergent spike outputs in neighboring 
neurons. Most importantly, we can routinely perform population voltage imaging in 15 
neurons at once. The high performance of SomArchon makes it suitable for a variety of 
experiments that will help understand longstanding questions in systems neuroscience. 
In chapter 3, we optimize FingR synaptic labels and develop a toolbox of FingR 
viruses for synaptic profiling of brain regions or individual neurons. Many synaptic 
probes perturb synaptic physiology or require fixed tissue which prevents study in live 
animals or tissues.  These FingR labels do not disrupt endogenous machinery and express 
at levels matching their endogenous targets101. Synaptic labeling is important for 
understanding inputs to specific cell types, synaptic development, and synaptic plasticity 
in learning and disease. Here, we explore all three of these avenues with our new viral 
FingR variants. Specifically, we perform global synaptic labeling, track synaptic 
integration in adult born granule cells, profile the synaptic density of aspiny cholinergic 





CHAPTER TWO: POPULATION IMAGING OF NEURAL ACTIVITY IN 
AWAKE BEHAVING MICE 
2.1 ABSTRACT 
A longstanding goal in neuroscience has been to image membrane voltage, with 
high temporal precision and sensitivity, in awake behaving mammals.  Here, we report a 
genetically encoded voltage indicator, SomArchon, which exhibits millisecond response 
times and compatibility with optogenetic control, and which increases the sensitivity, 
signal-to-noise ratio, and number of neurons observable, by manyfold over previous 
reagents.  SomArchon only requires conventional one-photon microscopy to achieve 
these high-performance characteristics. These improvements enable population analysis 
of neural activity, both at the subthreshold and spiking levels, in multiple brain regions – 
cortex, hippocampus, and striatum – of awake behaving mice.  Using SomArchon, we 
detect both positive and negative responses of striatal neurons during movement, 
highlighting the power of voltage imaging to reveal bidirectional modulation.  We also 
examine how the intracellular subthreshold theta oscillations of hippocampal neurons 
govern spike output, finding that nearby cells can exhibit highly correlated subthreshold 






Imaging of the activity of neurons using genetically-encoded fluorescent calcium 
indicators offers the ability to survey neural activity in densely labeled neural circuits, but 
lacks the temporal precision and sensitivity of less-scalable techniques such as patch 
clamp electrode neural recording.  Due to the desire to be able to image population neural 
activity with high temporal precision and sensitivity, much recent interest has focused on 
the development of genetically-encoded voltage indicators (GEVIs). Near-infrared 
fluorescent GEVIs derived from rhodopsins offer high temporal fidelity, and are 
compatible with optogenetics63,64,105, whereas green fluorescent GEVIs derived from 
voltage sensing domains of phosphatases or opsins are slower and brighter54,57,65,66,70,106. 
Translating these into the living mouse brain has been challenging, because poor 
membrane localization, photostability, and sensitivity of previous molecules has resulted 
in poor signal-to-noise ratio (SNR) in vivo.  In published work, only Ace2N has been 
used to optically report voltage dynamics in multiple single cells in a living mouse brain, 
reporting only a single example of the activities from just two cells in one field of view65. 
Recently, we developed a robotic directed evolution approach that could perform 
multidimensional optimization of fluorescent voltage indicators along the axes of 
photostability, sensitivity, and membrane localization, resulting in the rhodopsin-based 
voltage sensor Archon1, which performed well in the C. elegans nervous system, larval 
zebrafish brain, and in mouse brain slice64. Here, we report a variant we call SomArchon, 
which exhibits improved SNR sufficient to achieve a key milestone: the ability to 




behaving mice, using inexpensive and simple conventional one-photon microscopes. To 
synthesize SomArchon we built on prior work targeting opsins to neural somata107–110: we 
conducted a screen for peptides to localize Archon1 to the soma, causing increased signal 
and reduced background (by eliminating neuropil signals from indicator-expressing 
axons and dendrites that corrupt the imaging of somatic voltage transients; Figure 7). 
The impact was significant, resulting in improvements in sensitivity, SNR, and the 
number of neurons imageable by manyfold in each case, over prior published reagents.  
Taking advantage of this improved SNR, we were able to use simple one-photon 
fluorescence optics to perform wide-field voltage imaging in multiple cortical (visual and 
motor cortex) and subcortical (hippocampus and striatum) brain regions in awake, 
attentive and/or behaving mice. We were able to detect neurons in the striatum whose 
activities were negatively modulated by movement, previously reported by 
electrophysiology but not easily detected using modern calcium imaging techniques111–
113, and highlighting the complexity of how the striatum encodes voluntary movement.  
We were also able to measure the phase of spiking relative to intracellular theta 
oscillations in hippocampal CA1 neurons, confirming earlier experimental results using 
in vivo patch clamping, and further extending these studies by examining how the spiking 






2.3.1 Development and characterization of a soma-localized genetically-encoded voltage 
indicator. 
To target Archon1 to the cell body, we chose amino acid sequences that were 
shown in the past to target microbial opsins, popular for optogenetic control of neural 
activity, to the cell bodies of neurons. We chose six such localization motifs and fused 
them with Archon1 for further validation (see Table 1 for the design of the fusion 
constructs and the full amino acid sequences of the selected motifs). The selected motifs 
were fragments of the N-terminus of the kainate receptor subunit KA2 (ref107), a 222-
amino-acid intracellular loop between transmembrane domains I and II of the NaV1.2 
sodium channel114, a 27-amino-acid segment within the intracellular loop between 
transmembrane domains II and III of  the NaV1.6 sodium channel
114–116, a 65-amino-acid 
segment at the C terminus of the KV2.1 potassium channel
110, and the membrane-binding 
domain of the adaptor protein ankyrinG117. Additionally, we tested other ankyrinG 
domains, such as the spectrin-binding domain (AnkSB-motif), the tail domain (AnkTail-
motif), the COOH-terminal domain (AnkCt-motif), and the serine-rich domain (AnkSR-
motif), that were shown to be sufficient to restrict GFP localization to cell bodies and 
axon proximal segments118. Screening constructs in primary cultured mouse neurons with 
wide-field fluorescence microscopy, we found that 4 out of 12 constructs showed 
fluorescence changes during spontaneous neuronal activity (Table 1). The Archon1-
KGC-EGFP-KV2.1-motif-ER2 fusion protein exhibited the highest ΔF/F during 100-mV 




SomArchon.  Under two-photon illumination with 1150 nm light, we did not observe 
fluorescence of SomArchon, so we chose to use familiar, inexpensive, fast one-photon 
methods for the purposes of this study. 
SomArchon was functional in mouse brain slice after in utero electroporation into 
mouse cortex and hippocampus (Figure 8), and after adeno-associated virus (AAV)-
mediated expression in mouse cortex, striatum, and thalamus (Figure 9), revealing 
spiking of multiple individual cells at once on a conventional one-photon microscope 
equipped with a sCMOS camera.  Quantification of SomArchon localization in neurons 
in mouse brain slices revealed that SomArchon fluorescence was negligible >30 μm away 
from the cell body in neurons of the mouse cortex and striatum, and >45 μm in mouse 
hippocampus, while still demonstrating excellent membrane localization (quantification, 
Figure 10; histology of Archon1 vs. SomArchon imaged under identical conditions, 
Figures 11, 12).  In short, we were able to target Archon1 to the cell body in multiple 
regions of the mouse brain (Figure 1a, b).   
We evaluated the performance of SomArchon in multiple regions of the mouse 
brain via simultaneous patch clamp electrophysiology and one-photon imaging in brain 
slice (Figure 1c). The voltage sensitivity of SomArchon obtained was ΔF/F of 42 ± 12%, 
37 ± 11%, and 26 ± 7% (mean ± standard deviation throughout) per action potential for 
cortex layer 2/3, hippocampus, and striatum, respectively (Figure 1d; imaging conditions 
described in the caption; n = 18, 8, 6 neurons from 5, 2, 2 mice for cortex layer 2/3, 
hippocampus, and striatum, respectively). This represents an improvement over the 




neuropil fluorescence (compared to the mouse cortex brain slice data of Piatkevich et. al. 
201864). SomArchon fluorescence followed high-speed changes in voltage during single 
action potentials, with fluorescence waveforms being only slightly broader than 
electrically-recorded action potential waveforms (Figure 1e, n = 14, 8, and 6 neurons 
from 5, 2, and 2 mice for cortex layer 2/3, hippocampus, and striatum, respectively; 
Table 2). During action potentials, SomArchon fluorescence changes exhibited SNRs 
(defined as the maximum fluorescence change observed during an action potential 
divided by the standard deviation of the baseline) of 13 ± 4, 20 ± 6, and 27 ± 13 per 
action potential, in the cortex, hippocampus, and striatum, respectively (Figure 1f; 
imaging conditions described in the caption; n = 18, 8, 6 neurons from 5, 2, 2 mice for 
cortex layer 2/3, hippocampus, and striatum, respectively). This is about the same as the 
parent Archon1 (compared to mouse cortex brain slice data in Piatkevich et. al. 2018 64). 
In addition, the dependence of SomArchon fluorescence on voltage was linear (r2 = 
0.9339) throughout the physiological range of membrane potentials from -100 mV to +60 
mV (Figure 1g; n = 12 neurons from 2 mice), with sufficient sensitivity to report 
subthreshold changes. SomArchon expression did not alter membrane resistance, 
membrane capacitance, or the resting potential of neurons in the cortex, hippocampus, 
and striatum in comparison to the control neurons recorded in acute brain slices, nor did 
expression induce gliosis (Figures 13, 14). SomArchon expression appeared to result in 
slightly broader waveforms in hippocampal brain slices, but not in any other brain region 
(Figure 13). In addition, imaging of SomArchon-expressing neurons did not cause 





Figure 1: SomArchon enables high fidelity neural voltage imaging in brain slices. 
(a) Representative low magnification confocal image of a brain slice with cortical and hippocampal 
neurons expressing Archon1-KGC-EGFP-KV2.1motif-ER2 (SomArchon for short). (b) 
Representative confocal images of neurons in cortex layer 2/3 (left), hippocampus (middle), and 
striatum (right) expressing SomArchon. Images acquired via EGFP fluorescence using laser excitation 
at 488 nm and emission 525/50 nm. Scale bars, 50 µm. (c) Single-trial optical recording of 
SomArchon fluorescence responses (red) during current injection through the recording pipette (gray) 
resulting in action potentials (APs), concurrently recorded via whole-cell patch-clamp in current-
clamp mode (black). Imaging conditions throughout the figure: 637-nm laser excitation at 0.8, 1.5, and 
1.5 W/mm2 (55 mW) for cortex layer 2/3, hippocampus, and striatum, respectively; emission 664 nm 
longpass; image acquisition rate: ~1 kHz using EMCCD for cortex layer 2/3 and sCMOS for 
hippocampus and striatum. (d) Quantification of ΔF/F per AP across all recordings performed as 
shown in b (n = 18, 8, and 6 neurons from 5, 2, and 2 mice for cortex layer 2/3, hippocampus, and 
striatum, respectively). Box plots with notches are used throughout this paper (narrow part of notch, 
median; top and bottom of the notch, 95% confidence interval for the median; top and bottom 
horizontal lines, 25th and 75th percentiles for the data; whiskers extend 1.5x the interquartile range 
from the 25th and 75th percentiles; horizontal line, mean; individual data points shown as open circles 
when n < 9). (e) Quantification of electrical and optical waveform full width at half maximum 
(FWHM; dashed lines connect data points from same neuron) per action potential (AP) across all 
recordings performed as shown in b (n = 14, 8, and 6 neurons from 5, 2, and 2 mice for cortex layer 




test between electrical and optical waveform FWHM). (f) Quantification of signal-to-noise ratio 
(SNR) per AP across all recordings performed as shown in b (n = 18, 8, and 6 neurons from 5, 2, and 
2 mice for cortex, hippocampus, and striatum, respectively). (g) Population data corresponding to 
fluorescence changes of SomArchon in response to a series of voltage steps in voltage-clamp mode 
(optical recordings for a representative neuron shown in inset) recorded in neurons in cortex layer 2/3 
(n=12 neurons from 2 mice). Data were normalized so that –70 mV was set to 0 ΔF/F.  
  
We performed a side-by-side comparison of soma-localized versions of  several 
sensors being considered in parallel to this manuscript, namely QuasAr3119, 
paQuasAr3119, ASAP3120, and Voltron525
121, with SomArchon in mouse cortical layer 2/3 
brain slices under identical expression conditions using wide-field microscopy (Table 
14). The spectrally similar sensors QuasAr3, paQuasAr3, and SomArchon were recorded 
under identical imaging conditions (1.5W/mm2), during action potentials evoked using 
co-expressed blue-light driven channelrhodopsin CoChR. The fluorescence of ASAP3 
and Voltron was recorded with filter sets used in their respective preprints120,121, under 
excitation intensities similar to those used for sensor characterization in the Voltron 
preprint121 (25-29 mW/mm2), during action potentials evoked upon application of 4-
aminopyridine. Under these imaging conditions, SomArchon outperformed all other 
sensors in terms of both ΔF/F and SNR per action potential (see Table 14 and Figure 16 
for details). In addition, SomArchon showed higher photostability than ASAP3-Kv and 
Voltron-ST/JF525 under comparable imaging conditions in cultured neurons (Figure 16).  
One can compare a new fluorescent indicator to older ones in terms of 
quantitative metrics as well as qualitative ones, e.g. what new kinds of science are 
enabled.  We compared ΔF/F and SNR of SomArchon to those values for all of the 
recently published genetically-encoded voltage indicators that were imaged under wide-




MacQ-mCitrine66. For comparison, ΔF/F per action potential for SomArchon was 4.7-, 7-
, and 17-fold higher than that of green fluorescent voltage sensors Ace2N-mNeon, 
ASAP1, and MacQ-mCitrine, respectively (Table 14). Although SNR is hard to compare 
across studies because it depends on camera acquisition rate and excitation light power, 
the SNR per action potential for MacQ-mCitrine at a light power of 30 mW/mm2 and a 
440 Hz acquisition rate was 6; for ASAP1 at a light power of 8-50 mW/mm2 and a 400 
Hz acquisition rate, 7.5 ± 2.5; for SomArchon at 1 kHz (a higher frame rate) and 0.8 
W/mm2 (0.55mW) the SNR (see Figure 1c and Figure 16 for raw traces) was ~2x better 
(Ace2N-mNeon SNR in slice was not reported)57,64,66. QuasAr2 in hippocampal brain 
slices showed a ΔF/F of 15% and an SNR of 8.5 ± 2.6 per action potential under the high 
light power of 8 W/mm2 (ref71), about half that achieved by SomArchon under 5x lower 
light power (Figure 1d, f).  Thus, SomArchon represents a manyfold improvement in 
terms of sensitivity and SNR over previously published state-of-the-art molecules. 
2.3.2 SomArchon enables in vivo voltage imaging with single cell, single spike precision 
using conventional wide-field microscopy. 
Having established the improved performance of SomArchon over prior 
molecules in terms of sensitivity and SNR, we next sought to quantify whether this was 
reflected in improved ability to observe neuronal activity in vivo.  We targeted multiple 
brain regions with AAV containing SomArchon under the synapsin promoter, including 
the motor cortex, visual cortex, striatum, and hippocampus. Mice were head-fixed and 
awake while under a simple, conventional wide-field one-photon microscope (Figure 




lens in the green channel, as SomArchon includes a GFP tag (Figure 2b), and then 
performed voltage imaging of near-infrared fluorescence of SomArchon using laser 
excitation light at 637 nm, with a 20x objective lens at ~1.6 W/mm2 (75mW), a 40x 
objective lens at ~4 W/mm2 (75mW), or a 16x objective lens at 1.6 W/mm2 (95mW). 
SomArchon baseline fluorescence levels were sufficient to resolve individual cells in the 
near-infrared voltage channel (Figure 2c, e, g, i), with single cell bodies resolvable at 
depths up to 180 μm below the imaging chamber surface, and with most cells imaged at 
depths of 50-150 μm for cortex and hippocampus, and 20-150 μm for striatum (see 
Figure 17 for histology of mice used for in vivo imaging).  
Optical voltage recordings of awake, head-fixed mice with an acquisition rate of 
390-910 Hz using an sCMOS camera consistently detected individual spikes, as well as 
bursts of spikes, in single cells across all four brain regions (Figure 2c, e, g, i). Since 
ΔF/F was less informative across imaging sessions due to the large variation in 
background fluorescence across imaged fields of view (FOV), we quantified the SNR per 
action potential in the motor cortex, visual cortex, striatum, and hippocampus as 7 ± 2 at 
~1.6 W/mm2 (75 mW) excitation power (n = 8 neurons from 3 mice), 7 ± 2 at ~1.6 
W/mm2 (75 mW) excitation power (n = 6 neurons from 2 mice), 12 ± 3 at ~4 W/mm2 (75 
mW) excitation power (n = 10 neurons from 3 mice), and 16 ± 7 at ~4 W/mm2 (75 mW) 
power (n = 17 neurons from 4 mice), respectively (Figure 2d, f, h, j).  Unfortunately, no 
other paper reports SNR values per action potential in the living mouse brain, so we 
cannot directly compare our molecule to others (and thus the most accurate comparison 




striatum, we were able to resolve short segments of proximal dendrites immediately next 
to the soma, and detected distinct voltage fluctuation patterns from those in the soma 
(Figure 18), which may enable the analysis of dendritic integration and other 
intracellular computational processes in vivo. 
Due to the high performance and soma-targeted nature of our construct, it was 
straightforward to image multiple neurons at once. While the brightest cells in multi-cell 
recordings such as in Figure 2k, l could be easily identified from a single frame, defining 
ROIs for simultaneously imaged dimmer cells adjacent to these bright cells was more 
challenging due to the wide dynamic range (16 bit) of the raw images. To select ROIs for 
these dimmer cells, we created max projection and standard deviation images of the 
entire raw video and stretched their LUTs (look up tables) to enhance visibility. 
Additionally, using the 16x objective lens (95mW), we were able to image an illuminated 
area of approximately 110 x 180 µm, where we can routinely identify 10-18 cells in a 
FOV with densely labelled cells (n = 13.07±3.48 neurons per FOV, mean±standard 
deviation, from 13 recording sessions in 2 mice). Of the 170 manually identified neurons, 
107 (63%) spiked during the recording periods (duration: 13.5-27 seconds; one session 





Figure 2: SomArchon-mediated voltage imaging with single cell resolution in multiple brain 




(a) Schematic representation of the experimental setup: awake mice were head-fixed and positioned 
under a conventional wide-field microscope that allowed imaging of SomArchon fluorescence in the 
green and near-infrared channels (left); example diagram of surgical window implant (right); for 
striatum and hippocampus, imaging windows were coupled with a viral infusion cannula and a LFP 
recording electrode). (b) SomArchon labeled neurons visualized via EGFP fluorescence in motor 
cortex, visual cortex, striatum, and hippocampus (ƛex=470/25 nm LED, ƛem=525/50 nm). Scale bars, 
50 μm. (c, e, g, i) Voltage imaging in (c) motor cortex, (e) visual cortex, (g) striatum, and (i) 
hippocampus: SomArchon fluorescence image of the cell in vivo (left) and optical voltage trace 
acquired from this cell (right; dashed boxes indicate time intervals shown at successively expanded 
time scales; vertical bars indicate peaks of action potentials identified by spike-sorting algorithm); 
ƛex=637 nm laser, ƛem=664LP, excitation intensity 1.5 W/mm2 (75 mW) for visual and motor cortex, 
4 W/mm2 (75 mW) for striatum and hippocampus). Scale bars, 25 μm. (d, f, h, j) Quantification of 
signal-to-noise ratio per action potential for (d) motor cortex, (f) visual cortex, (h) striatum, and (j) 
hippocampus (n = 8, 6, 10, and 17 cells from 3, 2, 3, and 4 mice, respectively). (k, l) Population 
voltage imaging in hippocampus: (k) SomArchon fluorescence images of cells in vivo; summed 
fluorescence intensity over ~250ms recording (top), with ROIs overlaid (bottom), zoomed-in views of 
two regions boxed in top to highlight individual cells (middle), and (l) optical voltage traces acquired 
from example cells (yellow labels in k, trace numbers correspond to cell numbers; see Figures 19-31 
for more FOVs); ƛex=637 nm laser, ƛem=664LP, excitation intensity 1.5 W/mm2 (75mW).  
 
The previous record for number of cells imaged in a single field of view in vivo 
was just 2 neurons, with Ace2N-mNeon65. In recent preprints, paQuasAr3-s was used to 
visualize 4 spiking cells 119, by deploying a specialty imaging setup that combines two-
photon and single-photon microscopy modalities with patterned excitation illumination 
targeting individual cell bodies119.  ASAP3 was used to image up to 3 dendrites using 2-
photon microscopy120, whereas the chemigenetic probe Voltron was capable of imaging 
46 neurons121 using conventional wide-field microscopy. Thus, SomArchon helps 
achieve a manyfold improvement in the number of cells that can be simultaneously 
imaged over all other molecules except Voltron. However, we note that Voltron requires 
addition of chemicals to the living brain, is not compatible with optogenetics, and 




2.3.3 All-optical electrophysiology in vivo using SomArchon in combination with a 
channelrhodopsin. 
The use of microbial rhodopsins has become widespread in neuroscience as a 
method for activating and silencing neuronal activity of genetically targeted cell 
populations122. Some high-performance channelrhodopsins are activated with blue light, 
and thus, could in principle be spectrally combined with near-infrared fluorescence 
indicators such as SomArchon for in vivo neural activation and voltage imaging. We used 
a bicistronic expression system, SomArchon-P2A-CoChR-KV2.1 (in our original paper 
on soma-targeted CoChR, we used the KA2 sequence which worked best with CoChR-
GFP, but in this paper we used fluorophore-free CoChR, which did not express well with 
KA2, and rather worked better with KV2.1), to co-express SomArchon and the high-
performance channelrhodopsin CoChR123 in the same cell via a 2A cleavage sequence 
(Figure 3a). Illuminating transduced cells in brain tissue with 2 ms blue light pulses at 10 
and 20 Hz reliably evoked single action potentials, (n = 8 neurons from 2 mice; Figure 
3b, c). We previously demonstrated that Archon1 exhibits no crosstalk under continuous 
or pulsed blue illumination64. We further expressed SomArchon-P2A-CoChR-KV2.1 via 
AAV injection in the hippocampus of the mouse brain, and optogenetically evoked neural 
activity in awake mice while simultaneously imaging voltage of the same cells (Figure 
3d). Blue light stimulation for durations of 100 ms reliably evoked spiking, as imaged in 
populations of neurons within the same field of view (Figure 3e), and across different 
fields of view (Figure 3f, n = 14 neurons, from 7 recording sessions from 2 mice). Thus, 




voltage dynamics in several cells simultaneously in an awake mouse.  
 
Figure 3: All-optical electrophysiology with CoChR and SomArchon. 
(a) Diagram of the construct used for co-expression of SomArchon and CoChR. (b) Fluorescence 
images of a selected field of view of hippocampal neurons in brain slice expressing SomArchon-P2A-
CoChR-KV2.1 (top) with the identified region of interest (ROI) corresponding to somas shown 
(bottom); ƛex=637 nm, ƛem=664LP, exposure time 1.3 ms. Scale bar = 25 µm. (c) Representative 
single-trial optical voltage traces from cells shown in b aligned with blue light stimulation (2 ms pulse 
at 20 Hz). Image acquisition rate: 777 Hz. (d) Fluorescence images of a selected field of view of 
hippocampal neurons in vivo expressing SomArchon-P2A-CoChR-KV2.1 (top) with the identified ROI 
corresponding to somas shown (bottom); ƛex=637 nm, ƛem=664LP, exposure time 1.2 ms. Scale bar = 
20 µm. (e) Representative single-trial optical voltage traces from cells shown in d aligned with blue 
light stimulation (100 ms pulse). Image acquisition rate: 826 Hz. (f) Firing rate changes during blue 
light off and blue light on conditions in individual neurons (n = 14 cells from 2 mice). 
2.3.4 In vivo single cell, single spike optical voltage imaging from striatal neurons during 
locomotion. 
Electrophysiology studies have demonstrated that striatal neurons selectively 
increase their responses during distinct phases of movement (i.e., encoding discrete 
aspects of movement initiation, execution, and termination)124–128. It has also been 




modulated, during motor behavior 125,127,129. While electrophysiology recordings largely 
discard spatial information regarding the relative location of the neurons being observed, 
recent calcium imaging studies have revealed that spatially clustered striatal neurons 
encode similar aspects of movement 111–113. These calcium imaging studies focused on 
the increases in activity during movement, perhaps because decreases in activity are hard 
to observe with calcium imaging due to its slow temporal resolution and therefore, low 
calcium event rate. Voltage imaging could help resolve these ambiguities by offering the 
temporal sensitivity and precision of electrophysiology, at the spatial resolution of 
calcium imaging. 
We optically recorded striatal neurons expressing SomArchon while mice ran on 
a spherical treadmill (Figure 4a). When imaged with the 40x objective lens, we could 
clearly identify individual cell bodies and record voltage dynamics from well-defined 
individual cells and sometimes multiple cells in a single field of view (Figure 4b, c), 
extracting spikes for correlation with movement (n = 14 neurons, from 8 recording 
sessions from 2 mice, Figure 4d, e). Individual striatal neurons exhibited highly different 
firing rates (Figure 33), with some exhibiting bursting patterns known to occur in striatal 
fast spiking interneurons130,131. We also identified one neuron with a large cell body 
which exhibited a tonic firing pattern of ~5 Hz (Figure 33), both properties of 
cholinergic interneurons132. Furthermore, when selectively expressing SomArchon in 
striatal cholinergic interneurons by injecting AAV-FLEX-SomArchon virus into a ChAT-
Cre transgenic mouse, we confirmed the tonic firing patterns of these neurons, consistent 




From each recording, we calculated the firing rate of striatal neurons for each 0.5-
second interval, and compared their firing rates during periods of high speed movement 
(speed ≥10 cm/s) and low speed movement (speed ≤5 cm/s) (see Figure 35 for 
identification of high and low speed thresholds). Of the 14 neurons recorded, 4 were 
positively modulated by movement speed (Figure 4e, f; Cells 3, 4, 8, 14; p<0.05 two-
sided Wilcoxon rank sum test, Table 3), and 2 were negatively modulated by movement 
speed (Figure 4f Cells 5, 12; p<0.05 two-sided Wilcoxon rank sum test). Thus, our data 
suggest that neurons negatively modulated during movement can be readily detected with 








Figure 4: Voltage imaging of striatal neurons during locomotion. 
(a) Schematic representation of the experimental setup: awake mice were head-fixed and positioned 
under a conventional wide-field microscope identical to that in Figure 2a, and positioned on a 
spherical treadmill. Animal locomotion was monitored using a pair of orthogonally-oriented motion 
sensors. All imaging was performed with a 40x NA = 0.8 water immersion objective lens. (b) 
SomArchon fluorescence image of striatal cells (left), with the identified ROIs corresponding to somas 
shown (right), ƛex=637 nm, exposure time 1.2 ms. Scale bar, 20 µm. NSD = no spikes detected. (c) 
Representative optical voltage traces acquired from cells shown in b, and corresponding mice 
movement speed (black: low pass filtered at 1.5 Hz; gray: raw data). Image acquisition rate 826 Hz. 
(d) Zoomed-in views of the three periods indicated by black boxes shown in c. (e) Representative 
optical voltage trace (red) for a neuron modulated by movement speed; corresponding movement 
speed (black: low pass filtered at 1.5Hz; gray: raw data). Image acquisition rate 826 Hz. (f) Firing 
rates of individual striatal neurons, during periods with low (open box) versus high (gray) movement 
speed (open circles: outlier periods). *, p<0.05, two-sided Wilcoxon rank sum test. Box plots are 
organized by field of view (i.e. neurons in the same FOV are listed adjacently to each other). 
 
We found that adjacent neurons did not respond to movement speed in identical 
ways. For example, in each of the two recordings where three neurons were 
simultaneously recorded, we found that one of the three neurons was positively 
modulated by movement speed (p<0.05 two-sided Wilcoxon rank sum test, Table 3), 
whereas the other two were not modulated (Figure 4b, c, f; see Cells 1, 2, 3, and Cells 6, 
7, 8, see Figure 33 for spatial arrangements of these FOVs).  Together, these results 
highlight the applicability of SomArchon to record from spatially clustered striatal 
neurons during behavior.  
2.3.5 Simultaneous recordings of intracellular membrane voltage and local field 
potentials (LFPs) revealed distinct phase relationships between spikes and theta 
oscillations in hippocampus. 
We performed wide-field imaging of hippocampal CA1 neurons in awake, head-
fixed mice, while simultaneously recording LFPs. CA1 neurons exhibited average firing 
rates ranging from 3.3 to 18.0 Hz (7.92±3.55 Hz, mean± standard deviation, n=16 




electrophysiology recordings 17,133. Theta oscillations are known to be prominent in the 
hippocampus and contribute to hippocampal-related behaviors 134,135, and indeed we 
detected LFP theta oscillations throughout our recording sessions (Figure 36). The gentle 
air puff for keeping the mouse in an awake state did not alter the power of LFP theta 
oscillations, but induced an increase in high frequency oscillations (Figure 36). Several 
theoretical frameworks have been developed to explain how spike and theta oscillation 
phase relationships may support hippocampal information processing 136–138. However, 
most of these studies compared spikes to extracellularly recorded LFP theta oscillations, 
leaving open the question of how subthreshold theta oscillations within an individual 
neuron relates to its own spiking output.   
In vivo patch clamp recordings have shown stronger phase-locking of a neuron’s 
spikes to its own intracellular theta oscillations, than to the across-neuron averaged LFP 
theta oscillations17,139.  We recorded classical electrode-measured LFPs, while 
performing optical voltage imaging in the CA1 region of awake mice, so that we could 
compare the phase relationships between spikes and intracellularly-measured theta 
oscillations vs. across-neuron averaged LFP theta oscillations (Figure 5a). We found that 
some neurons had spikes phase-locked to both intracellular and LFP theta oscillations 
(Figure 5a), whereas others were phase locked only to the intracellular theta oscillations, 
but not to LFP theta oscillations (Figure 5b). 15 out of the 16 recorded CA1 neurons 
showed significant phase locking between spikes and intracellular theta oscillations 
(Figure 5c; blue: p<0.05, cyan: not significant, 𝛘2 test, comparing to the null hypothesis 




theta oscillations (338±11 degrees, mean± standard deviation, peak of oscillation=0 
degree; n=16 neurons). In contrast, only 6 out of the 16 neurons showed significant phase 
locking between spikes and extracellular LFP theta oscillations (Figure 5c; red: p<0.05, 
pink: not significant, 𝛘2 test, comparing to the null hypothesis of uniform distribution). 
As a population, neurons exhibited a stronger phase locking relationship with 
intracellular theta oscillations than with LFP theta oscillations (phase vector for 
intracellular theta oscillations = 0.35±0.17, for LFP theta oscillations = 0.12±0.08, mean± 
standard deviation; Figure 5d).  
These results are consistent with in vivo whole cell patch clamp recordings in 
awake mice, where spikes exhibited greater phase locking to intracellular theta 
oscillations than to LFP theta oscillations 17,139. In addition, the phase locking of spikes 
occurred during the ascending phase of intracellular theta oscillations (338±11 degrees, 
mean± standard deviation, peak of oscillation=0 degree; n=16 neurons), similar to 
Harvey et. al17. Previous studies have also observed phase precession of spiking related to 
the LFP as a mouse runs through the preferred location of a place cell, which likely 
results from a phase shift between intracellular theta and the LFP17,136. We did not 
observe phase precession in our own data, likely because the mouse is head-fixed. Also, 
most reported electrophysiology in the CA1 of live mice was restricted to place cells, but 
there is little data regarding the phase-locking of spikes in non-place cells or conditions 
where the mouse is not navigating an environment17,133,136. It has been shown in 
hippocampal slices that phase locking of spikes to the intracellular membrane potential in 




frequency140. In our experiments, we could not control for these properties and did not 
sort neurons by firing rate, but we did see similar phase-locking vector strengths of 
similar magnitude. Overall, our results are consistent with existing literature which 






Figure 5: Phase relationships between hippocampal neuron spikes and theta oscillations of 
optically-recorded membrane voltage (Vmo) vs. those of local field potential (LFP) recordings. 
(a) An example neuron with spikes phase-locked to theta oscillations of both LFPs and Vmo. (i) Raw 
LFPs (blue trace, top) and raw Vmo (red trace, bottom), as well as theta frequency (4-10Hz) band-pass 
filtered LFPs (blue, 2nd to the top) and Vmo (red, 2
nd from the bottom). (ii) Zoomed-in views of the 




lines) and in Vmo (vertical red lines), and the timing of spikes (green dots). (iii) Probability distribution 
of spikes relative to the phases of LFP theta oscillations (blue shaded region) and Vmo theta 
oscillations (red shaded region). Arrows indicate the average phase vector (values next to the phase 
vectors indicate the vector length). Bin size = 20 degrees. Outer circle indicates probability = 0.3. (b) 
Similar to (a), but for an example neuron that is phase locked to Vmo theta oscillations, but not to LFP 
theta oscillations. Outer circle indicates probability = 0.4. (c) Population spike phase relationship to 
LFP theta oscillations (blue and cyan) and Vmo theta oscillations (red and pink). Each vector 
represents the average vector from one neuron. Blue and red: p<0.05; cyan and pink: not significant; 
𝛘2 test, comparing to the null hypothesis of uniform distribution. Outer circle indicates probability = 
0.7. (d) As a population, hippocampal neuron spikes show stronger phase locking to Vmo theta 
oscillations than to LFP theta oscillations (***, p<0.001, two-tailed paired Student’s t-test, n=16 
neurons in 7 recording sessions from 4 mice). Box plot used in this figure: top and bottom horizontal 
lines, 25th and 75th percentiles for the data; whiskers extend to the most extreme data points not 
considered outliers; + are outliers; and horizontal line represents the median. 
 
2.3.6 SomArchon retains stable fluorescence intensity and signal-to-noise ratio (SNR) in 
vivo during behavioral experiments. 
To evaluate the photostability of SomArchon during behavioral conditions, we 
calculated the intensity and SNR of action potentials per neuron throughout the 
behavioral experiments performed in striatum and hippocampus in awake mice (Figures 
4 and 5). In the striatum, although intensity decreased slightly (lowest: 88%), SNR 
remained stable over the entire recording session (5 trials, each trial was 12 seconds with 
inter-trial intervals of 30–60 seconds, n = 6 neurons in 5 field of views from one mouse, 
Figure 37). In the hippocampus, we also detected a slight decrease in SomArchon 
fluorescence intensity over time, where at the end of 10 trials, SomArchon fluorescence 
intensity dropped to 86% of that observed at the beginning of the experiment (10 trials, 
each trial was 6 seconds long with inter-trial intervals of 20-30 seconds, n=16 neurons in 
7 FOVs from 4 mice, Figure 37). The SNR of action potentials in the hippocampus 
showed a significant decrease between the first and second trial, but remained stable 




confirming that imaging of SomArchon-expressing neurons did not alter neuronal activity 
or cause phototoxicity in vivo, consistent with our results observed in cultured neurons 
(Figure 15). Moreover, the robustness of SomArchon allowed us to perform imaging for 
durations longer than 1 minute without changes in SNR (Figure 38). 
2.3.7 Population imaging of spiking and subthreshold oscillations in hippocampal 
neurons. 
Having established that SomArchon can report subthreshold intracellular 
oscillations in vivo, we next examined the extent to which they were coordinated across 
neural populations to regulate spiking.  The hippocampus has typically been regarded as 
having little topographical organization141,142, although some evidence suggested a degree 
of spatial clustering143,144. Recently, based upon multi-neuron automated patch clamp 
data145, we hypothesized that even when nearby neurons in the awake mouse 
hippocampus exhibit highly coordinated subthreshold activities, they might generate 
extremely divergent spiking outputs that are sensitive to transient and stochastic 
intracellular membrane voltage fluctuations. Since we were unable to analyze more than 
one cell in the hippocampus at a time over an extended period of time in awake mice, 
even with automated patch clamp, we were previously unable to test this hypothesis. 
We accordingly examined the coherence, both at the spiking level and at the 
subthreshold intracellular oscillation level, across populations of neurons, to determine 
whether nearby neurons exhibited similar subthreshold intracellular oscillations and how 
coordinated subthreshold activities impact spiking (with a focus on theta frequencies 




recording sessions where we recorded multiple neurons, we found that simultaneously 
recorded pairs of neurons (Figure 6a) could exhibit high coherence of subthreshold 
intracellular oscillations, but low coherence of spiking (Figure 6b, green vs. magenta 
traces).  Across the 25 neuron pairs simultaneously imaged (n = 25 neurons, from 9 
recording sessions from 4 mice), spike-spike coherence was not predicted from the 
subthreshold intracellular oscillation coherence at theta (Figure 6d, n = 25 pairs, linear 
regression, p = 0.086, r2 = 0.123). Since fluorescence signals measured with wide-field 
microscopy can suffer from spatial crosstalk, we examined pair-wise subthreshold 
oscillation coherence between neuron pairs across anatomical distances, to gauge the 
extent to which wide-field imaging compromised signals from SomArchon expressed in 
neighboring neurons. We found that the analysis of Figure 6d, repeated for close vs. 
distant neurons, showed qualitatively similar results for neurons 10-20, 20-30, 30-40, and 
40-50 microns apart (Figure 39a).  Furthermore, we found that subthreshold oscillation 
coherence did not decrease significantly with distance at theta frequencies or gamma 
frequencies (Figure 39b, c). Together, these results suggest that even if nearby neurons 
exhibit synchronized intracellular oscillations, their spike timing can be highly 
heterogeneous. These observations are consistent with the idea that nearby neurons may 
receive vast common synchronized inputs, but a small number of selective inputs may 






Figure 6: In vivo population voltage imaging reveals coupling between intracellular 
subthreshold oscillations and spiking in hippocampal neurons. 
(a) An example field of view containing three neurons. (b) Membrane voltage recorded optically 
(Vmo) from neurons identified in a (also color coded as in a) and simultaneously recorded local field 
potentials (LFPs).  Black vertical ticks above Vmos denote identified spikes. Spike-spike coherence 
values between neurons are shown at the left and Vmo-Vmo coherence values are shown at the right. (c) 
Theta frequency-filtered LFPs and Vmos for the four traces shown in b. Vmo-LFP coherence values are 
shown to the right. (d) Correlation between Vmo-Vmo coherence at theta and spike-spike coherence 
from all neuron pairs, fitted with a linear regression (n = 25 pairs, p = 0.086, r2 = 0.123). 
 
The coherence between two nearby neurons’ intracellular subthreshold 
oscillations was not constant, but fluctuated over time (coefficient of variation, 




coherence value (one sample t-test, p<0.001), revealing temporally dynamic input 
structures.  To further explore how intracellular subthreshold oscillations may relate to 
the across-neuron averaged LFP signals, we examined the coherence between 
intracellular subthreshold theta oscillations recorded in two neurons, versus the coherence 
between one neuron and the simultaneously recorded LFP theta oscillations. While 
simultaneously recorded neurons exhibited a wide range of coherence to LFP oscillations 
(Figure 6c), at a population level, adjacent neurons showed greater intracellular 
oscillation coherence amongst themselves than with LFPs (Vmo-Vmo 
coherence=0.32±0.13, Vmo-LFP coherence=0.10±0.05, mean±standard deviation, two-
sided Wilcoxon rank sum test, p=0.0008, n = 9 sessions, Table 5). These results highlight 
that among the diverse current sources that contribute to the spatiotemporally integrated 
LFP signals, some may exhibit a greater role in synchronizing post-synaptic responses 
(also see Figure 39 for supplementary discussion regarding potential cross-talk).  
2.4 DISCUSSION 
Each of the five next-generation voltage sensors (SomArchon, Ace2N-mNeon, 
QuasAr3, Voltron, and ASAP3) are sufficient to monitor spiking in individual neurons in 
live mice, and each sensor has its own unique key features as well as limitations. For 
instance, Voltron enables population voltage imaging in up to 46 cells in a single field of 
view121. However, these population experiments were conducted in a specialized scenario 
using a 0.55x magnification camera tube to increase the size of the field of view in 
addition to using a specific NDNF-cre mouse, which enabled sparse labeling restricted to 




chemigenetic indicator with a genetically encoded component and a separate dye 
component that must be injected prior to imaging; fully genetically encoded reagents only 
require genetic delivery and can be used in widely disseminated transgenic form122. In 
addition, the dyes used in conjunction with Voltron, are highly fluorescent in their free 
form and are internalized into cells very quickly, creating a high fluorescent background 
thus reducing identification of Voltron expressing cells (Figure 16). Therefore, extra care 
should be taken upon administration of the dye to the samples. The newest ASAP variant, 
ASAP3, is compatible with 2-photon microscopy and can be used to image deeper 
neurons below layer 2/3 in intact brain tissue, but this approach requires a complex 
microscopy technique, making it more difficult to use, and can only currently be used to 
optically record voltage in single cells at the fast acquisition rates necessary for voltage 
imaging120. The voltage indicator Ace2N-mNeon was the first genetically encoded 
voltage sensor to successfully report spikes in individual neurons in a live mouse brain65, 
and was demonstrated to enable imaging of 1-2 neurons simultaneously. The near 
infrared voltage indicator QuasAr3 enables all optical electrophysiology using blue light 
driven rhodopsins to drive neural activity, while supporting the imaging of neural activity 
in brain tissue119. However, 2-photon structural data is required for patterned illumination 
of individual neurons, and a photoactivatable variant, paQuasAr3, is needed in order to 
increase the SNR for in vivo use and to allow imaging of multiple cells simultaneously 
(up to 4 spiking cells in one field of view). In addition, the blue light activation of 
paQuasAr3 precludes the usage of commonly used pulsed blue light stimulation protocols 




compatible with conventional 1-photon widefield fluorescence microscopes already 
present in many neuroscience labs, and enables the routine imaging of a dozen neurons in 
a single field of view. In addition, SomArchon is compatible with blue light driven 
optogenetic actuation for all optical electrophysiology; SomArchon, unlike paQuasAr3, 
does not need blue light co-activation for voltage imaging. Thus, SomArchon can be used 
for optogenetics protocols involving either pulsed or constant blue light stimulation. 
Voltron, ASAP3, and Ace2N-mNeon all exhibit crosstalk with rhodopsins prohibiting 
their use with optogenetic actuators. Voltage imaging with SomArchon, as well as 
QuasAr3, is mainly limited by the high power and illumination spot of the 637 nm 
excitation laser. However, our data suggest high powered 637nm excitation does not 
induce any more phototoxicity than common, lower-powered 470nm excitation (Figure 
15). Finally, our side-by-side comparisons of SNR and ΔF/F in brain slices between 
SomArchon, and soma-targeted versions of ASAP3, Voltron, QuasAr3, and paQuasAr3 
demonstrate that SomArchon exhibits a significantly higher ΔF/F than all other voltage 
sensors, and significantly higher SNR than ASAP3 and QuasAr3, but not a significantly 
different SNR than Voltron and paQuasAr3, under the imaging conditions explored in 
this paper and in papers being considered in parallel to this one (n = 18, 14, 9, 13, and 14 
cells, respectively for ASAP3, Voltron, QuasAr3, paQuasAr3, and SomArchon; 
Wilcoxon Rank sum test, Table 11, 12 and Figure 16). 
In summary, SomArchon enables the simple, inexpensive observation of neural 
voltage in populations of individual neurons, in a number of brain regions in awake 




without needing chemical co-factors, and is compatible with optogenetic control. We 
anticipate that the practicality of SomArchon will enable its rapid deployment into a 
diversity of contexts in neuroscience.  As camera performance improves in years to 
come, and as further evolution of voltage indicators continues, we anticipate that perhaps 
dozens to hundreds of neurons will be imageable with simple one-photon optics in the 
near future.   
2.5 METHODS 
Molecular cloning. For screening candidates for the soma-localized Archon1 
voltage sensor in primary hippocampal neurons, DNA encoding for candidate 
localization motifs was synthesized de novo with mammalian codon optimization and 
subcloned with Archon1 (GenBank ID MG250280.1) and EGFP genes into the pAAV-
CAG vector to obtain the final constructs described in Table 1 (gene synthesis and 
subcloning were performed by Epoch Life Science Inc.). For in vivo expression in the 
mouse brain via in utero electroporation (IUE), the Archon1-KGC-EGFP-KV2.1motif-ER2, 
QuasAr3-PP-Citrine-KV2.1motif-ER2 (QuasAr3-s), paQuasAr3-PP-Citrine-KV2.1motif-ER2 
(paQuasAr3-s) and CoChR-mTagBFP2-KV2.2motif-ER2 genes were subcloned into the 
pCAG-WPRE vector. The QuasAr3-PP-Citrine-KV2.1-ER2 and paQuasAr3-PP-Citrine-
KV2.1-ER2 gene were synthesized de novo (GenScript Biotech Corp.) based on 
sequences reported in the original preprint119. The CoChR-mTagBFP2-KV2.2motif-ER2 
gene was assembled by Epoch Life Science Inc. using pAAV-Syn-CoChR-GFP 
(Addgene plasmid #59070) and pBAD-mTagBFP2 (Addgene plasmid #34632) as the 




synthesized de novo with mammalian codon optimization (Epoch Life Science Inc.). The 
pAAV-Syn-Archon1-KGC-EGFP-KV2.1motif-P2A-CoChR-KV2.1motif plasmid was also 
cloned by Epoch Life Science Inc. Plasmid amplification was performed using Stellar 
(Clontech Laboratories Inc.) or NEB10-beta (New England BioLabs Inc.) chemically 
competent E. coli cells. Small-scale isolation of plasmid DNA was performed with Mini-
Prep kits (Qiagen); large-scale DNA plasmid purification was done with GenElute HP 
Endotoxin-Free Plasmid Maxiprep Kits (Sigma-Aldrich Corp.). The ASAP3-Kv and 
Voltron-ST genes were synthesized de novo by GenScript, based on the sequences 
reported in the corresponding pre-prints120,121, and cloned into the pCAG-WPRE vector. 
Neuronal culture and transfection. All mouse procedures were performed in 
accordance with the National Institute of Health Guide for Laboratory Animals and 
approved by the Massachusetts Institute of Technology Institutional Animal Care and 
Use and Biosafety Committees. For dissociated hippocampal mouse neuron culture 
preparation, postnatal day 0 or 1 Swiss Webster mice (Taconic Biosciences Inc., Albany, 
NY) were used as previously described64. Briefly, dissected hippocampal tissue was 
digested with 50 units of papain (Worthington Biochemical Corporation) for 6-8 min at 
37 °C, and the digestion was stopped by incubating with ovomucoid trypsin inhibitor 
(Worthington Biochemical Corporation) for 4 min at 37 °C. Tissue was then gently 
dissociated with Pasteur pipettes, and dissociated neurons were plated at a density of 
20,000–30,000 per glass coverslip coated with Matrigel (BD Biosciences). Neurons were 
seeded in 100 µL plating medium containing MEM (Life Technologies Corp.), glucose 




Corning), Insulin (0.13%, Millipore), B27 supplement (2%, Gibco), and heat inactivated 
FBS (7.5%, Corning). After cell adhesion, additional plating medium was added. AraC 
(0.002 mM, Sigma) was added when glia density was 50–70% of confluence. Neurons 
were grown at 37°C and 5% CO2 in a humidified atmosphere.  
For in vitro screening of candidate soma-localized Archon1 sensors, primary 
hippocampal neuron cultures were transfected with 500 ng of plasmid DNA per well with 
a commercial calcium phosphate transfection kit (Life Technologies Corp.) after 4 days 
in vitro (DIV), as previously described. After 30–60 min of DNA-calcium phosphate 
precipitate incubation with cultured neurons at 37°C, neurons were washed twice with 
acidic MEM buffer (pH 6.7–6.8) to remove residual calcium phosphate particles and 
returned to the original plating media. All measurements on cultured neurons were taken 
between days in vitro (DIV) 14 and DIV 18 (~9–14 d post transfection) to allow for 
sodium channel maturation (and thus spiking). No all-trans-retinal was supplemented for 
any cultured neuron recordings. 
Electrophysiology and fluorescence microscopy in cultured primary 
hippocampal neurons. Whole-cell patch clamp recordings of cultured neurons for Table 
1 were acquired via an Axopatch 700B amplifier (Molecular Devices LLC) and Digidata 
1440 digitizer (Molecular Devices LLC). Neurons were patched between DIV14 and 
DIV18 and were bathed in Tyrode’s solution (125mM NaCl, 2mM KCl, 3mM CaCl2, 
1mM MgCl2, 10mM HEPES, 30mM glucose, pH 7.3 (NaOH adjusted)) at 32 °C during 
measurements. Synaptic blockers (NBQX, 10µM; d(–)-2-amino-5-phosphonovaleric 




cell electrophysiology. Borosilicate glass pipettes with an outer diameter of 1mm and a 
wall thickness of 0.2mm were pulled to produce electrodes with resistance of 3–10 MΩ 
and were filled with an internal solution containing 135mM potassium gluconate, 8mM 
NaCl, 10mM HEPES, 4mM Mg-ATP, 0.4mM Na-GTP, 0.6mM MgCl2, 0.1mM CaCl2, 
pH 7.25 (KOH adjusted) at 295mOsm. Measurements from primary neuron cultures were 
performed on the electrophysiology setup described above. Patch-clamp data was 
acquired only if the resting potential was below -45mV and access resistance was <25 
MΩ. Access resistance was compensated at 30–70%. Fluorescence imaging was 
performed on an inverted fluorescence microscope (Nikon Ti), equipped with a red laser 
(637 nm, 100 mW, Coherent, OBIS 637LX, Pigtailed) expanded by a beam expander 
(Thorlabs Inc) and focused onto the back focal plane of a 40×NA 1.15 objective lens 
(Nikon Corp.).  
Two-photon imaging of SomArchon expressing neurons was performed using an 
Olympus FVMPE-RS equipped with two lasers for fluorescence excitation. An InSight 
X3 laser (Spectra-Physics) tuned to 1150 nm at 50% transmissivity was used to excite 
SomArchon, and a MaiTai HP Ti:Sapphire laser (Spectra-Physics) tuned to 920 nm at 
15% transmissivity was used to excite EGFP. The laser beams were focused by a 25× 
1.05 NA water-immersion objective lens (Olympus). SomArchon emission was separated 
using a 590 nm dichroic mirror and imaged with 660-750 nm and 495-540 nm filters for 
near-infrared and green fluorescence, respectively, and signals were collected onto 
separate photomultiplier tubes. Imaging was performed at 2.0 µs/pixel sampling speed 




Phototoxicity and photobleaching measurements in cultured neurons. For 
phototoxicity and photostability measurements, primary mouse neuron cultures, prepared 
as described above, were imaged using an inverted Eclipse Ti-E microscope (Nikon) 
equipped with a sCMOS camera (OrcaFlash4.2, Hamamatsu), LED light source (Spectra, 
Lumencor), a 637 nm Laser (637 LX, OBIS) focused on the back focal plane of a 40× 
NA 1.15 objective lens (Nikon), and a Polygon400 Multi-wavelength Patterned 
Illuminator (Mightex) with a 470 nm LED (ThorLabs).  To express SomArchon, neurons 
were infected with AAV2-CaMKII-SomArchon or AAV2-Syn-SomArchon-P2A-
CoChR-KV2.1motif at DIV 5. To express ASAP3-Kv and Voltron-ST, neurons were 
transfected with the pCAG-ASAP3-Kv-WPRE and pCAG-Voltron-ST-WPRE plasmids, 
respectively, using the calcium phosphate method described above. For imaging of 
Voltron-expressing neurons, the cells were incubated with JF525 at final concentration 
1.25 µM for 60 min at 37oC (application of higher concentration of JF525 resulted in 
significant internalization of the dye with 40 min of incubation at 37oC thus completely 
preventing functional imaging due to high background fluorescence). After incubation, 
the cells were washed 3 times with fresh plating media for 3 h to removed unbound dye. 
The ROS measurements were performed using CellRox Orange dye (Invitrogen) 
according to the manufacturer’s protocol. Briefly, neurons were incubated with the 
CellROX Orange reagent at a final concentration of 5 μM for 30 minutes at 37°C in 
darkness, and then washed once with fresh plating media prior to imaging. Right before 
imaging, cells were supplemented with the NucGreen Dead 488 reagent for detection of 




>10 times increase in green fluorescence in the nucleus over background fluorescence 
levels were considered dead. Neurons were imaged between DIV 14 and DIV 18 in the 
plating media at 22oC. CellROX Orange fluorescence was acquired using 510/25 nm 
excitation at 0.8 mW/mm2 and 545/40 nm emission. NucGreen fluorescence was 
acquired using 475/36 nm excitation at 3.5 mW/mm2 and 527/50 nm emission.  
In utero electroporation, AAV injection, and acute brain slice preparation. 
For IUE, embryonic day (E) 15.5 timed-pregnant female Swiss Webster (Taconic 
Biosciences Inc., Albany, NY) mice were deeply anesthetized with 2% isoflurane. 
Uterine horns were exposed and periodically rinsed with warm sterile PBS. Plasmid 
DNA (1-2 μg total at a final concentration of ~2-3 μg/μL diluted in sterile PBS) was 
injected into the lateral ventricle of one cerebral hemisphere of an embryo. Five voltage 
pulses (50 V, 50 ms duration, 1 Hz) were delivered using 5 mm round plate electrodes 
(ECM™ 830 electroporator, Harvard Apparatus), placing anode or cathode on the top of 
the skull to target cortex or hippocampus, respectively. Electroporated embryos were 
placed back into the dam, and allowed to mature to delivery. Brain slices were prepared 
from electroporated mice at P12-P22. 
The electroporated mice were anaesthetized by isoflurane inhalation, decapitated, 
and cerebral hemispheres were quickly removed and placed in cold choline-based cutting 
solution consisting of (in mM): 110 choline chloride, 25 NaHCO3, 2.5 KCl, 7 MgCl2, 0.5 
CaCl2, 1.25 NaH2PO4, 25 glucose, 11.6 ascorbic acid, and 3.1 pyruvic acid (339-
341 mOsm/kg; pH 7.75 adjusted with NaOH) for 2 min, then blocked and transferred into 




electroporated with Voltron-ST, 50 μL of JF525 dye (Janelia Farm; 12.5 nM of JF525 in 
10µL of DMSO mixed with 10 µL Pluronic F-127 (20% w/v in DMSO; Invitrogen) and 
30 µL of sterile PBS) was injected into the retro-orbital sinus one day before slicing. 
Coronal slices (300 μm thick) were cut with a Compresstome VF-300 slicing machine, 
then transferred to a holding chamber with artificial cerebrospinal fluid (ACSF) 
containing (in mM) 125 NaCl, 2.5 KCl, 25 NaHCO3, 2 CaCl2, 1 MgCl2, 1.25 NaH2PO4 
and 11 glucose (300-310 mOsm/kg; pH 7.35 adjusted with NaOH), and recovered for 10 
min at 34 °C, followed by another 30 min at room temperature. Slices were subsequently 
maintained at room temperature (22oC) until use. Both cutting solution and ACSF were 
constantly bubbled with 95% O2 and 5% CO2.  
For AAV injection, 21-day-old C57 BL/6J mice were anesthetized with isoflurane 
and placed in a small animal stereotaxic apparatus (David Kopf Instruments, CA, USA). 
Animals were injected with a volume of 200 nl rAAV8-Syn-Archon1-KGC-EGFP-
Kv2.1motif-ER2 using a Nanoject (Drummond Scientific Co Inc, Broomall, PA) via 
glass pipettes with 20-30 µm diameter tips in striatum: anteroposterior (AP) 1.2, 
mediolateral (ML) 2.1, dorsoventral (DV) 3.2. Brain slices were then prepared from these 
AAV-injected mice at postnatal day 30-35. Mice were deeply anesthetized with 
isoflurane and perfused transcardially using cold saline containing (in mM): 194 sucrose, 
30 NaCl, 4.5 KCl, 1.2 NaH2PO4, 0.2 CaCl2, 2 MgCl2, 26 NaHCO3, and 10 D-(+)-glucose 
saturated with 95% O2 and 5% CO2, pH=7.4 adjusted with NaOH, 320-340 mOsm/L. 
Coronal slices (250-300 µm thick) were cut using a slicer (VT1200 S, Leica 




Scientific System Design Inc., USA) at 32°C with regular ACSF containing (in mM): 136 
NaCl, 3.5 KCl, 1 MgCl2, 2.5 CaCl2, 26 NaHCO3 and 11 glucose saturated with 95% O2 
and 5% CO2, followed by at least one hour recovery at room temperature (21–25°C) 
before recording. 
Concurrent electrophysiology and fluorescence imaging in acute brain slice. 
For recording in Figure 1 and Figure 13, individual slices were transferred to a recording 
chamber mounted on an upright microscope (Olympus BX51WI, see below) and 
continuously superfused (2–3 mL/min) with carbogenated ACSF at room temperature. 
Whole cell patch-clamp recordings were performed with borosilicate glass pipettes 
(KG33, King Precision Glass Inc.) heat polished to obtain direct current resistances of 
∼4–6 MΩ. For cortex recordings, pipettes were filled with an internal solution containing 
in mM: 120 K-Gluconate, 2 MgCl2, 10 HEPES, 0.5 EGTA, 0.2 Na2ATP, and 0.2 
Na3GTP. For hippocampus and striatum recordings, pipettes were filled with an internal 
solution containing in mM: 131 K-Gluconate, 17.5 KCl, 9 NaCl, 1 MgCl2, 10 HEPES, 
1.1 EGTA, 2 Na2ATP, and 0.2 Na3GTP. Voltage clamp recordings were made with a 
microelectrode amplifier (Multiclamp 700B, Molecular Devices LLC). Cell membrane 
potential was held at -60 mV, unless specified otherwise. Signals were low-pass filtered 
at 2 kHz and sampled at 10–20 kHz with a Digidata 1440A (Molecular Devices LLC), 
and data were stored on a computer for subsequent off-line analysis. Cells in which the 
series resistance (Rs, typically 8–12 MΩ) changed by >20% were excluded from 
subsequent data analysis. In addition, cells with Rs more than 25 MΩ at any time during 




was made in both voltage and current clamp configurations. Positive neurons were 
identified for recordings on the basis of EGFP expression visualized with a microscope 
equipped with a standard GFP filter (BX-51WI, Olympus Corp.). Optical voltage 
recordings were taken through a 40x water immersion objective (Olympus LUMFL N 
40x/0.8W). Fluorescence was excited using a fiber-coupled 637 nm red laser (140mW, 
Coherent Obis 637-140 LX), and the emission was filtered through a 664 long pass filter. 
Images were collected on an EMCCD camera (Andor iXON Ultra 888) or sCMOS 
camera (Andor Zyla4.2 Plus Andor) in a reduced pixel window to enable acquisition at 
~1kHz. Each trial was about 30 seconds in duration. 
For optical recordings in Figure 3a, b, c and Figures 7, 8, 9, 14, acute brain slices 
were transferred to a recording chamber mounted on an inverted Eclipse Ti-E (Nikon) 
equipped with a CMOS camera (Zyla5.5, Andor), LEDs (Spectra, Lumencor), a 637nm 
Laser (637 LX, OBIS) focused on the back focal plane of a 40×NA 1.15 objective 
(Nikon), and a Polygon400 Multiwavelength Patterned Illuminator (Mightex) with 470 
nm LED (ThorLabs), and continuously superfused (2–3 mL/min) with carbogenated 
ACSF at room temperature. Positive cells were imaged under 0.8 or 1.5 W/mm2 (55 mW) 
excitation light power at 637 nm from the laser. 4-aminopyridine at a final concentration 
of 1 mM was added to induce neuronal activity for experiments in Figures 8, 16. For 
Figure 3a, b, c and Figure 16 cells were illuminated with 2 ms blue light pulses at light 




Mouse surgery. All in vivo mouse procedures were performed in accordance with 
the National Institute of Health Guide for Laboratory Animals and approved by the 
Boston University Institutional Animal Care and Use and Biosafety Committees.  
Virus injection surgery: All AAV was produced by the University of North 
Carolina Chapel Hill Vector Core. Adult female C57BL/6 mice (Charles River 
Laboratories, Inc.) or Chat-Cre mice (Chat-cre;129S6-Chattm2(cre)Lowl/J, the Jackson 
Laboratory), 8-12 weeks at the time of surgery, were used for all experiments. AAV-Syn-
SomArchon (5.9e12 genome copies (GC)/ml) or AAV-syn-SomArchon-P2A-CoChR-
Kv2.1 (2.19e13 GC/ml) was injected into the motor cortex (AP: +1.5, ML: +/-1.5, DV: -
0.3, 0.5uL virus), visual cortex (AP: -3.6, ML: +/-2.5, DV: -0.3, 0.5uL virus), 
hippocampus (AP: -2.0, ML: +1.4, DV: -1.6, 1uL virus) or striatum (AP: +0.8, ML: -1.8, 
DV: -2.1, 1uL virus). Viral injection occurred at 50-100nL/min (ten minutes total) using a 
10uL syringe (NANOFIL, World Precision Instruments LLC) fitted with a 33-gauge 
needle (World Precision Instruments LLC, NF33BL) and controlled by a microinfusion 
pump (World Precision Instruments LLC, UltraMicroPump3–4). The syringe was left in 
place for an additional 10 minutes following injection to facilitate viral spread. About one 
week following the viral injection, mice underwent a second surgery to implant the 
cranial window for in vivo imaging.  
Cortex imaging window implantation. The imaging window consisted of a 
stainless steel cannula (OD: 3.17mm, ID: 2.36mm, 1mm height, AmazonSupply, 
B004TUE45E) fitted with a circular coverslip (#0, OD: 3mm, Deckgläser Cover Glasses, 




Products Inc., Norland Optical Adhesive 60, P/N 6001). A craniotomy of ~3mm in 
diameter was created, with the dura left intact, over the motor cortex (centered at AP: 
+1.5, ML: +/-1.75) or visual cortex (AP: -3.6, ML: +/- 2.15). The imaging window was 
positioned over the cortex so that it was flush with the dura surface. Kwik sil adhesive 
(World Precision Instruments LLC, KWIK-SIL) was applied around the edges of the 
imaging window to hold the imaging window in place and to prevent any dental cement 
from touching the brain. Three small screws (J.I. Morris Co., F000CE094) were screwed 
into the skull to further anchor the imaging window to the skull. Dental cement was then 
gently applied to affix the imaging window to the exposed skull, and to mount an 
aluminum headbar posterior to the imaging window. 
Hippocampus and striatum imaging window implantation. Hippocampal and 
striatal window surgeries were performed similar to those described previously34. For 
each imaging window, a virus/drug infusion cannula (26G, PlasticsOne Inc., C135GS-
4/SPC) was attached to a stainless steel imaging cannula (OD: 3.17mm, ID: 2.36mm, 1 or 
2mm height, AmazonSupply, B004TUE45E). The bottom of the infusion cannula was 
flush with the base of the stainless steel cannula, and a circular coverslip (#0, OD: 3mm, 
Deckgläser Cover Glasses, Warner Instruments Inc., 64-0726 (CS-3R-0)) was adhered 
using a UV curable glue (Norland Products Inc., Norland Optical Adhesive 60, P/N 
6001).  An additional insulated stainless steel wire (Diameter: 130µm, PlasticsOne Inc., 
005SW-30S, 7N003736501F) was glued to the viral/drug infusion cannula with super 
glue (Henkel Corp., Loctite 414 and Loctite 713) and protruded from the bottom of the 




A craniotomy ~3mm in diameter was made over the hippocampus CA1 region 
(AP: -2.0, ML: +2.0) or the striatum (AP: +0.8, ML: -1.8). A small notch was made on 
the posterior edge of the craniotomy to accommodate the infusion cannula and LFP 
recording electrode. The overlying cortex was gently aspirated using the corpus callosum 
as a landmark. The corpus callosum was then carefully thinned in order to expose the 
hippocampus CA1 region or the dorsal striatum. The imaging window was positioned in 
the craniotomy, and Kwik sil adhesive (World Precision Instruments LLC, KWIK-SIL) 
was applied around the edges of the imaging window to hold it in place and to prevent 
any dental cement from touching the brain. Three small screws (J.I. Morris Co., 
F000CE094) were screwed into the skull to further anchor the imaging window to the 
skull, and a small ground pin was inserted into the posterior part of the brain near the 
lambda suture as a ground reference for LFP recordings. Dental cement was then gently 
applied to affix the imaging window to the exposed skull, and to mount an aluminum 
headbar posterior to the imaging window.  
In mice that did not receive a virus injection prior to window implantation, 1uL of 
AAV-syn-SomArchon (5.9e12 GC/ml) or 1uL of AAV-syn-SomArchon-P2A-CoChR-
Kv2.1 (2.19e13 GC/ml), or 1µL of AAV-CAG-FLEX-SomArchon (6.3e12 GC/ml) was 
injected through the virus/drug infusion cannula at 100nL/min through an internal 
infusion cannula (33G, PlasticsOne Inc., C315IS-4/SPC) connected to a microinfusion 
pump (World Precision Instruments LLC, UltraMicroPump3–4), one week after the 
window implantation surgery. The internal infusion cannula was left in place for 10 




throughout the injection period.  
All mice were treated with buprenex for 48 hours following surgery and single-
housed to prevent any damage to the headbar or window implant. 
In vivo imaging in the live mouse brain. All optical recordings were acquired on 
a conventional one-photon fluorescence microscope equipped with an ORCA Flash 4.0 
V3 Digital CMOS camera (Hamamatsu Photonics K.K., C13440-20CU) or Hamamatsu 
ORCA Fusion Digital CMOS camera (Hamamatsu Photonics K.K., C14440-20UP), 10x 
NA0.25 LMPlanFI air objective (Olympus Corp.), 40x NA0.8 LUMPlanFI/IR water 
immersion objective (Olympus Corp.), 20x NA1.0 XLUMPlanFL N water immersion 
objective (Olympus Corp.), 16x NA0.8 CFI LWD Plan Fluorite water immersion 
objective (Nikon), 470nm LED (ThorLabs Inc., M470L3), 140mW 637nm red laser 
(Coherent Obis 637-140X), a green filter set with a 470/25nm bandpass excitation filter, 
a 495nm dichroic, and a 525/50nm bandpass emission filter, and a near infrared filter set 
with a 635nm laser dichroic filter, and a 664nm long pass emission filter. The near 
infrared laser illuminated an area of ~80-150µm in diameter, and a mechanical shutter 
(Newport Corporation, model 76995) was positioned in the laser path to control the 
timing of illumination over the imaging window. Optical recordings were acquired at 
390-900Hz with HCImage Live (Hamamatsu Photonics K.K.) or NIS Elements (Nikon) 
software. HC Image Live data were stored as DCAM image files (DCIMG), and further 
analyzed offline in Fiji/ImageJ and MATLAB (Mathworks Inc.). NIS Elements data were 
stored as .nd2 files and further analyzed offline using the NIS Elements software. 




1024x1024 pixels with 2x2 binning to show cell structure and distribution. Optical 
voltage recordings were imaged in the near infrared channel (λex=637nm) with 2x2 or 
4x4 binning. OmniPlex system (PLEXON Inc.) was used to synchronize data acquisition 
from different systems. In all experiments, the OmniPlex system recorded the start of 
image acquisition from the sCMOS camera, the acquisition time of each frame, and other 
experiment-dependent signals described below. 
Optical imaging of spontaneous neural activity. All in vivo optical imaging of 
spontaneous neural activity was performed when mice were awake and head fixed in a 
custom holder that allowed for attachment of the headplate at the anterior end. Animals 
were covered with an elastic wrap to prevent upward movement. Spontaneous neural 
activity recordings lasted continuously up to 30,000 frames (~36 seconds).  
Eye puff. During some in vivo hippocampal imaging recordings, an eye puff was 
applied to evoke high frequency local field potential responses in the hippocampus 
(Figure 36). The mice were head fixed in a custom holder that allowed for attachment of 
the headplate at the anterior end, and they were covered with an elastic wrap to prevent 
upward movement. Each experimental session consisted of 20-30 trials, with each trial 
lasting for 5000 frames (~6 seconds). Three seconds after the start of image acquisition, 
the sCMOS camera sent a TTL pulse to a function generator (Agilent Technologies, 
model 33210A), which triggered a 100ms long air puff. The air puff was 5-10 psi, and 
administered via a 0.5mm cannula placed 2-3cm away from the mouse’s eye. The puff 




movement was monitored using a USB webcam (Logitech, Carl Zeiss Tessar 2.0/3.7 
2MP Autofocus). 
Optopatch blue light stimulation. All in vivo optopatch experiments were 
performed when mice were awake and head fixed in a custom holder that allowed for 
attachment of the headplate at the anterior end. Animals were covered with an elastic 
wrap to prevent upward movement. A 470nm LED (ThorLabs Inc., M470L3) was 
coupled to a Polygon400 Multiwavelength Patterned Illuminator (Mightex), and the blue 
light was focused through the objective lens to illuminate the center of the field of view. 
At the onset of imaging, the sCMOS camera sent a TTL pulse to trigger Axon CNS 
(Molecular Devices LLC, Digidata 1440A) which controlled the 470 nm LED 
(ThorLabs). Each trial lasted 1.1 second and consisted of a single 100 ms long blue light 
pulse, 500 ms after trial onset. Each recording session consisted of 10 trials with 
increasing blue light power from 0.1 to 1 mW/mm2, with a step of ~ 0.1 mW/mm2 per 
trial. The OmniPlex system (PLEXON Inc.) recorded the timing of TTL pulses used to 
trigger the Axon CNS. 
Head-fixed voluntary movement experiments. All voluntary movement 
experiments were performed while awake, head-fixed mice were freely navigating a 
spherical treadmill. The spherical treadmill was constructed following the design of 147. 
Briefly, a 3D spherical Styrofoam ball was supported by air, and motion was tracked 
using two computer mouse sensors positioned roughly +/- 45 degrees from center along 
the equator of the ball. All motion sensor displacement data was acquired at 100 Hz on a 




displacement data were then sent to the image acquisition computer to be accumulated 
using a modified ViRMEn MATLAB script. The timing of each motion sensor 
displacement data point was also recorded using the OmniPlex system (PLEXON Inc.) to 
synchronize movement data with optical voltage recordings. 
In order to determine the mouse movement speed, ball movement was first 
calibrated. The ball was pinned on the two sides and rotated vertically to calibrate sensor 
displacement. 
All mice were habituated on the spherical treadmill for at least three days, at least 
20 minutes per day, prior to image acquisition. During optical imaging, mice were 
imaged while freely navigating the spherical treadmill. Each field of view was recorded 
for at least 36 seconds total. In some fields of view, we performed multiple trials, and 
each trial was at least 12 seconds in duration with an inter-trial interval of at least 30 
seconds in duration. 
Local field potential recording. Local field potentials were recorded using an 
OmniPlex system (PLEXON Inc.) at a 1 kHz sampling rate. To synchronize optical 
recordings with LFP recordings, the camera sent out a TTL pulse to the OmniPlex system 
at the onset of imaging and after each acquired frame.  
Motion correction. In Figures 2i, 4, and 5, motion correction was performed 
with a custom Python script. For each field of view (FOV), if multiple video imaging 
files were collected for the same FOV, we started with the first imaging file to ensure 
speedy data processing (a single video file contains a series of images). We first 




performed a series of image processing procedures to enhance the contrast of the 
reference image and every image in the file to facilitate motion correction. We first 
removed 10% of the pixels along all edges of an image to remove any camera induced 
artifact. We then applied a high-pass filter (Python scipy package, 
ndimage.gaussian_filter, sigma=50) to remove low frequency components within the 
images. To enhance the boundary of high intensity areas, we identified the boundary as 
the difference between two low pass filtered images (sigma=2 and 1). We then enhanced 
the boundary by adding 100 times the boundary back to the low pass filtered image 
(sigma=2). We then limited the intensity range of the processed images within one 
standard deviation above and below the average intensity of the image, by setting the 
pixels with intensity higher than mean+std as mean+std, and the pixels with intensity 
lower than mean-std as zeroes. Finally, to counter any potential bleaching over time, we 
normalized the intensity of each image by shifting the mean intensity to zero and divided 
intensity values by the standard deviation of all pixel intensities in that image. After 
image processing, we calculated the displacement of each image, by identifying the max 
cross-correlation coefficient between each image and the reference image, and then 
corrected motion by shifting the displacement in the original, unenhanced image 
sequence. If the same FOV was imaged over an extended period of time, where multiple 
files were acquired, we motion-corrected subsequent files by aligning them to the first 
file, so that the same ROIs from the same FOV could be applied across the entire imaging 
session. Specifically, we first refined the reference frame by generating the mean 




reference image was then used to motion-correct all files of the same FOV, including the 
first file, using the same procedure described above. The motion-corrected, original, 
unenhanced image sequences, were then used for subsequent manual ROI segmentation, 
and further analysis.  
ROI identification. We imported the image files (motion-corrected as above, if 
necessary) into Fiji/ImageJ or NIS Elements and manually segmented ROIs by 
examining the time-series images to identify the area with clear neuron outlines and/or 
intensity dynamics over time. The optically-recorded voltage traces for each ROI were 
generated from the motion-corrected image sequences using the “multiple measurement” 
function and were then used for analyses. 
For Figure 2l and Figure 6, cells were densely packed, so we identified and 
tracked ROIs semi-manually across image sequences without performing motion 
correction. We first visually inspected all image sequences and identified those with 
minimal motion and with an SNR greater than ~2 for further analysis. We then performed 
an iterative ROI-selection procedure to identify ROIs that best fit each cell. Specifically, 
we started by manually selecting ROIs from the max projection image of the entire image 
sequence. The image sequence was then visually inspected to identify frames whose cells 
exhibited shifts of more than three pixels from the defined ROI. We then used these 
frames to separate the image sequence into multiple time intervals, and obtained a new 
set of max projection images to identify new ROIs within these time intervals for these 
cells. This procedure was repeated iteratively until the ROI represented the cell across all 




ROI. Thus, with this procedure, we created multiple ROIs representing the same cell 
across different frames. For each cell, we extracted traces for every ROI during its 
corresponding time interval, and stitched the baseline-normalized traces for the same 
cell(s) in time. The fluorescence traces of each cell were then detrended for further 
analysis. See Figure 40 for an example of raw and processed traces for two cells in the 
same field of view. 
Hippocampal spike detection. Spikes were associated with a rapid increase in 
intensity, followed by a rapid decrease. In contrast, occasional motion artifacts were 
usually associated with a decrease in intensity as a neuron moved out of the ROI. To 
facilitate spike detection, we first removed motion artifacts. For each time point of the 
fluorescence intensity trace for each ROI, we calculated the change in intensity from that 
of the prior time point (Ichange). We then defined noise as the time points where 
instantaneous Ichange were three standard deviations below the mean value of Ichange across 
the entire trace. We excluded any time points where the Ichange of the previous time point 
was more than one standard deviation above the average Ichange, because this might have 
indicated a spike. These noise time points and their following three time points (since we 
found that motion artifacts are typically >4ms) were then considered motion artifacts, and 
removed from further analysis. We then recalculated the standard deviation of the Ichange, 
excluding the data points of motion artifact. The peaks of spikes were then identified as 
time points with the following two criteria: 1) the intensity change of the time point 




above the average Ichange, and 2) the intensity change over the next two time points was 
less than two standard deviations below the average Ichange.  
Hippocampal spike phase calculation. Hippocampal spike-phase analysis was 
performed on 16 neurons from 7 FOVs from 4 mice. For each FOV, we analyzed data 
collected over 10 trials (~60 seconds total), where animals experienced an eye puff in 
each trial as described above in Eye puff. To calculate the phase of spikes at theta 
frequency (4-10 Hz), we first band-pass filtered both the optical voltage trace and the 
simultaneously recorded LFP at theta frequency (eegfilt, EEGLAB toolbox). The peaks 
of theta oscillation power were then identified with the findspike function in MATLAB. 
For each spike, we obtained the phase of the spike by calculating the timing of each spike 
relative to the period of that oscillation cycle in degrees. We averaged the phases of all 
spikes from the same neuron as the average phase of a given neuron. 
Analysis for pair-wise coherence between hippocampal neurons and LFPs. 
The coherence analysis was performed on 9 FOVs that contained multiple neurons from 
4 mice. Each FOV contained imaging data over a period of 6-36 seconds. For each FOV, 
we first re-sampled the LFP at the acquisition rate of the optical imaging. We then 
divided the optical voltage traces and LFPs into segments of 1000 data points. We then 
calculated the averaged coherence, at theta frequency (4-10 Hz), with the functions in the 
Chronux toolbox (optical voltage trace to optical voltage trace or LFP: coherencyc, and 
spike to spike: coherencypt) with tapers=[10 19], fpass=[4 10] and trialave=1. To 
compare Vmo-Vmo coherence vs. Vmo-LFP coherence across nine FOVs, we averaged the 




then performed statistical tests across FOVs using the individual FOV’s mean 
coherences. To understand the relationships between pairs of coherence, we used the 
MATLAB function, fitlm, to perform a linear regression between coherent pairs and 
obtain the p-value and r2 value.  
Striatum, motor cortex, and visual cortex spike detection. After motion 
correction, we first identified large fluorescence increases using a threshold of 4 standard 
deviations above the baseline. The baseline was manually selected as a period of >500ms 
without spiking or drifting due to z-plane shifting or photobleaching. From these large 
fluorescence increases, we selected those with shorter than 4 ms rise times and 4 ms 
decay times as spikes. 
Firing rate comparison of striatal neurons during high versus low speed 
movement. Animals’ movement data was first interpolated to the voltage imaging frame 
rate with MATLAB function interp1, and then smoothed using a 1.5Hz low pass 
Butterworth filter to remove any motion sensor artifact. We calculated the average 
movement speed at 0.5-second intervals and defined low speed periods as intervals where 
the average speed was ≤5cm/s and high speed periods as intervals where the average 
speed was ≥10cm/s. The firing rates during these high and low motion periods were 
compared, and a two-sided Wilcoxon rank sum test was used to determine significance 
between these periods. 
Signal to noise ratio (SNR) calculation for in vivo photostability evaluation 
over imaging duration in striatum and hippocampus. We defined noise as the 




neuron, we first calculated the SNR for each action potential by dividing the intensity 
change observed during an action potential by the noise, and then calculated the average 
SNRs across all spikes detected in a trial as the corresponding SNR for the trial. For the 
striatum dataset, only neurons imaged over at least 5 consecutive trials were analyzed. 
For the hippocampus dataset, all neurons were analyzed. 
Detrending. All optically-recorded SomArchon traces reported in the manuscript 
(except those in Figure 5) were corrected for photobleaching or focus shift by subtracting 
baseline fluorescence traces that were low-pass filtered and fit to a double or single 
exponential function. 
Histology. Mice were transcardially perfused with PBS followed by 4% 
paraformaldehyde. The brain was gently extracted from the skull and post-fixed in 4% 
paraformaldehyde for 1-4 hours at room temperature or overnight at +4oC. Fixed brains 
were transferred to a 30% sucrose-PBS solution and rotated 24-48 hours at 4C for 
cryoprotection. Cryoprotected brains were frozen in OCT in a dry ice bath and sliced 
(coronal) to 50µm thickness using a cryostat. Glial and microglial antibody staining were 
performed with anti-GFAP (1:250, Clone N206/A8, Neuromab) and anti-Iba1 (1:500, 
019-19741, Wako Chemicals) primary antibodies, followed by Alexa Fluor 568 and 633 
secondary antibodies (1:1000, InVitrogen). Slice imaging was performed using an 
inverted Nikon Eclipse Ti microscope equipped with a spinning disk sCSUW1 confocal 
scanner unit (Yokogawa, Tokyo, Japan), 488, 561, and 642 nm solid state lasers, 525/25 




a 4.2 PLUS Zyla camera (Andor), controlled by NIS-Elements AR software. Acquired 
images were contrast-enhanced to improve visualization. 
Brain temperature measurements. Under general anesthesia, a craniotomy 
~3mm in diameter was made to expose the brain surface, with a small notch on the 
posterior edge to accommodate the insertion of a temperature probe (Physitemp, IT-1E) 
coupled to a Thermocouple DAQ (DATAQ Instruments, Model DI-245). An imaging 
window, identical to those used in all imaging experiments, was positioned on the 
craniotomy. Kwik sil adhesive was applied around the edges of the imaging window to 
hold it in place, but not around the craniotomy notch to allow insertion of the temperature 
probe. Dental cement was then gently applied to affix the imaging window to the skull 
and to mount an aluminum headbar. Once recovered from anesthesia, mice were head 
fixed awake and the temperature probe was inserted under the imaging window above the 
brain surface, through the craniotomy notch. The 637 nm laser was directed through the 
40x objective under identical conditions to those used while imaging (75-95mW laser 
power), and brain temperature was recorded. We noted a temperature increase of 
1.88±0.80°C (mean±standard deviation, n = 3 mice) over the 12 second illumination 
period commonly used in our experiments.   
Sample size. No statistical methods were used to estimate sample size for animal 
studies throughout. We did not perform a power analysis, since our goal was to create a 
new technology; in the reference (Dell, R. B., Holleran, S. & Ramakrishnan, R. Sample 
size determination. ILAR. J. 43, 207–213 (2002)), as recommended by the NIH, “In 




required is difficult to estimate...”  As noted in the aforementioned paper, “The number of 
animals required is usually estimated by experience instead of by any formal statistical 
calculation, although the procedures will be terminated [when the goal is achieved].” 
These numbers reflect our past experience in developing neurotechnologies. 
Data exclusions. Voltage imaging datasets with significant motion or where no 
spikes were detected were excluded from analysis. 
Replication. All attempts at replication were successful. 
Randomization and blinding. No randomization or blinding were used for 






2.6 SUPPLEMENTARY INFORMATION 
Table 1: Characteristics of screened candidates of soma-localized Archon1.   
Full name of 
construct 
How far from the soma, 
approximately, was the 
fluorescence detected 
using visual inspection, 
in this study? 
Membrane/cytoplasmic 
localization detected using 
visual inspection in near-

























Membrane with significant 




30-60 μm Membrane with no aggregation 
12% of ΔF/F 





20-40 μm Membrane with no aggregation 
30% of ΔF/F 

























Membrane with minor 
aggregation in soma 
15% of ΔF/F 





Membrane with minor 
aggregation in soma 
15% of ΔF/F 





Cytoplasmic with bright puncta 
in soma 
Non-functional 


































































































































2.6.2 Statistical analyses  
Two-sided Wilcoxon Rank Sum test for Figure 1e between electrical and optical FWHM 
(full width, half maximum) of SomArchon-expressing neurons in mouse brain slices 
Table 2: Statistics for Figure 1e. 
FWHM Cortex 
p-value 0.0010 








Wilcoxon rank sum statistic 26 
 
Two-sided Wilcoxon Rank Sum test for Figure 4f comparing striatal neurons’ firing rate 
during periods of low speed movement vs. high speed movement  
Table 3: Statistics for Figure 4f. 
Cell p-value Wilcoxon rank sum statistic zval 
1 0.583 698.5 0.5497 
2 0.072 451 -1.7989 
3 0.043 417.5 -2.0238 
4 2.27E-07 3303 -5.176 
5 7.23E-05 2359 3.9684 
6 0.525 1071 -0.6359 
7 0.655 1086 -0.4468 
8 0.0012 865.5 -3.228 
9 0.815 1084.5 0.2336 
10 0.219 1418.5 1.228 
11 0.144 1075 -1.4617 
12 0.0015 7239 3.1753 
13 0.782 1296.5 -0.2768 





𝛘2 test for neurons included in Figure 5 testing against the null hypothesis of a uniform 
distribution. DOF is degrees of freedom. 
Table 4: Statistics for Figure 5. 
  LFP Vmo 
Cell # p-value 𝛘2 test statistic DOF p-value 𝛘2 test statistic DOF 
1 1.58E-07 64.925 17 1.10E-07 65.849 17 
2 0.0557 27.168 17 6.23E-40 232.946 17 
3 0.619 14.670 17 2.23E-29 180.564 17 
4 0.00117 40.308 17 4.14E-171 856.475 17 
5 0.12 23.983 17 1.67E-49 279.756 17 
6 0.51 16.190 17 1.72E-31 191.132 17 
7 0.271 20.064 17 3.66E-20 133.677 17 
8 0.618 14.688 17 1.11E-04 47.280 17 
9 0.643 14.340 17 7.73E-13 94.909 17 
10 0.718 13.263 17 3.92E-02 28.526 17 
11 0.0263 30.000 17 1.14E-08 71.596 17 
12 4.54E-06 56.109 17 1.00E-10 83.263 17 
13 2.23E-34 205.508 17 2.40E-165 829.457 17 
14 0.0636 26.641 17 5.47E-02 27.237 17 
15 2.87E-05 51.073 17 1.46E-22 146.035 17 
16 0.891 10.283 17 4.57E-04 43.146 17 
 
 
Two-sided Wilcoxon Rank Sum test between the averaged Vmo-Vmo coherence and Vmo-
LFP coherence in main text results about Figure 6, “Population imaging of spiking and 
subthreshold oscillations in hippocampal neurons.” 
Table 5: Statistics for Figure 6. 
p-value 7.82E-04 
Wilcoxon rank sum statistic 121 
 
Two-sample Kolmogorov-Smirnov (K-S) tests comparing fluorescence intensity of 
Archon1 vs. SomArchon at different positions along neurites in cortex, hippocampus, and 





Cortex          Hippocampus       Striatum 
















5 0.0006  5 0.1543  5 0.1103 
10 0.1451  10 1.54E-05  10 0.1672 
15 0.0973  15 0.0007  15 0.5598 
20 1.43E-05  20 5.83E-05  20 0.1542 
25 3.81E-08  25 3.74E-06  25 0.0011 
30 1.54E-09  30 2.53E-07  30 8.34E-05 
35 1.22E-13  35 6.37E-08  35 5.48E-07 
40 5.06E-15  40 6.37E-08  40 5.48E-07 
45 3.14E-16  45 1.16E-08  45 1.65E-09 
50 7.69E-16  50 1.73E-08  50 5.48E-07 
55 4.91E-18  55 2.97E-09  55 1.27E-08 
60 6.44E-17  60 5.89E-11  60 1.65E-09 
65 8.50E-18  65 1.26E-11  65 1.65E-09 
70 3.83E-17  70 2.59E-12  70 8.12E-07 
75 3.83E-17  75 2.59E-12  75 1.96E-07 
80 2.38E-17  80 2.59E-12  80 3.80E-08 
85 3.30E-16  85 2.78E-11  85 6.90E-08 
90 1.08E-15  90 2.78E-11  90 1.08E-08 
95 1.19E-13  95 1.42E-11  95 1.30E-07 
100 2.75E-12  100 4.42E-11  100 4.56E-08 
 
 
Two-sided Wilcoxon Rank Sum test for the membrane resistance of SomArchon-






Table 7: Statistics for Figure 13, part 1. 
Membrane Resistance Cortex 
p-value 0.0124 
Wilcoxon rank sum statistic 37 
 
Membrane Resistance Hippocampus 
p-value 0.6294 
Wilcoxon rank sum statistic 68.5 
 
Membrane Resistance Striatum 
p-value 0.7308 
Wilcoxon rank sum statistic 52 
 
Two-sided Wilcoxon Rank Sum test for the membrane capacitance of SomArchon-
expressing vs. non-expressing neurons in mouse brain slices (see Figure 13) 
 
Table 8: Statistics for Figure 13, part 2. 
Membrane Capacitance Cortex 
p-value 0.0024 
Wilcoxon rank sum statistic 121 
 
Membrane Capacitance Hippocampus 
p-value 0.9720 
Wilcoxon rank sum statistic 52 
 
Membrane Capacitance Striatum 
p-value 0.8357 





Two-sided Wilcoxon Rank Sum test for the resting potential of SomArchon-expressing 
vs. non-expressing neurons in mouse brain slices (see Figure 13) 
Table 9: Statistics for Figure 13, part 3. 
Resting Potential Cortex 
p-value 0.5482 
Wilcoxon rank sum statistic 84.5 
 
Resting Potential Hippocampus 
p-value 0.7789 
Wilcoxon rank sum statistic 67 
 
Resting Potential Striatum 
p-value 0.7308 
Wilcoxon rank sum statistic 39 
 
Two-sided Wilcoxon Rank Sum test for the full width half maximum (FWHM) per action 
potential of SomArchon-expressing vs. non-expressing neurons in mouse brain slices (see 
Figure 13) 
 
Table 10: Statistics for Figure 13, part 4. 
FWHM Hippocampus 
p-value 0.0037 









Two-sided Wilcoxon Rank Sum test for Figure 16c,  ∆F/F tested in mouse brain slices, 
between SomArchon and  other voltage sensors (ASAP3-Kv, Voltron-ST, QuasAr3-s, 
and paQuasAr3-s). 
 
Table 11: Statistics for Figure 16, part 1. 
∆F/F ASAP3-Kv 
p-value 0.0029 












Wilcoxon rank sum statistic 153 
 
Two-sided Wilcoxon Rank Sum test for Figure 16d, the SNR of SomArchon versus 
other voltage sensors (ASAP3-Kv, Voltron-ST, QuasAr3-s, and paQuasAr3-s) in mouse 
brain slices 
 
Table 12: Statistics for Figure 16, part 2. 
SNR ASAP3-KV 
p-value 6.75x10−6 















Wilcoxon rank sum statistic 123 
 
Repeated measures ANOVA for Figure 37 





post hoc Tukey’s HSD test 
Trial 1 2 3 4 5 
1  0.979088 0.600956 0.515978 0.36467 
2 0.979088  0.440704 0.401273 0.214062 
3 0.600956 0.440704  0.901844 0.003871 
4 0.515978 0.401273 0.901844  0.1066 






post hoc Tukey’s HSD test 
Trial 1 2 3 4 5 
1  0.907207 0.958312 0.999869 0.982537 
2 0.907207  0.576767 0.705478 0.617842 
3 0.958312 0.576767  0.831883 0.997305 
4 0.999869 0.705478 0.831883  0.931505 









post hoc Tukey’s HSD test 
Trial 1 2 3 4 5 
1  0.055919 0.882805 1 0.98906 
2 0.055919  0.999996 0.991153 0.944225 
3 0.882805 0.999996  0.996383 0.95811 
4 1 0.991153 0.996383  0.804642 






post hoc Tukey’s HSD test 
Trial 1 2 3 4 5 6 7 8 9 10 
1  0.001593 0.04591 0.574795 0.688343 0.999087 1 1 0.93142 0.580117 
2 0.001593  0.012262 2.57E-06 9.58E-05 9.54E-05 1.50E-05 0.000104 0.000122 0.000486 
3 0.04591 0.012262  0.061443 0.000648 0.001063 8.37E-06 0.000308 0.000151 0.000585 
4 0.574795 2.57E-06 0.061443  0.999964 0.923573 0.144261 0.223195 0.053445 0.055324 
5 0.688343 9.58E-05 0.000648 0.999964  0.860278 0.004366 0.028524 0.004819 0.009799 
6 0.999087 9.54E-05 0.001063 0.923573 0.860278  0.556941 0.270504 0.017902 0.040012 
7 1 1.50E-05 8.37E-06 0.144261 0.004366 0.556941  0.95185 0.038815 0.102821 
8 1 0.000104 0.000308 0.223195 0.028524 0.270504 0.95185  0.007861 0.14383 
9 0.93142 0.000122 0.000151 0.053445 0.004819 0.017902 0.038815 0.007861  0.684809 











post hoc Tukey’s HSD test 
Trial 1 2 3 4 5 6 7 8 9 10 
1  0.000291 0.000278 0.002971 1.02E-05 0.002021 0.000753 0.000878 0.000441 0.000109 
2 0.000291  1 0.97404 0.999693 0.999988 0.999997 1 0.999996 0.947458 
3 0.000278 1  0.455752 0.999813 1 0.999999 1 0.999994 0.878177 
4 0.002971 0.97404 0.455752  0.343328 0.872355 0.453222 0.304404 0.176835 0.179375 
5 1.02E-05 0.999693 0.999813 0.343328  1 1 0.999487 1 0.762035 
6 0.002021 0.999988 1 0.872355 1  1 1 1 0.981192 
7 0.000753 0.999997 0.999999 0.453222 1 1  0.999909 1 0.936697 
8 0.000878 1 1 0.304404 0.999487 1 0.999909  0.99915 0.581095 
9 0.000441 0.999996 0.999994 0.176835 1 1 1 0.99915  0.584717 
10  0.000291 0.000278 0.002971 1.02E-05 0.002021 0.000753 0.000878 0.000441 0.000109 
 




post hoc Tukey’s HSD test 
Trial 1 2 3 4 5 6 7 8 9 10 
1  0.921965 0.944598 0.996829 0.70055 0.907368 0.992801 0.944117 0.959096 0.999999 
2 0.921965  0.999999 1 0.994524 1 0.999985 1 1 0.973125 
3 0.944598 0.999999  0.999876 0.999961 1 0.995943 0.999998 0.999875 0.896394 
4 0.996829 1 0.999876  0.946252 0.99998 1 1 1 0.883532 
5 0.70055 0.994524 0.999961 0.946252  0.991271 0.883536 0.986476 0.874771 0.601617 
6 0.907368 1 1 0.99998 0.991271  0.995514 0.999999 0.999564 0.940647 
7 0.992801 0.999985 0.995943 1 0.883536 0.995514  0.999995 0.999999 0.995133 
8 0.944117 1 0.999998 1 0.986476 0.999999 0.999995  0.999999 0.951565 
9 0.959096 1 0.999875 1 0.874771 0.999564 0.999999 0.999999  0.936649 












post hoc Tukey’s HSD test 
Trial 1 2 3 4 5 6 7 8 9 10 
1  0.28304 0.68783 0.68004 0.99142 1 0.99999 0.99998 0.99643 0.99777 
2 0.28304  0.46636 0.99993 0.049266 0.020181 0.00056424 0.00079058 4.7664e-05 0.973 
3 0.68783 0.46636  0.98407 0.41356 0.071376 0.0015959 0.0010367 4.797e-05 0.99967 
4 0.68004 0.99993 0.98407  0.031141 0.022343 0.0013281 0.00019081 2.2154e-05 0.9435 
5 0.99142 0.049266 0.41356 0.031141  0.51441 0.019361 0.0057928 0.0012401 1 
6 1 0.020181 0.071376 0.022343 0.51441  0.11384 0.05668 0.061031 0.98715 
7 0.99999 0.00056424 0.0015959 0.0013281 0.019361 0.11384  1 0.87884 0.79075 
8 0.99998 0.00079058 0.0010367 0.00019081 0.0057928 0.05668 1  0.68336 0.63414 
9 0.99643 4.7664e-05 4.797e-05 2.2154e-05 0.0012401 0.061031 0.87884 0.68336  0.4607 












post hoc Tukey’s HSD test 
Trial 1 2 3 4 5 6 7 8 9 10 
1  0.00035545 0.010149 0.0058873 0.0020157 0.022518 0.31433 0.10414 0.098306 0.011564 
2 0.00035545  0.46828 0.029797 0.2885 9.255e-05 0.9993 0.090932 0.030078 0.70542 
3 0.010149 0.46828  0.99018 0.99993 0.9636 1 0.95964 0.75254 0.39425 
4 0.0058873 0.029797 0.99018  0.99932 1 0.99893 1 0.99922 0.22413 
5 0.0020157 0.2885 0.99993 0.99932  0.99972 0.99983 0.99927 0.86987 0.18828 
6 0.022518 9.255e-05 0.9636 1 0.99972  0.99824 1 0.99486 0.28566 
7 0.31433 0.9993 1 0.99893 0.99983 0.99824  0.97896 0.89708 0.60837 
8 0.10414 0.090932 0.95964 1 0.99927 1 0.97896  0.99913 0.2488 
9 0.098306 0.030078 0.75254 0.99922 0.86987 0.99486 0.89708 0.99913  0.22088 






2.6.3 Comparison of GEVI performance in mouse brain slices and live mice 


















Slice In vivo Slice In vivo 
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neocortical 
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26 in striatum; 
ND 37 in cortex 
L2/3 at 
1.5W/mm2, 
500Hz; 20 in 
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1.5W/mm2, 





























12 in striatum 
at 4W/mm2, 




Ex – excitation wavelength; 
Em – emission wavelength; 
ND – not determined; 
avoltage kinetics evaluated by bi-exponential fitting (in the format fast/slow), where the value in parentheses represents the % of current magnitude in 
the fast τ component; bestimated from traces presented in the indicated paper; cdata from this study measured for soma localized version of the sensors, 





Table 15: Number of manually selected neurons during in vivo population imaging in the 
hippocampus of awake mice.  






Mouse1_FOV1 15 8 27 741 
Mouse1_FOV2 9 8 27 741 
Mouse1_FOV3 18 10 27 741 
Mouse1_FOV4 11 9 27 741 
Mouse1_FOV5 15 11 27 741 
Mouse1_FOV6 18 12 27 741 
Mouse1_FOV7 11 6 13.5 741 
Mouse2_FOV1 12 8 24.2 826 
Mouse2_FOV2 6 4 24.2 826 
Mouse2_FOV3 11 9 24.2 826 
Mouse2_FOV4 15 9 24.2 826 
Mouse2_FOV5 14 7 24.2 826 
Mouse2_FOV6 15 6 24.2 826 
 
Table 16: Fitting line parameter for correlations between the spike-spike coherence and the 
Vmo-Vmo coherence at theta frequency for various cell-cell distances.   
Distance (m) # Neuron Pairs R2 Slope Intercept 
10-20 4 0.3962 0.280 0.072 
20-30 9 0.2063 0.140 0.041 
30-40 6 0.0072 0.043 0.130 






2.6.4 Supplementary Figures for Chapter 2 
 
Figure 7: Wide-field fluorescence imaging of live mouse brain slice expressing Archon1 and 
SomArchon.  
Individual cell bodies of neurons cannot be resolved using high-resolution wide-field microscopy of 




labeling densities achievable with a standard gene expression technique like in utero electroporation 
(IUE). In contrast, under identical expression and imaging conditions Archon1-KGC-EGFP-
Kv2.1motif-ER2 (SomArchon)-expressing neurons are easily resolvable. Fluorescence images of 
cortical neurons in 300-µm coronal live brain slices expressing (a, b) Archon1 and (c, d) SomArchon 
acquired using a wide-field microscope with (a, c) 10x and (b, d) 40x objective lenses (imaging 
conditions: excitation 475/34BP from an LED and emission 527/50BP; camera Andor Zyla5.5, 
binning 1x1; objective lens: 10x NA0.45, 40x NA1.15). Scale bar, 100 µm. (e, f) Normalized green 
fluorescence intensity profiles measured along white lines for the images shown in b and d, 
respectively. Black dots correspond to the resolvable cell bodies along the white lines. Resolvable 
cells were identified using two parameters: 1) peak intensity was 15-20% above baseline and 2) peak 
widths were between 10-20µm corresponding to neuron diameters. (g) Quantification of number of 
resolvable cell bodies per field of view (FOV) for Archon1- and SomArchon-expressing brain slices 
imaged with an Andor Zyla5.5 camera under a 40x NA1.15 objective (n = 7 slices from 2 mice each 
for Archon1 and SomArchon, respectively). SomArchon enables a 9-fold increase in number of 
resolvable cell bodies per voxel under wide-field microscopy in the cortex over Archon1 (number of 







Figure 8: Voltage imaging using SomArchon in IUE transduced mouse brain slice. 
 (a) Fluorescence wide-field images of a selected field of view in cortex layer 2/3 (top) with selected 
ROIs corresponding to somata (bottom). Imaging conditions: ƛex = 637-nm laser light at 1.5 W/mm2, 
emission with 664LP, exposure time 2.3 ms. Scale bar, 25 µm. (b) Representative single-trial 
fluorescence traces from cells shown in a. Image acquisition rate 440 Hz. (c) Fluorescence images of a 
selected field of view in the hippocampus (top) with selected ROIs corresponding to somata (bottom). 
Imaging conditions: ƛex = 637-nm laser light at 1.5 W/mm2, emission with 664LP, exposure time 3 ms. 
Scale bar, 25 µm. (d) Representative fluorescence traces from cells shown in c. Image acquisition rate 






Figure 9: Voltage imaging using SomArchon in AAV transduced mouse brain slice. 




ROIs corresponding to somata (bottom). Imaging conditions: ƛex = 637-nm laser light at 1.5 W/mm2, 
emission with 664LP, exposure time 1.6 ms. Scale bar = 25 µm. (b) Representative single-trial 
fluorescence traces from cells shown in a. Image acquisition rate 632 Hz. (c) Fluorescence images of a 
selected field of view in the striatum (top) with selected ROIs corresponding to somata (bottom). 
Imaging conditions: ƛex = 637-nm laser light at 1.5 W/mm2, emission with 664LP, exposure time 1.4 
ms. Scale bar = 25 µm. (d) Representative single-trial fluorescence traces from cells shown in c. 
Image acquisition rate 733 Hz. (e) Fluorescence images of a selected field of view in the thalamus 
(top) with selected ROIs corresponding to somata (bottom). Imaging conditions: ƛex = 637-nm laser 
light at 1.5 W/mm2, emission with 664LP, exposure time 3 ms. Scale bar = 25 µm. (f) Representative 






Figure 10: Quantification of Archon1 and SomArchon localization in neurons in brain slices. 
(a) Representative confocal images of neurons in cortex layer 2/3 (top), hippocampus (middle), and 
striatum (bottom) expressing Archon1-KGC-EGFP-ER2 (Archon1; left column) and Archon1-KGC-
EGFP-Kv2.1motif-ER2 (SomArchon; right column). Images acquired via EGFP fluorescence using 
laser excitation at 488 nm and emission 525/50 nm. Scale bars, 50 µm. (b-d) Quantification of EGFP 
brightness versus position along a neurite, normalized to EGFP brightness at the soma, extracted from 
neurites of Archon1 (left) and SomArchon (right) expressing neurons in (b) cortex layer 2/3 (n= 39 
and 37 neurites taken from 10 cells from 2 mice each for Archon1 and SomArchon, respectively), (c) 
hippocampus (n= 20 and 34 neurites taken from 9 and 17 cells from 2 mice each for Archon1 and 
SomArchon, respectively), and (d) striatum (n= 17 and 20 neurites taken from 7 cells from 2 mice 
each for Archon1 and SomArchon, respectively). Shown are box plots with notches (narrow part of 
notch, median; top and bottom of the notch, 95% confidence interval for the median; top and bottom 
horizontal lines, 25% and 75% percentiles for the data; whiskers extend 1.5× the interquartile range 
from the 25th and 75th percentiles; horizontal line, mean). P > 0.05 compared to Archon1 at 
corresponding position away from the soma, not significant (n.s.), throughout all panels of this figure; 
P* < 0.002 compared to Archon1 at corresponding position away from the soma; two-sample 









Figure 11: Expression of Archon1 and SomArchon in cortex and hippocampus.  
Archon1 or SomArchon expression in mouse brain transduced by IUE at E15.5 and analyzed at P20-
P30. (a-f) Fluorescence images from 50-µm thick coronal sections of (a, c, e) Archon1- and (b, d, f) 
SomArchon-expressing brain slices (EGFP channel shown in green; Nissl staining is shown in 
magenta; near-infrared fluorescence of Archon1 and SomArchon did not survive formaldehyde 
fixation). (a, b) Whole brain overview from the hemisphere targeted by IUE demonstrating expression 
of (a) Archon1 and (b) SomArchon in neurons in cortex layers 2/3 and hippocampus. Scale bar, 250 
μm. (c-f) Higher magnification confocal images show expression of (c, e) Archon1 and (d, f) 
SomArchon in (c, d) cortex layer 2/3 and (e, f) hippocampus. Scale bar, 50 µm. Under such confocal 
imaging conditions, SomArchon enables a 15-fold increase in the number of resolvable cell bodies in 
the cortex per voxel over Archon1 (n = 4, 8, 9, 11, 11, 18, and 20 neurons from 7 slices for Archon1 
and n = 180, 187, and 137 neurons from 3 slices for SomArchon, respectively; dimensions of FOV are 






Figure 12: Expression of Archon1 and SomArchon in striatum. 
Archon1 or SomArchon were expressed in mouse brain by AAV2-Syn-Archon1 and AAV2-Syn-
SomArchon injection. Fluorescence images from 50-µm thick coronal sections of (a, c) Archon1- and 
(b, d) SomArchon-expressing brain slices visualized via EGFP fluorescence (near-infrared 
fluorescence of Archon1 and SomArchon did not survive formaldehyde fixation). (a, b) Overview 
from the hemisphere targeted by AAV injection demonstrating expression of (a) Archon1 and (b) 
SomArchon in neurons in striatum. Scale bar, 1 mm. (c-d) Higher magnification confocal images 









Figure 13: Membrane properties of neurons in mouse brain slices. 
(a) Quantification of membrane resistance (left), membrane capacitance (middle), and resting 
potential (right) of Archon1-expressing (hashed boxes) and SomArchon-expressing (open boxes) 
neurons in cortex layer 2/3 of live mouse brain slices (n = 8 and 18 cells from 1 and 2 mice for 
Archon1 and SomArchon, respectively). (b) Quantification of (from left to right) membrane 
resistance, membrane capacitance, resting potential, and full width half maximum per action potential 
(FWHM) of SomArchon-negative (hashed boxes) and SomArchon-expressing (open boxes) neurons 
in hippocampus of acute mouse brain slices (n = 8 and 7 cells from 2 mice each for negative and 
SomArchon, respectively). (c) Quantification of (from left to right) membrane resistance, membrane 
capacitance, resting potential, and full width half maximum per action potential (FWHM) of 
SomArchon-negative (hashed boxes) and SomArchon-expressing (open boxes) neurons in striatum of 
mouse brain slices (n = 7 and 6 cells from 2 mice each for negative and SomArchon, respectively). 
Wilcoxon Rank Sum tests were performed (see Table 7, 8, 9 for full statistics). Box plots with notches 
are used throughout this paper (narrow part of notch, median; top and bottom of the notch, 95% 
confidence interval for the median; top and bottom horizontal lines, 25th and 75th percentiles for the 
data; whiskers extend 1.5x the interquartile range from the 25th and 75th percentiles; horizontal line, 






Figure 14: Expression of SomArchon does not cause gliosis. 
SomArchon was expressed in the mouse brain by an AAV2-Syn-SomArchon-P2A-CoChR-KV2.1motif 
injection targeted to the cortex in P0 Swiss Webster mice. Brain tissues were analyzed 63 days post 
viral injection.  Fluorescence images from 50-µm thick coronal sections were visualized via the EGFP 
fluorescence of SomArchon (ii), anti-Iba1 immunofluorescence (iii), and anti-GFAP 
immunofluorescence (iv). (a) Expression throughout the coronal section. (b) Zoomed-in view on the 
virally injected area (high expression cortex). (c) Zoomed-in view on the non-injected hemisphere 
(low expression cortex).  GFAP and Iba1, commonly used glial and microglial markers, showed 
similar appearance on the virally injected hemisphere versus the non-injected hemisphere, suggesting 






Figure 15: Long-term imaging of SomArchon does not cause phototoxicity.  
Illumination of live cells can result in photo-induced cell damage, generally termed phototoxicity, that 
can compromise the results obtained using live-cell fluorescence imaging. Therefore, we assessed 
phototoxicity under various imaging conditions to assess whether optical voltage recordings using 
SomArchon had impact on biological processes or cell health. To quantify phototoxicity, we 
quantified (a,b) relative reactive oxygen species (ROS) concentration, (c) live/dead cell ratios, (d) cell 
morphology, and (e,f,g) the probability of evoking spikes upon optogenetic stimulation. Control 
samples were negative neurons without SomArchon expression. (a) Changes of relative ROS 
concentration measured in representative negative- (solid line) and SomArchon-expressing (dashed 
line) cultured mouse neurons at days in vitro (DIV) 14-18, under 10 minutes of continuous LED 
illumination at 390/22 nm and 475/36 nm, and laser illumination at 637 nm, followed by 10 mins in 




details), 10 mins after the offset of illumination. Cell death was detected using the NucGreen live/dead 
stain as described in the Methods section. (b) Quantification of maximal normalized increase in ROS 
concentration during continuous illumination for experiments performed as in a (n = 45, 24, and 8 
negative neurons from 2, 2, and 1 cultures for 390/22 nm, 475/36 nm, and 637 nm illumination, 
respectively, and n = 24 SomArchon-expressing neurons for 637 nm illumination from 1 culture). 
Increase in ROS concentration was normalized to the baseline concentration of ROS before 
illumination. Shown are box plots with notches (narrow part of notch, median; top and bottom of the 
notch, 95% confidence interval for the median; top and bottom horizontal lines, 25% and 75% 
percentiles for the data; whiskers extend 1.5 × the interquartile range from the 25th and 75th 
percentiles; horizontal line, mean). (c) Cell death for negative- (solid line) and SomArchon-expressing 
(dashed line) cultured mouse neurons at DIV 14-18 under 10 minutes continuous LED illumination at 
390/22 nm and 475/36 nm, and laser illumination at 637 nm. Percentage of dead cells was measured 
using NucGreen live/dead stain (n = 45, 35, 91, 40, and 27 neurons from 2, 1, 2, 1, and 1 cultures 
respectively for 390/22 nm at 2.8 mW/mm2, 390/22 nm at 5.5 mW/mm2, 475/36 nm at 12 mW/mm2, 
475/36 nm at 25 mW/mm2, and 637 nm at 1500 mW/mm2 illumination). (d) Bright-field and 
fluorescence images of representative neurons expressing SomArchon before and after 10 min of 
continuous 637nm laser illumination at 1500 mW/mm2, followed by 10 min in darkness (93% of 
imaged cells did not exhibit noticeable changes in morphology; n = 27 cells from 1 culture; non-
imaged cells did not show any changes in morphology; n = 10 cells from 1 cultures). Scale bar, 50 
µm. (e) Representative fluorescence trace of SomArchon reporting activity of a neuron co-expressing 
SomArchon and CoChR-Kv2.1motif. Neuronal activity was triggered by pulsed LED blue light 
illumination (470/20 nm, 10 Hz, 2 ms per pulse at 0.14 mW/mm2, blue bars), and imaged by 
continuous red laser light excitation (637 nm, at 1.5 W/mm2; acquisition rate, 826 Hz). Baseline was 
corrected for photobleaching, reduction in spike amplitude over time was due to photobleaching under 
the light illumination applied (1.5 W/mm2). (f) Detection of spikes elicited by blue light illumination 
(as shown in e) dropped after 300 s of continuous recording due to the decrease in spike amplitude as 
a result of photobleaching (n = 10 neurons from 1 culture; black squares, mean value; error bars, 
standard deviation). (g) Normalized (to its initial value) full width half maximum (FWHM) of action 
potentials elicited by light in the experiment shown in f (n =10 neurons; black squares, mean value; 
error bars, standard deviation). All measurements were performed at 22oC. One of the effects related 
to phototoxicity is the generation of reactive oxygen species (ROS) that in turn trigger downstream 
physiological changes in cell condition. The high-intensity red illumination used for SomArchon 
imaging resulted in smaller changes in ROS concentration than blue light illumination of SomArchon-
negative neurons at the modest intensities typically used for GFP imaging. Moreover, the 
concentration of ROS relaxed to baseline levels after 10 min in darkness. Long-term voltage imaging 
did not influence cell morphology, excitability of neurons, and action potential waveforms, parameters 
often measured to assess the health of neuronal cells. In summary, these results indicate that 






Figure 16: Comparison of fluorescence voltage sensor performance in brain slices and cultured 
neurons. 
(a) Representative fluorescence images of mouse cortex layer 2/3 neurons expressing ASAP3- 
Kv2.1motif (ASAP3-Kv), Ace2N-HaloTag-KGC-ER2-KV2.1motif (Voltron-ST), QuasAr3-PP-mCitrine-
Kv2.1motif-ER2 (QuasAr3-s), and paQuasAr3-PP-mCitrine-Kv2.1motif-ER2 (paQuasAr3-s). ASAP3-
Kv, QuasAr3-s and paQuasAr3-s were visualized via cpGFP, mCitrine, and mCitrine fluorescence, 
respectively, using laser excitation at 488 nm and emission at 525/50 nm under a confocal microscope. 
Voltron-ST was visualized via JF525 fluorescence using LED excitation at 510/25 nm and emission at 
545/40 nm under a wide-field microscope. Scale bar, 50 µm. (b) Single-trial optical recordings of 
ASAP3-Kv (green) and Voltron-ST/JF525 (orange) fluorescence responses during 4-aminopyridine 
evoked neuronal activity, and QuasAr3-s (blue), paQuasAr3-s (brown), and SomArchon (red) 
fluorescence responses during CoChR-mTagBFP2-Kv2.2motif evoked neuronal activity. Imaging 
conditions: ASAP3-Kv excitation at 475/34 nm from an LED at 25 mW/mm2 and emission at 
527/50nm; Voltron-ST/JF525 excitation at 510/25 nm from an LED at 29 mW/mm2 and emission at 
545/40 nm; QuasAr3-s, paQuasAr3-s, and SomArchon excitation at 637-nm from a laser at 1.5 
W/mm2 and emission at 664LP; acquisition rate for all recordings ~500 Hz (the excitation light 
intensity for ASAP3-Kv and Voltron-ST/JF525 was chosen based on the imaging conditions used for 
the sensor comparison reported in ref121). Blue light (470/20 nm) pulses, shown as vertical blue bars, 2 




Quantification of (c) ΔF/F and (d) signal-to-noise ratio (SNR) per AP across all recordings performed 
in cortex layer 2/3(n = 18, 14, 9, 13, and 14 neurons from 1, 2, 2, 2, and 2 mice for ASAP3-Kv, 
Voltron-ST/JF525, QuasAr3-s, paQuasAr3-s, and SomArchon, respectively). Shown are box plots 
with notches (narrow part of notch, median; top and bottom of the notch, 95% confidence interval for 
the median; top and bottom horizontal lines, 25% and 75% percentiles for the data; whiskers extend 
1.5 × the interquartile range from the 25th and 75th percentiles; horizontal line, mean). *p-value < 
0.01, Wilcoxon rank sum test; see Table 11, 12 for full statistics. (e) Photobleaching curves of 
ASAP3-Kv, Voltron-ST/JF525, and SomArchon1 under continuous illumination (n= 11, 8, and 17 
neurons from 1 culture, respectively; 475/34BP from an LED at 25 mW/mm2 for ASAP3-Kv, 510/25 
nm from LED at 29 mW/mm2 for Voltron-ST, and 637-nm laser light at 1500 mW/mm2 for 
SomArchon; initial SNR of APs under used imaging conditions was 15 ± 5, 14 ± 4, and 19 ± 8 for 
ASAP3-Kv, Voltron-ST/JF525, and SomArchon). Administration of the JF525 dye was optimized to 
reduce background fluorescence created by the internalized dye (see Methods section for details). All 




Figure 17: Fluorescence images of mouse brain sections prepared after in vivo imaging. 
Fluorescence images of brain slices expressing SomArchon in (a) motor cortex, (b) visual cortex, (c) 
hippocampus, and (d) striatum. Dotted line indicates the position of optical imaging window used for 






Figure 18: Dendritic voltage imaging in the hippocampus and striatum of awake mice. 
(a) Fluorescence image of a hippocampal neuron expressing SomArchon with ROIs selected at the 
soma and on four proximal dendrites. Scale bar, 20 µm. (b) Optical voltage traces from the selected 
ROIs shown in a. (c) Fluorescence image of a striatal neuron expressing SomArchon with ROIs 
selected at the soma and on three proximal dendrites. Scale bar, 20 µm. (d) Optical voltage traces 
from the selected ROIs shown in c. Imaging conditions: 637-nm laser excitation at 4 W/mm2; 
emission 664 nm longpass filter; image acquisition rate: 826 Hz. Black arrows indicate some of the 
time points where dendritic voltage transients visibly differed from those in the soma. 
 
Figures 19-31: Population voltage imaging was performed in the CA1 region of 
hippocampus in awake mice. Images were acquired using a 16x objective lens with 1.6 
W/mm2 (95mW) laser power and acquired at 741-826 Hz. The average intensity 
projection image for each video (top image) was used to manually select neurons (bottom 
image). Optical voltage traces for each neuron are plotted below, with colors 
corresponding to the regions of interest (ROIs) in the image above. Shown are 1.2 
seconds of simultaneously recorded voltage for all neurons highlighted in ROIs (left), and 
a period showing activity for the neurons that exhibited prominent spikes during the 



















































































Figure 32: Voltage imaging in primary motor cortex in awake mice. 
(a) Fluorescence images of a selected field of view in motor cortex (left) with selected ROIs 
corresponding to somata (right), ƛex=637-nm laser light at 1.5 W/mm2, emission with 664LP, exposure 
time 1.2 ms. Scale bar = 50 µm. (b) Representative fluorescence traces from (a) with detected spikes 







Figure 33: Properties of striatal neurons recorded via SomArchon fluorescence. 
(a) Description of the average firing rate, size, and interspike interval (ISI) for the 14 neurons 
recorded in 9 FOV in 2 mice. Cells simultaneously recorded in the same FOV are color-coded (blue, 
red, green). Cells in rows with a white background were recorded individually. We noted that Cells 9 
and 14 are bursty, with short ISIs and high firing rates, which are consistent with that of PV cells. Cell 
12 is larger in size, with a tonic firing pattern, which is consistent with the characteristics of tonically 
active cholinergic interneurons. (b) Selected trace from Cell 9 exhibiting spike bursting (top). Zoomed 
view of boxed region in b to show spike bursting (bottom). A.U. represents mean fluorescence 
intensity values. (c) Single frame images for FOVs with multiple neurons. Each FOV is color-coded to 






Figure 34: Voltage imaging of striatal cholinergic interneurons in awake mice.  
SomArchon was expressed in striatal cholinergic neurons by injecting AAV2.9-Flex-SomArchon 
virus into a ChAT-Cre mouse (Chat-Cre;129S6-Chattm2(cre)Lowl/J (The Jackson Laboratory)). 
Voltage imaging was performed 4 weeks after viral injection. Voltage traces are shown from two 
striatal cholinergic interneurons (shown on the left, scale bar 20µm), recorded in three different 
sessions, while the mouse was awake, head-fixed and navigating the spherical treadmill. Imaging 
conditions: ƛex = 637-nm laser light at 1.5 W/mm2, emission with 664LP, exposure time 1.2 ms. Image 
acquisition rate 826 Hz. 
 
 
Figure 35: Movement speed thresholding for low vs. high speed periods. 
(a) Histogram of time intervals with different movement speeds. All recordings were segmented into 
0.5-second intervals, and movement speed is calculated as the average speed during each 0.5-second 
time interval. The red line indicates the threshold for low movement speed identification, and the 
green line indicates the threshold for high movement speed identification (n=14 neurons in 9 FOVs, 






Figure 36: Eye puff induced changes in LFP high frequency oscillations but not in theta 
frequency oscillations. 
(a) An example LFP recording from a session that consisted of 10 trials, aligned to puff onset. Green 
shading indicates the eye puff. (b) LFP power spectrum shows strong theta oscillations (4-10 Hz). (c) 
Changes in oscillation power at high frequencies (100-250 Hz, red) and at theta frequencies (4-10 Hz, 
blue) induced by puff onset (time 0). Each thin line represents an individual experiment session and 
the thick lines represent the average across all sessions. (d) The eye puff evoked a significant increase 
in high frequency oscillations (red; p<0.001), but not in theta frequency oscillations (blue; p=0.597, 













































































































































































































Figure 37: In vivo SomArchon performance over time in the striatum and hippocampus of 
awake mice.  
To quantify SomArchon performance over time throughout in vivo imaging sessions, we calculated 
average fluorescence intensity, spike SNR, and firing rates of each neuron imaged in the striatum and 
the hippocampus in awake mice. (A) In each striatal imaging session, we performed 5 trials. Each trial 
was 12 seconds long with inter-trial intervals of 30-60 seconds. Measurements were normalized to the 
first trial for each neuron. We found that average fluorescence intensity (A1) decreased slightly, while 
spike SNR (A2) and firing rates (A3) remained constant throughout the recording session (repeated 
measures ANOVA, n = 6 neurons in 5 FOVs from one mouse). Shown are box plots (the medians are 
indicated by the red lines within the box; top and bottom of the notch indicate 95% confidence interval 
for the median; top and bottom horizontal lines are 25% and 75% percentiles for the data; whiskers 
extend 1.5× the interquartile range from the 25th and 75th percentiles; outliers are shown as “+”) (B) 
In each hippocampal imaging session, we performed 10 trials. Each trial was 6 seconds long with 
inter-trial intervals of 20-30 seconds. Average fluorescence intensity showed a slight but significant 
decrease across trials (B1), SNR decreased between the 1st and 2nd trials but not afterwards (B2), and 
the firing rate remained constant (B3). Moreover, while the spike amplitude fluctuated randomly over 




measures ANOVA; *: p<0.05, post-hoc test: Tukey’s HSD test, n = 16 neurons in 7 FOVs from 4 
mice.) These results suggest that SomArchon can support imaging durations relevant for behavioral 
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Figure 38: Long duration voltage imaging in the hippocampus of awake, head-fixed mice. 
 (Top) An example of an optical voltage imaging trace of a hippocampal neuron over 80 seconds of 
imaging in an awake, head-fixed mouse. A 5-second time window was highlighted in the beginning 
(blue) and end (red) of the trial for further analysis. (Middle) The zoomed-in 5-second time windows 
indicated by the blue (left) and red (right) color bars above. The firing rate and the SNR of the spikes 
remain comparable. (Bottom) One-second time windows labeled by the purple and orange bars in the 





Figure 39: Correlation between spike-spike coherence and Vmo-Vmo coherence, and correlation 
between the Vmo-Vmo coherence at relevant frequencies and distance. 
 To investigate the impact of crosstalk on Vmo-Vmo coherence, we examined the relationship 
between the spike-spike coherence and the Vmo-Vmo coherence at theta (as in Figure 6D), and the 
relationship between the distances between neuron pairs and their Vmo-Vmo coherence, where neuron 
pairs spanned over a range of distances (~11.03 μm to 65.62 μm, center to center). (A) We found that 
the subthreshold intracellular theta oscillation coherence was not a reliable predictor of the spike-spike 
coherence, no matter the distance between the neuron pair examined. See Table 16 for details.  (B) 
The subthreshold oscillation coherence at theta frequency (4-10 Hz) was not dependent on the 
distance (B1), and the averaged coherence at difference distance ranges showed no significant 
difference (B2) (n=25, F=1.43, p=0.26, one-way ANOVA). (C) Similarly, the subthreshold oscillation 




coherence at difference distance ranges showed no significant difference (C2) (n=25, F=1.95, p=0.16, 
one-way ANOVA). Medians are indicated by the red lines within the box; top and bottom of the notch 
indicate 95% confidence interval for the median; top and bottom horizontal lines are 25% and 75% 
percentiles for the data; whiskers extend 1.5× the interquartile range from the 25th and 75th 





Figure 40: Processing of raw optical voltage traces to remove motion artifacts and global trends. 
Raw voltage traces were processed before downstream analysis to remove motion artifacts and global 
trends. Motion resulted in sharp coordinated changes in fluorescence intensity across all static region 
of interests for a given field of view. In addition, global trends in baseline fluorescence were observed 
due to slow photobleaching or slight drift in focus. (b) Here, we present raw voltage traces for two 
cells imaged in the same field of view (as seen in a). Both traces demonstrate collateral shifts in 
fluorescence for both traces as well as common global trend in the baseline shift.  (c) The motion 




CHAPTER THREE: A VIRAL TOOLBOX OF GENETICALLY ENCODED 
FLUORESCENT SYNAPTIC TAGS 
3.1 ABSTRACT 
Synaptic labeling in specific cell types is important in understanding the wiring of 
neural circuits and synaptic changes during development, plasticity, and disease. 
Fibronectin intrabodies generated with mRNA display (FingRs) have been used to label 
excitatory or inhibitory synapses without altering endogenous synaptic protein expression 
levels or synaptic transmission. Here, we generated several AAV vectors for simple, 
global labeling of excitatory or inhibitory synapses in multiple brain regions. Using cre-
inducible FingR variants, we labeled excitatory and inhibitory synapses in apsiny striatal 
cholinergic interneurons, and found that the density of inhibitory synapses remains 
unchanged in dopamine depleted states. With the optimization of a red fluorescent tag for 
inhibitory synapses, we demonstrate dual labeling of excitatory and inhibitory synapses 
in the same cells. In parallel, we generated FingR retroviruses, and tracked synaptic 
integration of hippocampal adult born granule cells throughout development. In 
particular, we were able to track changes in inhibitory synaptic density during cell 
maturation for the first time. These AAV and retrovirus variants that allow labeling of 
excitatory or inhibitory synapses in specific cell types, including adult born neurons, 
provide a comprehensive toolbox for multi-color, cell type specific synaptic labeling in a 






Precise electrical and chemical signaling at the synapses between neurons is 
essential for neural network computation. Tools that allow synaptic labeling could 
provide important information regarding neuronal connections and plasticity, and are 
essential for mapping and understanding neural circuits. Traditional 
immunohistochemistry methods use antibodies developed against individual endogenous 
synaptic proteins. However, antibody staining requires the fixation of tissue, and thus 
prevents the visualization of live tissues. At the synaptic level, traditional 
immunohistochemistry non-selectively labels the dense array of synaptic puncta, and it is 
often difficult to distinguish or assign particular synaptic puncta to a specific cell type 
from which each synapse originates. Synaptic staining, in particular, can be challenging 
because it is difficult for large antibodies to penetrate the dense packing of proteins in the 
synaptic density 148–150. Several methods do exist to enhance antibody penetration, but 
these methods require optimization and are often unreliable150.  
Genetically encoded fluorescent proteins enable cell type specific labeling of live 
or fixed tissue using cell type specific promoters or recombinase systems 151. Because of 
the unique bouton like structure of excitatory synapses, it is possible to identify excitatory 
dendritic spines based on shape alone 92,93. However, this method fails to work for 
identifying inhibitory synapses that are generally present on the dendritic shaft or for 
excitatory synapses on aspiny neurons81,152. Fusion of exogenously expressed synaptic 
proteins to fluorophores provides the benefits of being genetically encoded while offering 




to the synapses, exogenous overexpression of synaptic proteins produces non-
physiologically relevant protein levels and disturbs synaptic physiology96.  
Transgenic mice with fluorescent proteins fused to endogenous synaptic proteins, such as 
PSD95, have allowed visualization of excitatory synapses 154–157. However, the need of 
generating specific transgenic lines for each synapse type of interest has limited such 
transgenic strategies.  
Recently, new genetically encoded tools have been developed to map functional 
synapses or label excitatory or inhibitory synapses without modifying endogenous protein 
levels 100,101,158,159. In particular, fibronectin intrabodies generated with mRNA display 
(FingRs) developed against synaptic proteins PSD95 and gephyrin present an exciting 
new method to fluorescently label excitatory and inhibitory synapses without disrupting 
endogenous proteins 101. FingRs fused to fluorescent proteins act as genetically encoded 
intracellular antibodies in live and fixed neurons. It is well documented that PSD95 
serves as a scaffold protein at excitatory synapses, and gephyrin acts as a scaffold protein 
at inhibitory synapses. The genetically encoded PSD95.FingR and Gephyrin.FingR bind 
to and fluorescently label PSD95 and gephyrin, respectively. To prevent overexpression 
of the FingRs in the cell dendrites, a transcriptional control system has been used to 
ensure FingR expression levels matched those of the endogenous protein target 101. 
Because the FingRs bind to the endogenous synaptic proteins, there is no overexpression 
of endogenous proteins. Furthermore, it has been shown that the PSD95.FingR and 




in neurons, through transfection or in utero electroporation, have been successfully used 
in neuron cultures and mouse brain slices, and in live transgenic zebrafish 152,160–164.  
To promote the applicability of FingR based synaptic tags, we developed three 
types of new PSD95.FingR and Gephyrin.FingR viral vectors. We generated FingR 
AAVs, driven by a strong constitutive EF1A promoter, for labeling of excitatory or 
inhibitory synapses in cortical and subcortical brain regions, and generated an optimized 
red Gephyrin.FingR for dual color synaptic labeling. We further generated cre-inducible 
FingR AAV variants that can be used in cre-transgenic mice to label specific cells of 
interest. Furthermore, we developed FingR retroviruses to label excitatory and inhibitory 
synapses in adult born granule cells, and tracked the synaptic development of adult-born 
neurons throughout the maturation period. Overall, these new FingR viruses will 




3.3.1 Global labeling of excitatory and inhibitory synapses across cortical and 
subcortical brain regions. 
To improve the ease of use and expand the possible applications for using the 
FingRs, we generated viral vectors containing PSD95.FingR-GFP and Gephyrin.FingR-
GFP fused to a DNA recognizing zinc finger fused to the KRAB(A) transcriptional 
repressor domain as described previously 101. In this system, the FingRs were fused to 




recognizing zinc finger fused to the KRAB(A) transcriptional repressor domain. A 
specific sequence recognized by the zinc finger domain was inserted upstream of the 
promoter driving FingR expression. This way, when the endogenous protein targets were 
unsaturated with FingR binding, the FingRs would continue to express and bind to the 
target due to their high affinity. Once the target became saturated, the FingR fusion 
would then bind to the zinc finger recognition sequence upstream of the promoter and 
repress FingR expression, functioning as a negative feedback loop. In Gross et al, they 
identified two orthogonal transcriptional control systems using CCR5L and IL2RG2L 
zinc fingers and their DNA binding sites in order to express the PSD95.FingR and 
Gephyrin.FingR in the same cell in neuron culture101. 
We constructed AAV DNA vectors containing AAV-PSD95.FingR-GFP- and 
AAV-Gephyrin.FingR-GFP driven under a stronger elongation factor 1A (EF1A) 
promoter and with the transcription feedback regulator domain CCR5TC fused to the c-
terminus of the GFP (Figure 41A). We then packaged FingR-expressing AAV viral 
particles with AAV9 coat proteins, which exhibit excellent expression levels in the rodent 
central nervous system 165–167. We injected both viral vectors separately into the cortex, 
striatum, and hippocampus of the mouse brain. Three weeks following the injections, we 
analyzed the expression patterns in each brain region using histochemistry in fixed brain 
slices. We detected strong GFP fluorescence in the infected brain regions (see Figures 
1B-G (i) for 10x magnification). Cell nuclei were visible surrounded by a haze of green 
fluorescence in all brain regions using widefield fluorescence. Upon further examination 




exhibited a punctate expression pattern in all areas tested, along with labeled cell nuclei 
(Figure 41 B-G (ii and iii) for 60x and further magnified images). As expected, the 
PSD95.FingR puncta density appeared higher than the Gephyrin.FingR density in all 
brain regions tested, consistent with the observation that the excitatory synaptic density is 
higher than the inhibitory synaptic density 98,168,169.  
To verify the identity of the labeled puncta, we used traditional antibody staining 
and analyzed the co-localization patterns of immunofluorescence and GFP. We found 
strong co-localization between the Gephyrin.FingR-GFP and the gephyrin antibody in 
mouse brain slices (Figure 41I). Since the PSD95 antibody performs poorly in brain 
slices, we examined the co-localization of PSD95.FingR-GFP with the excitatory 
synaptic marker homer and the pre-synaptic marker bassoon in brain slices and found 





Figure 41: PSD95.FingR and Gephyrin.FingR AAVs globally label excitatory and inhibitory 
synapses with sub-micron resolution. 
A) DNA construct diagrams for i) PSD95.FingR and ii) Gephyrin.FingR. Both constructs use the 
AAV2 transfer backbone and were packaged with the serotype 9 coat proteins. CCR5TC is the 
transcriptional repressor domain responsible for transcriptional control, which recognizes the CCR5 
binding site upstream of the EF1A promoter to prevent overexpression of the FingR proteins. B, C, D) 
Representative images of PSD95.FingR expression in the motor cortex (B), striatum (C), and 
hippocampus (D) of mouse brain slices. Images shown at 10x (i), 60x (ii), and 60x with 4x zoom (iii). 
Scale bars are 200µm (i), 25µm (ii), and 10µm (iii). E, F, G) Representative images of 
Gephyrin.FingR expression in the motor cortex (E), striatum (F), and hippocampus (G) of mouse brain 
slices. Images shown at 10x (i), 60x (ii), and 60x with 4x zoom (iii). Scale bars are 200µm (i), 25µm 
(ii), and 10µm (iii). H) Brain slices expressing PSD95.FingR (i), stained with a homer antibody (ii), 
and co-localization (iii). Note cell bodies in (ii) are stained with the nuclear Topro3 dye. I) Brain slices 
expressing Gephyrin.FingR (i), stained with a gephyrin antibody (ii), and co-localization (iii). 
 
It’s useful to note that expression of the PSD95.FingR-GFP under a slightly 
weaker, but neuron specific synapsin promoter still displayed a punctate expression 
pattern in all three brain regions (Figure 46). We also generated FingR lentiviruses 




kinase IIa (CamKIIa) promoter, and found that these lentiviruses mediated weak 
expression in mouse brain slices (Figure 47). While the lentivirus designed to express 
PSD95.FingR-GFP showed punctate expression patterns, the lentivirus designed to 
express Gephyrin.FingR-mRuby2 only showed expression in the nuclei of cells with no 
punctate patterns in the dendrites. Overall, the AAV-PSD95.FingR-GFP and AAV-
Gephyrin.FingR-GFP enable synaptic labeling in multiple brain regions while 
maintaining sub-micron spatial resolution. 
3.3.2 Optimization of a red Gephyrin.FingR variant enables dual synaptic labeling in 
brain tissue. 
We next wanted to label both excitatory and inhibitory synapses in the same 
neurons. While dual-color synaptic labeling is possible in neuron cultures and zebrafish, 
there has been no demonstration of two color synaptic labeling in mammalian brain tissue 
using the FingR tags 101,162. It has previously been shown that red fluorescent proteins are 
dimmer than GFP, are more susceptible to aggregation, and don’t function well in fusion 
proteins 172. In order to address this, we selected the bright monomeric red fluorescent 
protein mScarlet, which exhibits a 70% quantum yield and high performance as a fusion 
tag, as the red fluorescent tag for our red FingR 172.  
We generated the red mScarlet variant of the Gephyrin.FingR using the IL2RG 
transcriptional control system that is orthogonal to the CCR5 transcriptional control 
system 101,162.Because protein fusion could alter FingR binding to endogenous proteins 
and mScarlet fluorescence levels, we first examined the effects of the configuration of 




terminal of Gephyrin.FingR (Figure 42A). Interestingly, we found that the N-terminally 
fused mScarlet-Gephyrin.FingR yielded a much more punctate expression pattern than 
the C-terminally fused Gephyrin.FingR-mScarlet (Figure 48). We then further screened 
the other red fluorescent proteins mRuby2 and mCherry fused to the N-terminal of 
Gephyrin.FingR (Figure 42A) 173,174. In neuron culture, mScarlet-Gephyrin.FingR and 
mRuby2-Gephyrin.FingR co-localized with the immunofluorescence of the gephyrin 
antibody, but mCherry-Gephyrin.FingR did not (Figure 48).  
To demonstrate the use of dual-color synaptic labeling, we co-injected AAV-
PSD95.FingR-GFP (CCR5 transcriptional control) with each of the four red 
Gephyrin.FingR variants (IL2RG transcriptional control) into the mouse brain (Figure 
42C). This way, we could determine not only if the red Gephyrin.FingR properly labels 
inhibitory synapses, but also if it interacts with the PSD95.FingR GFP. Similar to the 
neuron culture results, mRuby2-Gephyrin.FingR and mScarlet-Gephyrin.FingR exhibited 
a punctate expression pattern in mouse brain slices (Figure 42 E, F, and Figure 49). 
Further validation with the homer and gephyrin antibodies confirmed that the FingR 
proteins properly localized to excitatory and inhibitory synapses respectively (Figure 
50). Thus, AAV-PSD95.FingR-GFP (CCR5 transcriptional control) and AAV-mRuby2-
Gephyrin.FingR (IL2RG transcriptional control) represent a pair of FingR tags that can 






Figure 42: Optimization of a red Gephyrin.FingR AAV enables dual synaptic labeling of 
excitatory and inhibitory synapses. 
A) DNA construct diagrams for the red Gephyrin AAV variants tested. The IL2RGTC domain acts 




recognizes the IL2RG binding site upstream of the EF1A promoter to prevent overexpression of the 
FingR proteins. B) Each red Gephyrin variant was tested in neuron cultures. The best variant, 
mRuby2-Gephyrin.FingR expresses in a punctate manner in neuron culture (ii) and co-localizes with 
gephyrin antibody staining (i and iii). Scale bar 25µm. C) DNA construct diagrams for the co-injected 
viruses PSD95.FingR-GFP (label excitatory synapses in green) and mRuby2-Gephyrin.FingR (label 
inhibitory synapses in red). D, E, F) Representative images of the expression patterns of the co-
injected PSD95.FingR-GFP (i) and mRuby2-Gephyrin.FingR (ii) AAVs in mouse hippocampal brain 
slices shown at 10x (D), 60x (E), and 60x with 4x zoom (F). Note the co-localization of cell bodies 
labeled, but not in punctate synaptic expression as expected. Scale bars are 200µm (i), 25µm (ii), and 
10µm (iii). 
 
3.3.3 Post synaptic labeling of excitatory and inhibitory synapses in adult born granule 
cells. 
While most neurons are non-dividing, adult neurogenesis occurs in the 
subventricular and subgranular zones of mammalian brains. Neurons born in the 
subgranular zone develop into granule cells and functionally integrate into the dentate 
gyrus of the hippocampus 92,175,176. Several studies have demonstrated important 
functions of adult neurogenesis in hippocampal-dependent behavioral tasks 177–179. 
Interestingly, newborn granule cells undergo a critical period about one to two months 
after cell birth where they exhibit increased excitability and display heightened plasticity 
180,181.   
Adult born hippocampal granule cells have been shown to first form GABAergic 
synapses along the dendrites starting within a week after birth, whereas excitatory 
synapses and dendritic spines do no become prominent until about the third week after 
birth 182. Peak spine formation occurs during the third and fourth weeks after birth, 
coinciding with the previously described critical period 182. Although several studies have 
outlined the detailed timeline for synaptic development in adult born cells using 




identity of individual synapses on these cells. In particular, no morphological marker 
exists to label inhibitory synapses, which generally form on the dendritic shaft 81,152. 
Although antibodies exist for labeling excitatory and inhibitory synapses, it is impossible 
to distinguish synapses formed onto newborn cells from those in mature granule cells, 
even if the newborn cells are labeled with fluorescent proteins. Therefore, genetically 
encoded FingR synaptic tags, can overcome these issues by only labeling synapses within 
adult born neurons.  
To express the PSD95-FingR and Gephyrin FingR proteins in adult born neurons, 
we used a murine stem cell virus (MSCV) retroviral expression system driven under a 
synapsin (Syn) promoter that has been shown to mediate strong and specific gene 
expression in adult born neurons in the dentate gyrus born within a day of viral injection 
177. While the negative feedback transcriptional control of the FingR proteins ensures that 
transgene expression matches the levels of endogenous proteins, our lentivirus mediated 
very low levels of FingR expression as demonstrated in Figure 47. Since lentivirus 
pseudotyped with VSVg has similar or higher transduction efficiency than MSCV 
retroviral vectors, we thus constructed retroviral vectors containing synapsin-driven 
FingR-GFP expression with and without transcriptional control. Upon initial testing in 
HEK cells, we could not detect any GFP fluorescence in the transcriptionally regulated 
retrovirus FingR variants (Figure 51). Thus, we injected retrovirus MSCV-Syn-FingR-
GFP, without transcriptional control, and an MSCV-Syn-GFP control into the dentate 
gyrus of adult mice, and analyzed synapse formation in the adult born neurons at 4 weeks 




We found that MSCV-Syn-FingR labeled neurons exhibited a distinct and 
punctate GFP expression pattern, (Figure 43B). MSCV-Syn-FingR-GFP labeled neurons 
also showed weak fluorescence in the dendrites, which was rather useful for visualizing 
the dendritic tree. However, synaptic puncta were brighter and could be distinguished 
from the dendrites. In contrast, in control mice injected with MSCV-Syn-GFP, labeled 
adult born neurons showed more uniform expression along dendrites, without punctate 
structures, further confirming the synaptic punctate expression pattern is due to the 
PSD95 and Gephyrin FingR expression. As expected, the PSD95.FingR expression is 
concentrated in the dendritic spines where over 90% of excitatory synapses are formed 
183, whereas the Gephyrin.FingR puncta were generally confined to the dendritic shaft as 
described previously for inhibitory synapses 81,152.  
By examining PSD95.FingR-GFP and Gephyrin.FingR-GFP labeled neurons at 
different time points after viral injection, we were able to track excitatory and inhibitory 
synapse formation throughout the maturation period at 2, 4, and 12 weeks following cell 
birth (Figure 43C) 92,182.  
In PSD95.FingR injected mice, we observed that although two-week old adult 
born cells have developed dendrites protruding into the molecular layer, they have 
formed few excitatory synapses (0.12 +/- 0.09 (mean+/-standard error) synapses per µm, 
4709 µm dendrite length, n=3 mice, Figure 43D, J). In one rare case, we discovered a 
two-week old granule cell that exhibited accelerated maturation with a more intricate 
dendritic tree and the presence of dendritic spines and excitatory synapses (Figure 52). A 




cells with more mature dendritic trees have more spines, which supports the observations 
regarding this fast-maturing cell 175. By four weeks of age, a dense labeling was evident 
and mainly restricted to the dendritic spines, with a synaptic density of 0.97 +/- 0.11 
synapses per micron (7379 µm dendrite length, n=4 mice, Figure 43E, J), consistent with 
previous studies 92,176,184. Furthermore, this significant increase in excitatory synapse 
formation is consistent with the critical period where newborn cells have heightened 
excitability and plasticity. By 12 weeks of age, synapse density was increased but not 
significantly different from that at 4 weeks of age (1.32 +/- 0.11 synapses per µm, 7657 
µm dendrite length, n=3 mice at 12 weeks, Figure 43F, J).  
While excitatory synapses form dendritic spines and thus can be visualized 
through the formation of spine structures using soluble GFP expression, it has not been 
possible to visualize inhibitory synapses based on morphology. In mice injected with the 
Gephyrin.FingR-GFP retrovirus, we found that two week old adult born neurons formed 
sparse GABAergic synapses along their dendrites (0.05 +/- 0.03 synapses per µm, 3440 
µm dendrite length, n=3 mice, Figure 43G, K). Although GABA afferents are present as 
early as seven days after birth, some cells do not develop functional synapses until after 
two weeks of age 185. This was consistent with our findings where cells with more mature 
dendritic branching had developed multiple GABAergic synapses, whereas cells with less 
complex dendrites had little to no synaptic clusters visible. By four weeks of age, we 
observed a moderate increase in the density of inhibitory synapses (0.13 +/- 0.02 
synapses per µm, 14341 µm dendrite length, n=4 mice, Figure 43H, K). By 12 weeks of 




micron (4635 µm dendrite length, n=3 mice, Figure 43I, K). 
 
Figure 43: Retroviral FingRs enable tracking of synaptic integration of adult born dentate 
granule cells throughout maturation. 
A) DNA construct diagrams for the retroviruses used in this study. i) GFP control, ii) PSD95.FingR-
GFP (no transcriptional control) and iii) Gephyrin.FingR-GFP (no transcriptional control). B) 
Representative images of i) GFP, ii) PSD95.FingR-GFP, and iii) Gephyrin.FingR-GFP expression in 
4-week old adult born cells. C) Timeline of retroviral injections and subsequent perfusion of mice for 
tracking synaptic development in adult born neurons. D, E, F) Representative images of the expression 
patterns of PSD95.FingR-GFP in adult born cells at 2 weeks (D), 4 weeks (E), and 12 weeks (F) 
following birth. Cells were imaged at 60x (i) and 60x with a 4x zoom (ii, iii, iv). Scale bars are 25µm 
(i), and 10µm (ii, iii, iv). G, H, I) Representative images of the expression patterns of 
Gephyrin.FingR-GFP in adult born neurons at 2 weeks (G), 4 weeks (H), and 12 weeks (I) following 
birth. Cells were imaged at 60x (i) and 60x with a 4x zoom (ii, iii, iv). J, K) Quantification of synaptic 
density (synapses per µm) of excitatory (J) and inhibitory (K) synapses at 2, 4, and 12 weeks 




3.3.4 Cre-inducible AAV FingR viral vectors allow synaptic labeling of striatal aspiny 
cholinergic interneurons. 
Although several studies have explored the density of excitatory synaptic spines 
on projection neurons in the cortex, hippocampus, and striatum, little is known about the 
synaptic density of aspiny neurons, such as striatal cholinergic interneurons, due to the 
lack of spines. Striatal cholinergic interneurons only make up 1-2% of striatal cells, but 
they have been implicated in movement behavior and learning 186. To label the synapses 
of cholinergic interneurons, we generated cre-inducible AAV vectors containing a double 
inverted operator (DIO). To determine whether FingRs could label synapses in the aspiny 
cholinergic interneurons, we co-injected AAV-DIO-mRuby2 and AAV-DIO-
Gephyrin.FingR-GFP-CCR5TC to label inhibitory synapses, or AAV-DIO-mRuby2 and 
AAV-DIO-PSD95.FingR-GFP-CCR5TC to label excitatory synapses, into the striatum of 
ChAT-Cre mice (Figure 44A and C). Cholinergic interneurons and their dendrites were 
labeled with AAV-DIO-mRuby2 and thus appear red. We found that AAV-DIO- 
Gephyrin.FingR-GFP-CCR5TC successfully labeled inhibitory synapses that appear in a 
punctate manner (Figure 44B and D). Similarly, AAV-DIO-PSD95.FingR-GFP-
CCR5TC labelled excitatory synapses as green puncta.  We confirmed the 
mRuby2/FingR expression was limited to cholinergic interneurons using antibody 
staining (Figure 53). The cre-lox system is a powerful tool in neuroscience for labeling 
or manipulating distinct cell types expressing cre recombinase, and hundreds of 
transgenic cre mouse lines have been developed 187. Therefore, the AAV-DIO-FingRs 





In Parkinson’s Disease (PD) dopamine depleted mouse models, it has been noted 
that the striatum undergoes synaptic rewiring93,188. We thus examined the impact of 
dopamine depletion on inhibitory synapses in cholinergic neurons. We co-injected cre-
inducible AAV-DIO-mRuby2 and AAV-DIO-Gpehyrin.FingR-GFP-CCR5TC into both 
hemispheres of the striatum in ChAT-cre mice. After one week, we unilaterally injected 
the neurotoxin 6OHDA into one hemisphere of the striatum to selectively deplete 
dopaminergic inputs to the striatum unilaterally. Three weeks following the 6OHDA 
injection, we confirmed 6-OHDA lesioning using tyrosine hydroxylase antibody staining 
(Figure 44F and G, see Figure 53 for whole brain slice). We measured the length of 
select cholinergic dendrites where the synapses were distinctly labeled, and quantified the 
synaptic density in the lesioned vs. non-lesioned hemispheres. Interestingly, we did not 
observe a noticeable change in inhibitory synaptic density between the two hemispheres, 






Figure 44: Cre-inducible FingR variants label synapses in aspiny striatal cholinergic 
interneurons. 
A) DNA construct diagrams for labeling of neurons and inhibitory synapses. B) 60x (i-iii) and 60x 
with 4x zoom (iv-vi) representative images of cholinergic interneurons with inhibitory synapses 
labeled in green (i, iv), cell bodies and dendrites labeled in red (ii, v), and a merge of both channels 
(iii, vi). Scale bars are 25µm (i-iii) and 10µm (iv-vi). C) DNA construct diagrams for labeling of 
neurons and excitatory synapses. D) 60x (i-iii) and 60x with 4x zoom (iv-vi) representative images of 
cholinergic interneurons with excitatory synapses labeled in green (i, iv), cell bodies and dendrites 
labeled in red (ii, v), and a merge of both channels (iii, vi). Scale bars are 25µm (i-iii) and 10µm (iv-
vi). E) Experimental timeline of virus injection, 6OHDA injection, and sacrificing of animals. F) 
Representative 60x (i-iv) and 60x with 4x zoom (v-viii) images of a cholinergic interneuron with 
inhibitory synapses labeled with Gephyrin.FingR-GFP (i, v) and the whole cell labeled with mRuby2 
(ii, vi) along with TH staining for dopaminergic terminals (iii, vii) in the non-lesioned hemisphere of 
striatum. Scale bars are 25µm (i-iv) and 10µm (v-viii). G) Representative 60x (i-iv) and 60x with 4x 
zoom (v-viii) images of a cholinergic interneuron with inhibitory synapses labeled with 
Gephyrin.FingR-GFP (i, v) and the whole cell labeled with mRuby2 (ii, vi) along with TH staining for 
dopaminergic terminals (iii, vii) in the lesioned hemisphere of striatum. Scale bars are 25µm (i-iv) and 
10µm (v-viii). H) Quantification of inhibitory synaptic density in cholinergic interneurons with and 





We engineered a set of new viral vectors that allow broad application of FingR 
based synaptic tagging of excitatory and inhibitory synapses in the mouse brain in a 
global or cell specific manner. We further screened a number of red FingRs that can be 
used in conjunction with green FingRs for dual color synaptic labeling. We demonstrated 
the ability to estimate the density of excitatory and inhibitory synapses in adult born 
granule cells during development and the density of inhibitory synapses in cholinergic 
interneurons in healthy and diseased brains. We also showed that the FingRs are bright 
enough for in vivo imaging in a live mouse (Figure 54). Overall, the toolbox of FingR 
viral vectors generated here provides a powerful method for mapping the synaptome, and 
understanding synaptic changes during development or plasticity related to learning or 
disease.  
The AAV global labeling strategy is useful for visualizing excitatory synapses 
because it is difficult for antibodies to properly penetrate the densely packed post 
synaptic density 148–150. The development of a red Gephyrin.FingR demonstrates the 
possibility of engineering the FingRs with different fluorophores. Our efforts highlight 
that not all fluorophores perform well in fusions with the FingRs and some specific 
variants interact with each other. Dual labeling of excitatory and inhibitory synapses is 
useful in understanding the excitation/inhibition balance in different brain regions and 
how this balance is altered in disease states such as autism. The AAV FingRs can be 
stereotaxically delivered via intracranial injection to any brain region and can be confined 




labeling can also be performed by tail vein or facial vein injections of AAVs 165–167.  
We found that similar to Gross et al and Son et al, transcriptional regulation of 
FingR protein expression yielded punctate expression in the dendrites and reduced 
background signal in the dendrites101,162. As expected, we also saw fluorescence in the 
cell nucleus due to the targeting of the FingR protein back to the nucleus for 
autoregulation. In addition, the PSD95.FingR and Gephyrin.FingR co-expressed in a 
punctate manner during dual synaptic labeling experiments demonstrating the two 
orthogonal zinc finger transcriptional control systems exhibited no cross-talk when used 
in conjunction in mouse brain slices. We found that the FingR retrovirus containing 
transcriptional control resulted in nearly no expression when tested, due to the generally 
lower titer of the retrovirus. Without transcriptional control, the FingR retroviruses 
successfully tagged excitatory and inhibitory synapses. Indeed, the background signal in 
the dendrites of retrovirus-labeled neurons actually made it easier to visualize the 
individual cell from which each synapse was affiliated. 
While several studies have outlined the timeline of synaptic formation in adult 
neurogenesis, we here provide the first visualization of the location of inhibitory 
synapses, and quantification of the density of inhibitory synapses during the maturation 
of these cells. Previously, inhibitory synapses were identified using electrophysiology 
and GABA agonists or antagonists 185. Our data reflects the previously held belief that 
inhibitory synapses form as early as 8 days after cell birth and the number of synapses 
increases during maturation. Electrophysiology studies suggest perisomatic inhibitory 




accurately confirm this due to the higher concentration of Gephyrin.FingR protein in the 
soma. In addition, it is interesting that we found the largest increase in inhibitory synaptic 
density comes between 2 and 4 weeks after cell birth which coincides with the large 
increase in the number of excitatory synapses. This could likely be a homeostatic method 
for the cell to maintain its excitation/inhibition balance.  
Many studies have explored the density of excitatory and inhibitory synapses in 
pyramidal cells in the cortex 81,98,152. Others have tracked the absolute number and ratio 
of synapses in hippocampal pyramidal cells and interneurons 168,189. In the striatum, most 
studies have focused on studying the number of spines on the medium spiny neurons 93. 
Most excitatory inputs to striatal cholinergic interneurons originate from the cortex and 
thalamus; inhibitory inputs generally come from the local striatal medium spiny neurons 
and parvalbumin neurons; and dopaminergic axon terminals project from the substantia 
nigra pars compacta 186,190. Newer studies have identified inputs to cholinergic 
interneurons using monosynaptic tracing 94. Only two studies have specifically identified 
synapse density in cholinergic interneurons, and this was done using electron microscopy 
191,192. The ~0.36 inhibitory synapses per micron we found is consistent with the results 
reported in these two studies, but we were able to do this on a much larger scale, 
quantifying thousands of synapses with the FingRs, whereas the electron microscopy 
studies only examined tens of synapses191,192.  
Although we found no significant changes in the density of inhibitory synapses 
following 6OHDA lesioning, dopamine depletion still may cause plasticity changes at 




one time point after dopamine depletion, it is unclear whether there is a simultaneous 
addition and subtraction of synapses that may be occurring. Future studies using FingRs 
in different striatal cell types could provide a more comprehensive analysis of structural 
remodeling upon dopamine depletion. 
One key advantage of the set of FingR viral vectors developed here are their 
flexibility for future studies. These viruses can be used in transgenic mice or combined 
with other viruses. In particular, the red FingR variants can be used to identify synapses 
while working with common green fluorescent sensors such as GCaMP 9. Additionally, 
the development of a similar genetically encoded presynaptic tag will enable the study of 
synapses in greater detail. These probes are also compatible with super-resolution 
imaging methods such as PALM and STORM 163. Future studies with longitudinal in vivo 
imaging of the FingRs will yield insight into the formation and pruning of individual 
synapse over days and weeks. Finally, the FingRs can act as a targeting sequence for 






Molecular Cloning. The following plasmids served as the backbones for all viral 
genomic transfer plasmids: AAV-ReaChR-citrine (Addgene #50954) for AAV global 
synaptic labeling, pAAV-EF1A-DIO-mCherry-WPRE-pA (Addgene #37083) for cre-
inducible AAV expression, and pMSCV-GFP (Addgene #86537) for retroviral labeling 
of adult born neurons. The EF1A promoter from the 8x2C mAGNET (Addgene #67955) 
was used for synaptic labeling. All other plasmids used the original EF1A or synapsin 
promoters from the backbones listed above. The PSD95.FingR, GPHN.FingR, GFP, and 
CCR5 or IL2RG transcriptional control regions were derived from pCAG-PSD95.FingR-
GFP-CCR5TC (Addgene #46297) and pCAG-GPHN.FingR-mKate2-IL2RGTC 
(Addgene #42697). All DNA linker regions remained the same as in pCAG-
PSD95.FingR-GFP-CCR5TC. The CCR5 or IL2RG transcriptional control DNA binding 
sites were inserted upstream of the promoter using custom DNA oligos (IDT DNA). Red 
fluorescent proteins and exogenous PSD95 were cloned from pmScarlet-i_C1 (Addgene 
#85044), pcDNA3-mRuby2 (Addgene #40260), or FU-dio-PSD95-mCherry (Addgene 
#73919). All plasmids were built using Gibson assembly or traditional cloning, and all 
plasmids will be available on Addgene for distribution. 
AAV Production. AAV2 serotype 9 viral particles were packaged as described 
previously193. Briefly, HEK293FT cells (R70007 Life Technologies) were triple 
transfected with an AAV genomic transfer plasmid, a pXX680 helper packaging plasmid, 
and a cap-9 plasmid coding for the Rep and Cap proteins to make AAV2 serotype 9 viral 




cell media and lysed cells into a single tube. Viral particles were centrifuged to remove 
cell debris and the supernatant was filtered at 0.45µm. PEG-IT was added to the filtered 
viral supernatant and rotated at 4C overnight to precipitate viral particles out of solution. 
Supernatant was removed and AAV viral particles were re-suspended in PBS. All red 
Gephyrin.FingR AAVs were produced by the Janelia Virus Service Facility. 
Retrovirus Production. All retrovirus was produced using methods similar to 
Zhuo et al 2016. Briefly, HEK293FT cells (R70007 Life Technologies) were triple 
transfected with a Murine stem cell virus retroviral vector expressing GFP, 
PSD95.FingR-GFP or GPHN.FingR-GFP under a synapsin promoter, pMD2.G which 
encodes the VSVg pseudotyping coat protein (Addgene #12259), and the Gag/pol 
packaging plasmid (Addgene #14887). Viral particles were collected from the cell media, 
passed through a 0.45µm filter, and concentrated using ultracentrifugation. Supernatant 
was removed and viral particles were reconstituted in PBS. 
Neuron Culture Preparation, Maintenance and Infection. Primary rat neuron 
cultures were prepared as described previously 194. Briefly, brains were removed from 
embryonic day 18 pups, and dissociated neurons from the cortex and hippocampus were 
seeded onto glass coverslips coated in poly-l-lysine and cultured in supplemented 
neurobasal media. Fluorodeoxyuridine was added after one week to inhibit glial mitosis. 
Neuron cultures were infected between DIV7-DIV10 with 1-5ul of AAV per coverslip. 
Cells were imaged at least 3 days post infection to enable gene expression and ensure 




Animal Surgery and Handling. All animal procedures were reviewed and 
approved by Boston University Institutional Animal Care and Use Committee. All 
stereotaxic viral or drug injections into the brain occurred while mice were anesthetized 
with isofluorane, using a 10uL syringe (NANOFIL, World Precision Instruments) fitted 
with a 33-gauge needle (World Precision Instruments, NF33BL) and controlled by a 
microinfusion pump (World Precision Instruments, UltraMicroPump3-4). The syringe 
was left in place for an additional 10 minutes to facilitate viral spread. 
For global synaptic labeling, 2-6 month old, female C57BL/6 mice (Charles River 
Laboratories) were stereotaxically injected with 0.5-1ul of AAV, at a speed of 100nl/min, 
into the motor cortex (+1.8 AP, +/-1.5 ML, -1.0 Z), striatum (+0.7 AP, +/-1.8 ML, -2.45 
Z), and CA1 region of hippocampus (-2.0 AP, +/-1.4 ML, -1.6 Z). 2 mice were injected 
per condition. 
All retrovirally injected 8–10 week old adult C57BL/6 mice were housed with 
running wheels from one week before viral injection until they were sacrificed. 1.5ul of 
retrovirus was stereotaxically injected at a speed of 100nl/min into the dentate gyrus at 
sites: -2 AP, +1.5 ML, -1.9 Z and -2.8 AP, +2.0 ML, -2.0 Z. 3-4 mice were injected per 
condition. 
For cre-dependent labeling and 6OHDA experiments, male and female ChAT-Cre 
(GM24Gsat, Mutant Mouse resource Center, Davis, CA) mice, 2-6 months old, were 
stereotaxically injected with AAV-DIO-mRuby2/AAV-DIO-PSD95.FingR-GFP-
CCR5TC or AAV-DIO-mRuby2/AAV-DIO-GPHN.FingR-GFP-CCR5TC. Viruses were 




into both hemispheres of the striatum (+0.7 AP, +/-1.8 ML, -2.45 Z).  
One week later, mice were given an intraperitoneal injection of desipramine 
hydrochloride (10ml/kg) before stereotaxic injection of 1ul of freshly prepared 6OHDA 
(6mg/ml, Sigma Aldrich) at a rate of 100nl/min into one hemisphere of the striatum (+0.7 
AP, +1.8 ML, -2.45 Z). The 6OHDA injection procedure was completed in the dark to 
prevent oxidation. 
Immunocytochemistry. Neuron cultures were fixed for 10 minutes in a 4% 
paraformaldehyde and 4% sucrose solution and washed three times in PBS. Cell were 
incubated in 0.3% Triton for 10 minutes and blocked in 10% goat serum for 30 minutes. 
Primary antibodies (PSD95 1:200, Neuromab 75-028), Gephyrin 1:300, Synaptic 
Systems 147011) were diluted in a 2.5% goat serum solution and incubated with the 
neurons overnight at 4C. Cells were washed three times in PBS, incubated with the 
secondary antibody diluted 1:500 in a 2.5% goat serum solution, washed three times in 
PBS, and then mounted for imaging. 
Histology. All mice were perfused with PBS followed by 4% paraformaldehyde 
and brains were post-fixed in 4% paraformaldehyde for 1-4 hours. Brains were 
cryoprotected in 30% sucrose at 4C, frozen, and sliced at 50µm on a cryostat for imaging 
or staining. The following primary and secondary antibodies were used: mouse anti-
Gephyrin (1:200, Synaptic Systems 147011), rabbit anti-Homer (1:200, Synaptic Systems 
160003), mouse anti-Bassoon (Abcam ab82958), goat anti-ChAT (1:500, EMD Millipore 
AB144P), or rabbit anti-Parvalbumin (1:1000, Swant Inc. PV27), followed by Alexa 




During staining, slices were incubated in PTG buffer (PBS with 0.5% Triton X-100 and 
100mM glycine) to quench spare formaldehyde for 30 minutes followed by blocking 
buffer (PBS with 0.5% Triton X-100 and 2% goat/donkey serum) for 2 hours. Primary 
antibodies were diluted at the specified concentrations in blocking buffer and incubated 
with slices overnight at 4C. Following washes with PTG buffer, secondary antibodies 
(1:200-1:1000) diluted in blocking buffer were added for 2 hours. Slices were washed 
with PTG buffer three times, incubated in PBS with 100mM glycine for 30 minutes, and 
subsequently mounted on glass slides for imaging. 
Staining with tyrosine hydroxylase was performed using a similar protocol, but 
with Tris-HCl serving as the buffer. Tyrosine hydroxylase (Abcam Ab112) was diluted 
1:750 and incubated with brain slices for 48 hours at 4C. The secondary antibody was 
used at a concentration of 1:200. 
Image Acquisition. All images of synapses were taken using an Olympus 
FV1000 scanning confocal microscope.  
For global synaptic staining, images were collected using a 10x air and 60x water 
immersion objective. Fluorescence was excited with 470nm and 543nm lasers and 
collected with Alexa Fluor 488 and 568 emission filters.  Image stacks were acquired in 
2µm steps with a 60x objective and additionally with a 4x magnification to help visualize 
individual synapses. 
To image synaptic labeling in adult born neurons, one stack (z=4µm) was taken at 
20x to identify viral expression in the dentate gyrus. For each slice, 1-2 fields of view 




from neighboring cells. Each field of view was imaged using a 60x water immersion 
objective at 2µm intervals. Further, 4 images were taken within each field of view using a 
4x magnification for analyzing synaptic density along the dendrites at 0.53-0.57µm z-
intervals. All images were acquired using a 470nm and 543nm laser for excitation and 
Alexa Fluor 488 and 568 emission filters. With unstained cells, the 568 emission filter 
was used to identify autofluorescence. 
In 6-OHDA injected brain slices, stacks were acquired at 5µm intervals with a 
10x objective in each hemisphere. Fluorescence was excited with 543nm and 633nm 
lasers and collected using Alexa Fluor 594 and Alexa Fluor 647 emission filters. 
Additional stacks were acquired at 60x magnification in 2µm step intervals and at 60x 
magnification with a 4x zoom in 1µm step intervals using 470nm, 543nm, and 633nm 
lasers with Alexa Fluor 488, 594, and 647 emission filters. 
Tiled images to observe tyrosine hydroxylase staining were taken using a Nikon 
Eclipse fluorescence microscope. All slices were imaged with a 4x objective lens in the 
red and far red channels. Images were taken in a 4x4 grid centered in the middle of the 
brain slice. 
Synaptic Density and Synapse Quantification. A maximum intensity projection 
was taken of each image stack to measure dendrite length. Dendrites were traced and 
measured using the Neuron J plugin 
(http://imagescience.org/meijering/software/neuronj/) in Fiji195. 
Synapses in adult born neurons were analyzed using a custom Matlab program. 




The image was then sharpened and binarized. Connected components were selected as 
preliminary synapses and then filtered to identify regions of interest greater than 1µm2 to 
remove noise. 
Synapses in cholinergic interneurons were manually selected. Synapse 
quantification was only performed in cells expressing both the mRuby2 cell marker and 
green FingR virus. Furthermore, only dendritic shafts that were clearly labeled by 
mRuby2 and expressed green puncta along the dendrite were used in quantification. 
Statistical Analysis. For synaptic integration of adult born granule cells, between 
group differences were analyzed by running a one-way ANOVA with a Bonferroni 
correction. The synaptic density in cholinergic interneurons with or without 6OHDA 






3.6 SUPPLEMENTARY INFORMATION 
3.6.1 FingR viruses used in Chapter 3 























3.6.2 Supplementary Figures for Chapter 3 
 
Figure 45: Validation of PSD95.FingR AAV labeling of excitatory synapses. 
A) PSD95.FingR-GFP co-localizes with the PSD95 antibody in neuron culture. Scale bar 25µm. We 
further validated the expression patterns in mouse brain slices. B) PSD95.FingR-GFP co-localizes 
with exogenously expressed PSD95-mCherry. Representative images at 60x (i-iii) and 60x with 4x 
zoom (iv-vi). Scale bars 25µm (i-iii) and 10µm (iv-vi). C) PSD95.FingR-GFP co-localizes with the 
antibody Homer, a marker of metabotropic glutamate receptors. Representative images at 60x (i-iii) 
and 60x with 4x zoom (iv-vi). Scale bar 25µm (i-iii) and 10µm (iv-vi). D) PSD95.FingR-GFP co-
localizes with the antibody bassoon, a marker of pre-synaptic terminals. Representative images in the 
hippocampus at 60x (i-iii) and 60x with 4x zoom (iv-vi) and in the cortex at 60x with 4x zoom (vii-
ix). Scale bars 25µm (i-iii) and 10µm (iv-ix). E) PSD95.FingR-GFP does not co-localize with the 






Figure 46: AAV expression of PSD95.FingR-GFP under the synapsin promoter in multiple 
brain regions. 
A) DNA construct diagram. PSD95.FingR-GFP expression under the neuron specific synapsin 
promoter works well in cortex (B), striatum (C), and hippocampus (D). Representative images at 60x 






Figure 47: Lentivirus expression of PSD95.FingR-GFP and Gephyrin.FingR-mRuby2 
FingR lentiviruses were injected into the mouse brain and analyzed 2 weeks following injection. The 
PSD95.FingR-GFP lentivirus labeled cell nuclei and expressed in a punctate manner in the dendrites 
(A), but the overall expression was weak. The Gephyrin.FingR-mRuby2 lentivirus faintly labeled cell 






Figure 48: Testing of red Gephyrin.FingR variants in neuron culture with gephyrin antibody 
staining. 
Neuron cultures were infected with each virus at ~DIV7 and subsequently fixed and stained 10-14 
days post infection. Representative images of Gephyrin.FingR-mScarlet (A), mScarlet-
Gephyrin.FingR (B), mRuby2-Gephyrin.FingR (C), mCherry-Gephyrin.FingR (D) infected neurons 
(ii) and stained with the gephyrin antibody (i). mScarlet-Gephyrin.FingR and mRuby2-





Figure 49: Dual labeling of excitatory and inhibitory synapses with PSD95.FingR-GFP and the 
four red Gephyrin.FingR variants.  
AAV-PSD95.FingR-GFP-CCR5TC was co-injected into the hippocampus with A) AAV-
Gephyrin.FingR-mScarlet-IL2RGTC, B) AAV-mScarlet-Gephyrin.FingR-IL2RGTC, C) AAV-
mRuby2-Gephyrin.FingR-IL2RGTC, and D) AAV-mCherry-Gephyrin.FingR-IL2RGTC. Green 






Figure 50: Antibody staining validation of dual synaptic labeling  
Brain slices co-injected with AAV-PSD95.FingR-GFP-CCR5TC (i) and AAV-mRuby2-
Gephyrin.FingR-IL2RGTC (ii) were stained with gephyrin (A, B (iii)) or homer (C, D (iii)) antibodies 
to validate that the labeling patterns were correct (iv). B) The Gephyrin.FingR was pseudocolored 
green (ii) and the gephyrin antibody was pseudocolored red (iii) to make it easier to visualize co-
localization (iv). D) The PSD95.FingR was pseudocolored green (ii) and the homer antibody was 






Figure 51: Testing of retroviruses in HEK cell cultures 
After production, retroviruses were tested in HEK cells. MSCV-Syn-GFP expression was strongest 
(left), but MSCV-Syn-PSD95.FingR-GFP (middle) and MSCV-Syn-Gephyrin.FingR-GFP (right) 
showed good expression. MSCV FingR viruses with transcriptional control did not show any 
fluorescence (data not shown). 
 
 
Figure 52: A 2-week-old neuron with excitatory synapses and a longer dendritic tree  
A) 60x image of the neuron. B) Zoomed in 4x near the cell body. C) Zoomed in 4x to show the 






Figure 53: Validation of cholinergic labeling and 6OHDA lesion  
A) Neurons in ChAT-Cre mice co-infected with AAV-DIO-Gephyrin.FingR-GFP-CCR5TC (i) and 
AAV-DIO-mRuby2 (ii) were stained with a choline acetyltransferase antibody (iii) to confirm 
expression was restricted to cholinergic interneurons (iv). 91.5 +/- 4.5% (mean +/- standard deviation) 
of co-labeled cells were ChAT positive (n=4 mice). Scale bar 200µm. B) Representative tyrosine 






Figure 54: In vivo fluorescence images of AAV-PSD95.FingR-GFP-CCR5TC 
A) Widefield fluorescence imaging at 10x magnification. Cell bodies were visible but no puncta could 
be resolved. Scale bar 200µm. B) 2-photon fluorescence imaging with high magnification. Several 
images were acquired per field of view and max intensity projections for each field of view are shown. 




CHAPTER FOUR: CONCLUSION 
4.1 Summary 
Overall, in this thesis, we developed SomArchon, a new, optogenetics compatible, 
GEVI for in vivo population voltage imaging with single cell, single spike resolution, and 
we assembled a viral toolbox of FingRs for multi-color labeling of synapses to facilitate 
the study of synaptic architecture, plasticity, and development.  
In chapter 2, we first characterized SomArchon’s performance in mouse brain 
slices compared to patch clamping and explored SNR, FWHM, dF/F, and voltage 
sensitivity. We optically monitored voltage in neurons of live mice in the cortex, 
hippocampus, and striatum, and demonstrated that SomArchon is compatible with blue 
light activated rhodopsins. Furthermore, we could routinely record voltage from 15 cells 
simultaneously in the hippocampus, highlighting the possibility of using SomArchon in 
populations of neurons. We were also able to use SomArchon to record neurons in the 
striatum while mice were running, which suggests SomArchon can be used in behaving 
mice. Finally, we explored how the coherence of subthreshold oscillations relates to the 
spike coherence in neighboring cells and found that high subthreshold coherence did not 
necessarily dictate high spike coherence.  
Then, in chapter 3, we generated AAV variants of both the PSD95 and gephyrin 
FingRs for global fluorescent labeling of excitatory and inhibitory synapses, respectively. 
Optimization of a red gephyrin FingR variant enabled dual labeling of excitatory and 
inhibitory synapses in the same neurons. We also made cre-inducible FingR variants for 




the density of inhibitory synapses on cholinergic interneurons does not significantly 
change in a mouse model of PD. Finally, we modified the FingRs to make retroviruses 
for synaptic labeling in dividing cells. We monitored synaptic development in adult born 
granule cells during the maturation period. We validated and tested SomArchon and the 
new FingR variants, and we demonstrated their utility in the selected demonstrations 
listed above. We hope these tools will be widely adopted and believe they will be useful 
for neuroscientists in a wide variety of experiments. 
4.2 Significance and Future Directions 
4.2.1 SomArchon 
  The development of SomArchon represents a large step forward for optical 
monitoring of voltage in live mice. Previously published voltage sensors could only be 
used to monitor 1-2 cells simultaneously in vivo65. A skilled electrophysiologist could 
perform intracellular recording in the same number of cells. With SomArchon, we 
demonstrate that it is possible to routinely monitor voltage in 15 cells at a time. We have 
now reached a point where optical voltage imaging provides a significant benefit over 
intracellular recording in the number of cells recorded, while still maintaining 
millisecond, millivolt precision. Furthermore, SomArchon can be expressed in 
genetically defined cell types and is capable of voltage monitoring in behaving mice. The 
near infrared spectrum of SomArchon also allows for an all optical dissection of neural 
circuits with blue light activated optogenetic rhodopsins. These features will enable 




Although new GEVIs have been highlighted in recent pre-prints, we still believe 
SomArchon will be a best-in-class tool for optical voltage recording. We compared 
SomArchon performance to paQuasAr3, Voltron, and ASAP3 in brain slices and found 
SomArchon had a significantly higher dF/F than all three, a significantly higher SNR 
than ASAP3, and similar SNR to Voltron and paQuasAr3119–121. In practice, SomArchon 
is also the easiest of the new GEVIs to use. SomArchon is fully genetically encoded and 
can be imaged using a conventional one photon microscope. However, paQuasAr3 
requires a blue light co-activation and patterned illumination, ASAP3 uses a specialized 
ULOVE 2-photon microscopy technique, and Voltron is a chemigenetic indicator 
requiring dye injection before imaging119–121. SomArchon can be used to image large 
neuron populations, second only to Voltron, and is compatible with pulsed or constant 
blue light driven optogenetic actuation unlike the other sensors.  
In our experiments, we were able to collect a rich dataset regarding the spiking 
and subthreshold activity of hippocampal neurons. We found neurons with firing rates 
between 3-18Hz, which is consistent with previous literature describing place cells and 
interneurons in the hippocampus17,133,136. Using an optical voltage sensor enabled us to 
see the spatial location of each neuron and their proximity to one another. For this reason, 
we were also able to look at the Vmo-Vmo and spike-spike coherence between neuron pairs 
at varying distances. Because extracellular recordings cannot detect subthreshold 
membrane potentials and in vivo patch clamping is generally limited to one cell at a time, 
there is not existing literature to compare our results to. We did explore the phase-locking 




previous results17, we found that cell spiking was phase-locked to the ascending phase of 
the intracellular membrane potential. We did not observe phase precession between cell 
spiking and the LFP, but these differences are likely because our mice were not running 
and we did not restrict our recordings to place cells. 
The ability to optically monitor voltage in neuron populations will enable a vast 
number of new experiments. Possible future directions include, but are certainly not 
limited to the following: observing neural circuit spike patterns during different 
behaviors; looking at place cells in the hippocampus during navigation, and the spatial 
location of these place cells; identifying differences in neural activity between D1 and D2 
MSNs in the striatum; monitoring dendritic integration of synaptic inputs in proximal 
dendrites; identifying input/output relationships of neural activity using all optical 
electrophysiology; understanding how neural activity is altered or disrupted in disease 
states; identifying how the local field potential corresponds to individual neuron activity. 
In addition, there is still room for optimization of voltage indicators and 
acquisition setups. SomArchon still exhibits relatively low fluorescence levels which is 
why it is necessary to use relatively high laser excitation powers. To increase the power 
density, the excitation laser has to be focused into a spot around 150um in diameter 
which restricts the area being imaged. Finding a SomArchon variant with higher 
fluorescence levels would enable full field excitation with an LED. Furthermore, existing 
cameras are limited to a field of view around 125-150 µm in height due to the high, near 
kilohertz, acquisition rates. New cameras capable of full chip recording at kilohertz frame 




These improvements could lead to the simultaneous optical voltage recording in hundreds 
of neurons simultaneously. 
4.2.2 Toolbox of FingR Viruses 
The main benefits of the FingRs are that they are genetically encoded, label both 
excitatory and inhibitory synapses, and do no disrupt synaptic physiology. Our toolbox of 
new viral FingR variants will facilitate their use in a variety of different applications. 
Viral injection is a commonly used technique among neuroscience labs and enables the 
FingRs to be used in any brain region and in genetically defined cell types. The cre-
inducible FingRs can be paired with any of the hundreds of cre transgenic mouse lines, 
and the retrovirus variants can be used to track synaptic development in dividing cells 
such as adult born granule cells. Overall, these new FingR viruses make it much easier 
for neuroscientists to perform synaptic analysis of different brain regions and cell types 
or monitor synaptic development and plasticity. 
In future studies, the FingRs can be used in vivo for live monitoring of synaptic 
formation and elimination. Most current studies have only observed spine turnover with 
GFP or looked at excitatory and inhibitory synapses using exogenously overexpressed 
synaptic fusion proteins81,98,196. The number and density of synapses could potentially be 
more physiologically relevant using the FingRs rather than overexpressing synaptic 
fusion proteins152. Furthermore, in vivo studies of synapses have largely been restricted to 
a few cortical regions, leaving the opportunity for long term monitoring of synaptic 
density and plasticity in several other brain regions including hippocampus and striatum. 




experiments performed in acute or organotypic brain slices97,99. Furthermore, the FingRs 
could be used to study synaptic plasticity in different disease models. It has been 
previously shown that the number of synapses decreases in Alzheimer’s mouse models 
and that synaptic rewiring occurs in the striatum and motor cortex in PD93,196,197. The 
FingRs could be used to identify changes in excitatory or inhibitory synapses in specific 
cell types.  
Coupling the FingRs with a probe that marks the presynaptic terminal would 
allow for the identification for functional synapses and aid in connectivity mapping. In 
addition, the FingRs could be used as targeting sequences for other genetically encoded 
probes similar to the GFE3 tool which removes inhibitory synapses160. Furthermore, the 
FingRs could be co-expressed with existing tools, such as GCaMP or even SomArchon, 
to monitor dendritic activity while labeling synapses. This would yield novel insights into 
propagation of synaptic inputs through the dendrites and dendritic integration of these 
signals. There is still much to be understood about the billions of synaptic connections 







1. World Health Organization, Neurological Disorders: Public Health Challenges. 
(2006). Available at https://www.who.int/mental_health/neurology/neurodiso/en/ 
2. McGovern Institute for Brain Research, Brain Disorders: By The Numbers. 
McGovern Institute (2012). 
3. Abbott, A. Novartis to shut brain research facility: Drug giant redirects psychiatric 
efforts to genetics. Nature 480, 161–162 (2011). 
4. Carroll, J. Pfizer is axing its neurosciences division, laying off 300 and discarding 
new drugs. Endpoints News (2018). Available at: https://endpts.com/pfizer-is-
axing-its-neurosciences-division-laying-off-300-and-discarding-new-drugs/.  
5. OpenStax, Anatomy & Physiology. (OpenStax CNX, 2016). 
6. Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. & Prasher, D. Green fluorescent 
protein as a marker for gene expression. Science 263, 802–805 (1994). 
7. Chow, B. Y. et al. High-performance genetically targetable optical neural silencing 
by light-driven proton pumps. Nature 463, 98–102 (2010). 
8. Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G. & Deisseroth, K. Millisecond-
timescale, genetically targeted optical control of neural activity. Nature 
Neuroscience 8, 1263–1268 (2005). 
9. Chen, T.-W. et al. Ultrasensitive fluorescent proteins for imaging neuronal 
activity. Nature 499, 295–300 (2013). 
10. Livet, J. et al. Transgenic strategies for combinatorial expression of fluorescent 
proteins in the nervous system. Nature 450, 56–62 (2007). 
11. Bernstein, J. Untersuchungen zur Thermodynamik der bioelektrischen Ströme I. 
Pflügers Archiv für die Gesamte Physiologie 92, 521–562 (1902). 
12. Gasser, H. The classification of nerve fibers. Ohio Journal of Science. 41, 145–159 
(1941). 
13. Marmont, G. Studies on the axon membrane. I. A new method. Journal of Cellular 
and Comparative Physiology 34, 351–382 (1949). 
14. Hodgkin, A. & Huxley, A. A quantitative description of membrane current and its 





15. Segev, A., Garcia-Oscos, F. & Kourrich, S. Whole-cell Patch-clamp Recordings in 
Brain Slices. JoVE: Journal of Visualized Experiements e54024 (2016). 
doi:doi:10.3791/54024 
16. Kodandaramaiah, S. B., Franzesi, G. T., Chow, B. Y., Boyden, E. S. & Forest, C. 
R. Automated whole-cell patch-clamp electrophysiology of neurons in vivo. 
Nature Methods 9, 585–587 (2012). 
17. Harvey, C. D., Collman, F., Dombeck, D. A. & Tank, D. W. Intracellular 
dynamics of hippocampal place cells during virtual navigation. Nature 461, 941–
946 (2009). 
18. Huang, Z. in Signal Processing in Neuroscience (ed. Li, X.) 1–10 (Springer 
Singapore, 2016). doi:10.1007/978-981-10-1822-0_1 
19. Lewicki, M. S. A review of methods for spike sorting: the detection and 
classification of neural action potentials. Network Computation in Neural Systems. 
9(4), R53–R78 (1998). 
20. Mitzdorf, U. Properties of the evoked potential generators: current source-density 
analysis of visually evoked potentials in the cat cortex. International Journal of 
Neuroscience 33, 33–59 (1987). 
21. Baird, G., Zacharias, D. & Tsien, R. Circular permutation and receptor insertion 
within green fluorescent proteins. Proceedings of the National Academy of 
Sciences of the United States of America 96, 11241–11246 (1999). 
22. Nakai, J., Ohkura, M. & Imoto, K. A high signal-to-noise Ca 2 + probe composed 
of a single green fluorescent protein. Nature Biotechnology 3, 137–141 (2001). 
23. Peterka, D. S., Takahashi, H. & Yuste, R. Imaging Voltage in Neurons. Neuron 69, 
9–21 (2011). 
24. Tsien, R. Y. New Calcium Indicators and Buffers with High Selectivity Against 
Magnesium and Protons: Design, Synthesis, and Properties of Prototype 
Structures. Biochemistry 19, 2396–2404 (1980). 
25. Tsien, R. Y., Pozzan, T. & Rink, T. J. T-cell mitogens cause early changes in 
cytoplasmic free Ca2+and membrane potential in lymphocytes. Nature 295, 68–71 
(1982). 
26. Rochefort, N. L. et al. Sparsification of neuronal activity in the visual cortex at 
eye-opening. Proceedings of the National Academy of Sciences of the United 




27. Stosiek, C., Garaschuk, O., Holthoff, K. & Konnerth, A. In vivo two-photon 
calcium imaging of neuronal networks. Proceedings of the National Academy of 
Sciences of the United States of America 100, 7319–7324 (2003). 
28. Andermann, M., Kerlin, A. & Reid, R. Chronic cellular imaging of mouse visual 
cortex during operant behavior and passive viewing. Frontiers in Cellular 
Neuroscience 4, (2010). 
29. Grienberger, C. & Konnerth, A. Imaging Calcium in Neurons. Neuron 73, 862–
885 (2012). 
30. Miyawaki,  a et al. Fluorescent indicators for Ca2+ based on green fluorescent 
proteins and calmodulin. Nature 388, 882–887 (1997). 
31. Akerboom, J. et al. Optimization of a GCaMP calcium indicator for neural activity 
imaging. Journal of Neuroscience 32, 13819–40 (2012). 
32. Tian, L. et al. Imaging neural activity in worms, flies and mice with improved 
GCaMP calcium indicators. Nature Methods 6, 875–81 (2009). 
33. Tallini, Y. N. et al. Imaging cellular signals in the heart in vivo : Cardiac 
expression of the high-signal Ca 2 ؉ indicator GCaMP2. Proceedings of the 
National Academy of Sciences of the United States of America 103, 4753–4758 
(2006). 
34. Mohammed, A. I. et al. An integrative approach for analyzing hundreds of neurons 
in task performing mice using wide-field calcium imaging. Scientific Reports 6, 
20986 (2016). 
35. Cichon, J. & Gan, W.-B. Branch-specific dendritic Ca2+ spikes cause persistent 
synaptic plasticity. Nature 520, 180–185 (2015). 
36. Hansen, K. R. et al. Mild Blast Injury Produces Acute Changes in Basal 
Intracellular Calcium Levels and Activity Patterns in Mouse Hippocampal 
Neurons. Journal of Neurotrauma 1536, neu.2017.5029 (2018). 
37. Madisen, L. et al. Transgenic mice for intersectional targeting of neural sensors 
and effectors with high specificity and performance. Neuron 85, 942–958 (2015). 
38. Cruz-Martín, A. et al. A dedicated circuit links direction-selective retinal ganglion 
cells to the primary visual cortex. Nature 507, 358–361 (2014). 
39. Dana, H. et al. Sensitive red protein calcium indicators for imaging neural activity. 





40. Wu, J. et al. A long Stokes shift red fluorescent Ca2+indicator protein for two-
photon and ratiometric imaging. Nature Communications 5, (2014). 
41. Qian, Y. et al. A genetically encoded near-infrared fluorescent calcium ion 
indicator. Nature Methods In press, (2019). 
42. Inoue, M. et al. Rational design of a high-affinity, fast, red calcium indicator R-
CaMP2. Nature Methods 12, 64–70 (2014). 
43. Dana, H. et al. High-performance GFP-based calcium indicators for imaging 
activity in neuronal populations and microcompartments. bioRxiv 434589 (2018). 
doi:10.1101/434589 
44. Cohen, L., Keynes, R. & Hille, B. Light Scattering and birefringence changes 
during nerve activity. Nature 218, 438–441 (1968). 
45. Grinvald, A., Salzberg, B. & Cohen, L. Simultaneous recording from several 
neurones in an invertebrate central nervous system. Nature 268(5616), 140–142 
(1977). 
46. Ross, W., Salzberg, B., Cohen, L. & Davila, H. A large change in dye absorption 
during the action potential. Biophysical Journal 14, 983–986 (1974). 
47. Kuhn, B., Denk, W. & Bruno, R. M. In vivo two-photon voltage-sensitive dye 
imaging reveals top-down control of cortical layers 1 and 2 during wakefulness. 
Proceedings of the National Academy of Sciences of the United States of America  
105, 7588–7593 (2008). 
48. Siegel, M. & Isacoff, E. A genetically encoded optical probe of membrane voltage. 
Neuron 19, 735–741 (1997). 
49. Ataka, K. & Pieribone, V. A. A genetically targetable fluorescent probe of channel 
gating with rapid kinetics. Biophysical Journal 82, 509–516 (2002). 
50. Sakai, R., Repunte-canonigo, V., Raj, C. D. & Kno, T. Design and characterization 
of a DNA-encoded , voltage- sensitive fluorescent protein. European Journal of 
Neuroscience 13, 2314–2318 (2001). 
51. Baker, B. J. et al. Three fluorescent protein voltage sensors exhibit low plasma 
membrane expression in mammalian cells. Journal of Neuroscience Methods 161, 
32–38 (2007). 
52. Murata, Y., Iwasaki, H., Sasaki, M., Inaba, K. & Okamura, Y. Phosphoinositide 





53. Lundby, A., Mutoh, H., Dimitrov, D., Akemann, W. & Knöpfel, T. Engineering of 
a genetically encodable fluorescent voltage sensor exploiting fast Ci-VSP voltage-
sensing movements. PLoS One 3, 1–5 (2008). 
54. Jin, L. et al. Single Action Potentials and Subthreshold Electrical Events Imaged in 
Neurons with a Fluorescent Protein Voltage Probe. Neuron 75, 779–785 (2012). 
55. Dimitrov, D. et al. Engineering and characterization of an enhanced fluorescent 
protein voltage sensor. PLoS One 2, 2–6 (2007). 
56. Akemann, W. et al. Imaging neural circuit dynamics with a voltage-sensitive 
fluorescent protein. Journal of Neurophysiology 108, 2323–2337 (2012). 
57. St-Pierre, F. et al. High-fidelity optical reporting of neuronal electrical activity 
with an ultrafast fluorescent voltage sensor. Nature Neuroscience 17, 884–9 
(2014). 
58. Chanda, B. et al. A hybrid approach to measuring electrical activity in genetically 
specified neurons. Nature Neuroscience 8, 1619–1626 (2005). 
59. Wang, D., Zhang, Z., Chanda, B. & Jackson, M. B. Improved probes for hybrid 
voltage sensor imaging. Biophysical Journal 99, 2355–2365 (2010). 
60. Wang, D., McMahon, S., Zhang, Z. & Jackson, M. B. Hybrid voltage sensor 
imaging of electrical activity from neurons in hippocampal slices from transgenic 
mice. Journal of Neurophysiology 108, 3147–3160 (2012). 
61. Kralj, J. M., Hochbaum, D. R., Douglass, A. D. & Cohen, A. E. Electrical spiking 
in Escherichia coli probed with a fluorescent voltage-indicating protein. Science 
333, 345–348 (2011). 
62. Kralj, J. M., Douglass, A. D., Hochbaum, D. R., MacLaurin, D. & Cohen, A. E. 
Optical recording of action potentials in mammalian neurons using a microbial 
rhodopsin. Nature Methods 9, 90–95 (2012). 
63. Hochbaum, D. R. et al. All-optical electrophysiology in mammalian neurons using 
engineered microbial rhodopsins. Nature Methods 11, 825–833 (2014). 
64. Piatkevich, K. D. et al. Publisher Correction: A robotic multidimensional directed 
evolution approach applied to fluorescent voltage reporters. Nature Chemical 
Biology (2018). doi:10.1038/s41589-018-0023-6 
65. Gong, Y. et al. High-speed recording of neural spikes in awake mice and flies with 





66. Gong, Y., Wagner, M. J., Li, J. Z. & Schnitzer, M. J. Imaging neural spiking in 
brain tissue using FRET-opsin protein voltage sensors. Nature Communications 5, 
1–11 (2014). 
67. Xu, Y., Zou, P. & Cohen, A. E. Voltage Imaging with Genetically Encoded 
Indicators. Current Opinion in Chemical Biology 39, 1–10 (2017). 
68. Storace, D. et al. Toward Better Genetically Encoded Sensors of Membrane 
Potential. Trends in Neurosciences 39, 277–289 (2016). 
69. Yang, H. H. H. et al. Subcellular Imaging of Voltage and Calcium Signals Reveals 
Neural Processing In Vivo. Cell 166, 245–257 (2016). 
70. Chamberland, S. et al. Fast two-photon imaging of subcellular voltage dynamics in 
neuronal tissue with genetically encoded indicators. Elife 6, 1–35 (2017). 
71. Lou, S. et al. Genetically Targeted All-Optical Electrophysiology with a 
Transgenic Cre-Dependent Optopatch Mouse. Journal of Neuroscience 36, 11059–
11073 (2016). 
72. Bohland, J. W. et al. A proposal for a coordinated effort for the determination of 
brainwide neuroanatomical connectivity in model organisms at a mesoscopic scale. 
PLoS Computational Biology 5, (2009). 
73. Osten, P. & Margrie, T. W. Mapping brain circuitry with a light microscope. 
Nature Methods 10, 515–523 (2013). 
74. Bennett, M. R. The early history of the synapse: From plato to sherrington. Brain 
Research Bulletin 50, 95–118 (1999). 
75. Golgi, C. Nervosa, Sulla fina anatomia degli organi centrali del istema. Milano 
(1886). 
76. Golgi, C. Sur l’anatomie microscopique des organes centraux du systeme nerveux. 
Archives Italiennes Biologie. (1886). 
77. Cajal, R. Histology of the nervous system of man and vertebrates. (Oxford 
University Press). 
78. Robertson, J. Ultrastructure of two invertebrate synapses. Proceedings of the 
Society for Experimental Biology and Medicine 82(2), 219–223 (1953). 
79. Gray, E. G. Axo-somatic and axo-dendritic synapses of the cerebral cortex. 





80. Combs, C. A. Fluorescence microscopy: A concise guide to current imaging 
methods. Current Protocols in Neuroscience 79, 2.1.1–2.1.25, (2017). doi: 
10.1002/cpns.29 
81. Chen, J. L. et al. Clustered Dynamics of Inhibitory Synapses and Dendritic Spines 
in the Adult Neocortex. Neuron 74, 361–373 (2012). 
82. Cane, M., Maco, B., Knott, G. & Holtmaat, A. The Relationship between PSD-95 
Clustering and Spine Stability In Vivo. Journal of Neuroscience 34, 2075–2086 
(2014). 
83. F. Chen, P.W. Tillberg, E. S. B. Expansion microscopy. Science 347, 543–548 
(2015). 
84. Tillberg, P. W. et al. Protein-retention expansion microscopy of cells and tissues 
labeled using standard fluorescent proteins and antibodies. Nature Biotechnology 
34, 1–9 (2016). 
85. Chozinski, T. J. et al. Expansion microscopy with conventional antibodies and 
fluorescent proteins. Nature Methods 13, 1–7 (2016). 
86. Coons, A., Creech, H., Jones, R. & Berliner, E. Demonstration of pneumoccocal 
antigen in tissues by use of fluorescent antibody. Journal of Immunology 45, 159–
170 (1942). 
87. Nakane, P. K. Simultaneous Localization of Multiple Tissue Antigens Using the 
Peroxidase-Labeled Antibody Method: A Study On Pituitary Glands of the Rat. 
Journal of Histochemistry and Cytochemistry 16, (1968). 
88. Köhler, G. & Milstein, C. Continuous cultures of fused cells secreting antibody of 
predefined specificity. Nature 256, 495–497 (1975). 
89. Bayés, A. & Grant, S. G. N. Neuroproteomics: Understanding the molecular 
organization and complexity of the brain. Nature Reviews. Neuroscience 10, 635–
646 (2009). 
90. Collins, M. O. et al. Molecular characterization and comparison of the components 
and multiprotein complexes in the postsynaptic proteome. Journal of 
Neurochemistry 97 Suppl 1, 16–23 (2006). 
91. Micheva, K. D. & Smith, S. J. Array Tomography : A New Tool for Imaging the 






92. van Praag, H. et al. Functional neurogenesis in the adult hippocampus. Nature 415, 
1030–1034 (2002). 
93. Day, M. et al. Selective elimination of glutamatergic synapses on striatopallidal 
neurons in Parkinson disease models. Nature Neuroscience 9, 251–259 (2006). 
94. Klug, J. R. et al. Differential inputs to striatal cholinergic and parvalbumin 
interneurons imply functional distinctions. Elife 7, 1–25 (2018). 
95. Chen, S. X., Kim, A. N., Peters, A. J. & Komiyama, T. Subtype-specific plasticity 
of inhibitory circuits in motor cortex during motor learning. Nature Neuroscience 
18, 1109–1115 (2015). 
96. El-Husseini, A., Schnell, E. & Chetkovich, D. PSD-95 involvement in maturation 
of excitatory synapses. Science 290, 1364–8 (2000). 
97. Bosch, M. et al. Structural and molecular remodeling of dendritic spine 
substructures during long-term potentiation. Neuron 82, 444–459 (2014). 
98. Villa, K. L. et al. Inhibitory Synapses Are Repeatedly Assembled and Removed at 
Persistent Sites In Vivo. Neuron 89, 756–769 (2016). 
99. Meyer, D., Bonhoeffer, T. & Scheuss, V. Balance and stability of synaptic 
structures during synaptic plasticity. Neuron 82, 430–443 (2014). 
100. Kim, J. et al. mGRASP enables mapping mammalian synaptic connectivity with 
light microscopy. Nature Methods 9, 96–102 (2011). 
101. Gross, G. G. et al. Recombinant probes for visualizing endogenous synaptic 
proteins in living neurons. Neuron 78, 971–85 (2013). 
102. Koide, S., Koide, A. & Lipovšek, D. Target-binding proteins based on the 10th 
human fibronectin type III domain (10Fn3). Methods in Enzymology 503, 135–56 
(2012). 
103. Kim, E. & Sheng, M. PDZ domain proteins of synapses. Nature Reviews. 
Neuroscience 5, 771–781 (2004). 
104. Lévi, S., Logan, S. M., Tovar, K. R. & Craig, A. M. Gephyrin is critical for 
glycine receptor clustering but not for the formation of functional GABAergic 
synapses in hippocampal neurons. Journal of Neuroscience 24, 207–217 (2004). 
105. Flytzanis, N. C. et al. Archaerhodopsin variants with enhanced voltage-sensitive 
fluorescence in mammalian and Caenorhabditis elegans neurons. Nature 




106. Zou, P. et al. Bright and fast multicoloured voltage reporters via electrochromic 
FRET. Nature Communications 5, 1–10 (2014). 
107. Shemesh, O. A. et al. Temporally precise single-cell-resolution optogenetics. 
Nature Neuroscience 20, (2017). 
108. Baker, C. A., Elyada, Y. M., Parra-Martin, A. & Bolton, M. Cellular resolution 
circuit mapping in mouse brain with temporal-focused excitation of soma-targeted 
channelrhodopsin. Elife 5, 1–15 (2016). 
109. Daigle, T. L. et al. A Suite of Transgenic Driver and Reporter Mouse Lines with 
Enhanced Brain-Cell-Type Targeting and Functionality. Cell (2018). 
doi:10.1016/j.cell.2018.06.035 
110. Wu, C., Ivanova, E., Zhang, Y. & Pan, Z. H. rAAV-Mediated Subcellular 
Targeting of Optogenetic Tools in Retinal Ganglion Cells In Vivo. PLoS One 8, 1–
10 (2013). 
111. Barbera, G. et al. Spatially Compact Neural Clusters in the Dorsal Striatum 
Encode Locomotion Relevant Information. Neuron 92, 202–213 (2016). 
112. Cui, G. et al. Concurrent activation of striatal direct and indirect pathways during 
action initiation. Nature 494, 238–242 (2014). 
113. Klaus, A. et al. The Spatiotemporal Organization of the Striatum Encodes Action 
Space. Neuron 95, 1171–1180.e7 (2017). 
114. Garrido, Â. et al. Identification of an axonal determinant in the C-terminus of the 
sodium channel Na v 1 . 2. EMBO Journal 20, (2001). 
115. Garrido, J. J. et al. A targeting motif involved in sodium channel clustering at the 
axonal initial segment. Science 300, 2091–2094 (2003). 
116. Wu, C., Ivanova, E., Cui, J., Lu, Q. & Pan, Z.-H. Action Potential Generation at an 
Axon Initial Segment-Like Process in the Axonless Retinal AII Amacrine Cell. 
ournal of Neuroscience 31(41), 14654–14659. (2011). 
doi:10.1523/JNEUROSCI.1861-11.2011 
117. Greenberg, K. P., Pham, A. & Werblin, F. S. Differential Targeting of Optical 
Neuromodulators to Ganglion Cell Soma and Dendrites Allows Dynamic Control 
of Center-Surround Antagonism. Neuron 69, 713–720 (2011). 
118. Zhang, X. & Bennett, V. Restriction of 480/270-kD ankyrin(G) to axon proximal 
segments requires multiple ankyrin(G)-specific domains. Journal of Cell Biology 




119. Adam, Y. et al. All-optical electrophysiology reveals brain-state dependent 
changes in hippocampal subthreshold dynamics and excitability. bioRxiv (2018). 
doi:10.1101/281618 
120. Chavarha, M. et al. Fast two-photon volumetric imaging of an improved voltage 
indicator reveals electrical activity in deeply located neurons in the awake brain. 
bioRxiv (2018). 
121. Abdelfattah, A. S. et al. Bright and photostable chemigenetic indicators for 
extended in vivo voltage imaging. bioRxiv (2018). 
122. Boyden, E. A history of optogenetics: the development of tools for controlling 
brain circuits with light. F1000 Biology Reports 3, 1–12 (2011). 
123. Klapoetke, N. C. et al. Independent optical excitation of distinct neural 
populations. Nature Methods 11, 338–46 (2014). 
124. Kravitz, A. V. & Kreitzer, A. C. Striatal Mechanisms Underlying Movement, 
Reinforcement, and Punishment. Physiology 27, 167–177 (2012). 
125. Jin, X., Tecuapetla, F. & Costa, R. M. Basal ganglia subcircuits distinctively 
encode the parsing and concatenation of action sequences. Nature Neuroscience 
17, 423–430 (2014). 
126. Jaeger, D., Gilman, S. & Wayne Aldridge, J. Neuronal activity in the striatum and 
pallidum of primates related to the execution of externally cued reaching 
movements. Brain Research 694, 111–127 (1995). 
127. Gardiner, T. W. & Nelson, R. J. Striatal neuronal activity during the initiation and 
execution of hand movements made in response to visual and vibratory cues. 
Experimental Brain Research 15–26 (1992). 
128. Carelli, R. M. & West, M. O. Representation of the body by single neurons in the 
dorsolateral striatum of the awake, unrestrained rat. Journal of Comparative 
Neurology 309, 231–249 (1991). 
129. Shi, L. H., Luo, F., Woodward, D. J. & Chang, J. Y. Neural responses in multiple 
basal ganglia regions during spontaneous and treadmill locomotion tasks in rats. 
Experimental Brain Research 157, 303–314 (2004). 
130. Koós, T. & Tepper, J. M. Inhibitory control of neostriatal projection neurons by 
GABAergic interneurons. Nature Neuroscience 2, 467–472 (1999). 
131. Kawaguchi, Y. Physiological, Morphological, and Histochemical Characterization 





132. Zhou, F. M., Wilson, C. J. & Dani, J. A. Cholinergic interneuron characteristics 
and nicotinic properties in the striatum. Journal of Neurobiology 53, 590–605 
(2002). 
133. Royer, S. et al. Control of timing, rate and bursts of hippocampal place cells by 
dendritic and somatic inhibition. Nature Neuroscience 15, 769–775 (2012). 
134. Colgin, L. L. Rhythms of the hippocampal network. Nature Reviews. Neuroscience 
17, 239–249 (2016). 
135. Buzsáki, G. Theta oscillations in the hippocampus. Neuron 33, 325–340 (2002). 
136. O’Keefe, J. & Recce, M. L. Phase relationship between hippocampal place units 
and the EEG theta rhythm. Hippocampus 3, 317–330 (1993). 
137. Moser, E. I., Kropff, E. & Moser, M.-B. Place Cells, Grid Cells, and the Brain’s 
Spatial Representation System. Annual Review of Neuroscience 31, 69–89 (2008). 
138. Lisman, J. E. & Idart, M. a. P. Oscillatory Subcycles phorylated with each 
quantum of released Informational input. Science 267, 1512–1515 (1995). 
139. Bittner, K. C. et al. Conjunctive input processing drives feature selectivity in 
hippocampal CA1 neurons. Nature Neuroscience 18, 1133–1142 (2015). 
140. Broicher, T. et al. Spike Phase Locking in CA1 Pyramidal Neurons Depends on 
Background Conductance and Firing Rate. Journal of Neuroscience. 32, 14374–
14388 (2012). 
141. Wilson, M. A. & McNaughton, B. L. Dynamics of the hippocampal ensemble code 
for space. Science 261, 1055–1058 (1993). 
142. Knierim, J. J., Kudrimoti, H. S. & McNaughton, B. L. Interactions Between 
Idiothetic Cues and External Landmarks in the Control of Place Cells and Head 
Direction Cells. Journal of Neurophysiology 80, 425–446 (1998). 
143. Eichenbaum, H., Wiener, S. I., Shapiro, M. L. & Cohen, N. J. The organization of 
spatial coding in the hippocampus: a study of neural ensemble activity. Journal of 
Neuroscience 9, 2764–2775 (1989). 
144. Deadwyler, S. a, Bunn, T. & Hampson, R. E. Hippocampal ensemble activity 
during spatial delayed-nonmatch-to-sample performance in rats. Journal of 




145. Singer, A. C. et al. Mesoscale-duration activated states gate spiking in response to 
fast rises in membrane voltage in the awake brain. Journal of Neurophysiology 
118, 1270–1291 (2017). 
146. Song, S., Sjostrom, P. J., Reigl, M., Nelson, S. & Chklovskii, D. B. Highly 
Nonrandom Features of Synaptic Connectivity in Local Cortical Circuits. PLoS 
Biology 3, (2005). 
147. Dombeck, D. A., Khabbaz, A. N., Collman, F., Adelman, T. L. & Tank, D. W. 
Imaging Large-Scale Neural Activity with Cellular Resolution in Awake, Mobile 
Mice. Neuron 56, 43–57 (2007). 
148. Sheng, M. & Hoogenraad, C. C. The Postsynaptic Architecture of Excitatory 
Synapses: A More Quantitative View. Annual Review of Biochemistry 76, 823–847 
(2007). 
149. Ryan, T. J. & Grant, S. G. N. The origin and evolution of synapses. Nature 
Reviews. Neuroscience. 10, 701–712 (2009). 
150. Watanabe, M. et al. Selective scarcity of NMDA receptor channel subunits in the 
stratum lucidum (mossy fibre‐recipient layer) of the mouse hippocampal CA3 
subfield. European Journal of Neuroscience 10, 478–487 (1998). 
151. Sjulson, L., Cassataro, D., DasGupta, S. & Miesenböck, G. Cell-Specific Targeting 
of Genetically Encoded Tools for Neuroscience. Annual Review of Genetics 50, 
571–594 (2016). 
152. Kwon, T. et al. Ultrastructural, Molecular and Functional Mapping of GABAergic 
Synapses on Dendritic Spines and Shafts of Neocortical Pyramidal Neurons. 
Cerebral Cortex 1–11 (2018). doi:10.1093/cercor/bhy143 
153. Specht, C. G. et al. Quantitative nanoscopy of inhibitory synapses: Counting 
gephyrin molecules and receptor binding sites. Neuron 79, 308–321 (2013). 
154. Fortin, D. a. et al. Live Imaging of Endogenous PSD-95 Using ENABLED: A 
Conditional Strategy to Fluorescently Label Endogenous Proteins. Journal of 
Neuroscience 34, 16698–712 (2014). 
155. Broadhead, M. J. et al. PSD95 nanoclusters are postsynaptic building blocks in 
hippocampus circuits. Scientific Reports 6, 24626 (2016). 






157. Masch, J.-M. et al. Robust nanoscopy of a synaptic protein in living mice by 
organic-fluorophore labeling. Proceedings of the National Academy of Sciences of 
the United States of America 115, 201807104 (2018). 
158. Macpherson, L. J. et al. Dynamic labelling of neural connections in multiple 
colours by trans-synaptic fluorescence complementation. Nature Communications 
6, 10024 (2015). 
159. Chen, Y. et al. Cell-type-specific labeling of synapses in vivo through synaptic 
tagging with recombination. Neuron 81, 280–293 (2014). 
160. Gross, G. G. et al. An E3-ligase-based method for ablating inhibitory synapses. 
Nature Methods 13, 673–678, (2016). doi:10.1038/nmeth.3894 
161. Kannan, M., Gross, G. G., Arnold, D. B. & Higley, M. J. Visual Deprivation 
During the Critical Period Enhances Layer 2/3 GABAergic Inhibition in Mouse 
V1. Journal of Neuroscience 36, 5914–5919 (2016). 
162. Son, J.-H. et al. Transgenic FingRs for Live Mapping of Synaptic Dynamics in 
Genetically-Defined Neurons. Scientific Reports 6, 18734 (2016). 
163. Sinnen, B. L. et al. Optogenetic Control of Synaptic Composition and Function. 
Neuron 93, 646–660.e5 (2017). 
164. Walker, A. S. et al. Distance-dependent gradient in NMDAR-driven spine calcium 
signals along tapering dendrites. Proceedings of the National Academy of Sciences 
of the United States of America  201607462 (2017). doi:10.1073/pnas.1607462114 
165. Cearley, C. N. & Wolfe, J. H. Transduction characteristics of adeno-associated 
virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. 
Molecular Therapy 13, 528–537 (2006). 
166. Foust, K. D. et al. Intravascular AAV9 preferentially targets neonatal neurons and 
adult astrocytes. Nature Biotechnology 27, 59–65 (2009). 
167. Zincarelli, C., Soltys, S., Rengo, G. & Rabinowitz, J. E. Analysis of AAV 
serotypes 1-9 mediated gene expression and tropism in mice after systemic 
injection. Molecular Therapy 16, 1073–1080 (2008). 
168. Megı́as, M., Emri, Z., Freund, T. . & Gulyás, A. . Total number and distribution of 
inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. 
Neuroscience 102, 527–540 (2001). 
169. Tepper, J. M., Abercrombie, E. D. & Bolam, J. P. Basal ganglia macrocircuits. 




170. Dani, A., Huang, B., Bergan, J., Dulac, C. & Zhuang, X. Superresolution Imaging 
of Chemical Synapses in the Brain. Neuron 68, 843–856 (2010). 
171. Gutierrez-Mecinas, M. et al. Immunostaining for Homer reveals the majority of 
excitatory synapses in laminae I-III of the mouse spinal dorsal horn. Neuroscience 
329, 171–181 (2016). 
172. Bindels, D. S. et al. mScarlet: a bright monomeric red fluorescent protein for 
cellular imaging. Nature Methods 14, 1–12 (2017). 
173. Shaner, N. C. et al. Improved monomeric red, orange and yellow fluorescent 
proteins derived from Discosoma sp. red fluorescent protein. Nature 
Biotechnology 22, 1567–1572 (2004). 
174. Lam, A. J. et al. Improving FRET dynamic range with bright green and red 
fluorescent proteins. Nature Methods 9, 1005–12 (2012). 
175. Zhao, C., Teng, E. M., Summers Jr., R. G., Ming, G. & Gage, F. H. Distinct 
Morphological Stages of Dentate Granule Neuron Maturation in the Adult Mouse 
Hippocampus. Journal of Neuroscience 26, 3–11 (2006). 
176. Toni, N. et al. Synapse formation on neurons born in the adult hippocampus. 
Nature Neuroscience 10, 727–734 (2007). 
177. Zhuo, J. M. et al. Young adult born neurons enhance hippocampal dependent 
performance via influences on bilateral networks. Elife 5, 25 (2016). 
178. Danielson, N. B. B. et al. Distinct Contribution of Adult-Born Hippocampal 
Granule Cells to Context Encoding. Neuron 90, 101–112 (2016). 
179. Nakashiba, T. et al. Young dentate granule cells mediate pattern separation, 
whereas old granule cells facilitate pattern completion. Cell 149, 188–201 (2012). 
180. Schmidt-Hieber, C., Jones, P. & Bischofberger, J. Enhanced synaptic plasticity in 
newly generated granule cells of the adult hippocampus. Nature 429, 184–187 
(2004). 
181. Ge, S., Yang, C. hao, Hsu, K. sen, Ming, G. li & Song, H. A Critical Period for 
Enhanced Synaptic Plasticity in Newly Generated Neurons of the Adult Brain. 
Neuron 54, 559–566 (2007). 
182. Toni, N. & Sultan, S. Synapse formation on adult-born hippocampal neurons. 
European Journal of Neuroscience 33, 1062–1068 (2011). 
183. Harris, K. M. & Kater, S. B. Dendritic Spines : Cellular Specializations. Annual 




184. Sultan, S. et al. Synaptic Integration of Adult-Born Hippocampal Neurons Is 
Locally Controlled by Astrocytes. Neuron 88, 957–972 (2015). 
185. Esposito, M. S. Neuronal Differentiation in the Adult Hippocampus Recapitulates 
Embryonic Development. Journal of Neuroscience 25, 10074–10086 (2005). 
186. Lim, S. A. O., Kang, U. J. & McGehee, D. S. Striatal cholinergic interneuron 
regulation and circuit effects. Frontiers in Synaptic Neuroscience 6, 1–23 (2014). 
187. Schnütgen, F. et al. A directional strategy for monitoring Cre-mediated 
recombination at the cellular level in the mouse. Nature Biotechnology 21, 562–
565 (2003). 
188. Gittis, A. H. et al. Rapid target-specific remodeling of fast-spiking inhibitory 
circuits after loss of dopamine. Neuron 71, 858–868 (2011). 
189. Gulyá, A. I., Megías, M., Emri, Z. & Freund, T. F. Total Number and Ratio of 
Excitatory and Inhibitory Synapses Converging onto Single Interneurons of 
Different Types in the CA1 Area of the Rat Hippocapus. Journal of Neuroscience 
19, 10082–10097 (1999). 
190. Ding, J. B., Guzman, J. N., Peterson, J. D., Goldberg, J. A. & Surmeier, D. J. 
Thalamic gating of corticostriatal signaling by cholinergic interneurons. Neuron 
67, 294–307 (2010). 
191. Sizemore, R. J. et al. Marked differences in the number and type of synapses 
innervating the somata and primary dendrites of midbrain dopaminergic neurons, 
striatal cholinergic interneurons, and striatal spiny projection neurons in the rat. 
Journal of Comparative Neurology 524, 1062–1080 (2016). 
192. Sizemore, R. J., Reynolds, J. N. J. & Oorschot, D. E. Number and type of synapses 
on the distal dendrite of a rat striatal cholinergic interneuron: A quantitative, 
ultrastructural study. Journal of Anatomy 217, 223–235 (2010). 
193. Keaveney, M. K. et al. A MicroRNA-Based Gene-Targeting Tool for Virally 
Labeling Interneurons in the Rodent Cortex. Cell Reports 24, 294–303 (2018). 
194. Gilbert, J. & Man, H. The X-Linked Autism Protein KIAA2022 / KIDLIA 
Regulates Neurite Outgrowth via N-Cadherin and ؉ -Catenin Signaling. eNeuro 3, 
1–17 (2016). 
195. Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. 





196. Guo, L. et al. Dynamic rewiring of neural circuits in the motor cortex in mouse 
models of Parkinson’s disease. Nature Neuroscience 18, 1299–1309 (2015). 
197. Hong, S. et al. Complement and microglia mediate early synapse loss in 
Alzheimer mouse models. Science 352, 712–716 (2016). 
 
 191 
CURRICULUM VITAE 
 192 
 
 
193 
